Submitted URL: http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102101ashp&r=9372293-f406&l=008-012&t=c
Effective URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idU...
Submission: On October 21 via api from US

Summary

This website contacted 91 IPs in 9 countries across 60 domains to perform 349 HTTP transactions. The main IP is 13.225.78.7, located in Seattle, United States and belongs to AMAZON-02 - Amazon.com, Inc., US. The main domain is www.reuters.com.
TLS certificate: Issued by Amazon on April 2nd 2019. Valid for: a year.
This is the only time www.reuters.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 1 65.220.57.119 701 (UUNET)
3 13.225.78.7 16509 (AMAZON-02)
12 143.204.101.92 16509 (AMAZON-02)
2 2600:9000:200... 16509 (AMAZON-02)
1 2600:9000:21f... 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
6 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 2a04:4e42:3::714 54113 (FASTLY)
1 2a00:1450:400... 15169 (GOOGLE)
1 54.217.204.244 16509 (AMAZON-02)
15 23.0.46.190 16625 (AKAMAI-AS)
1 143.204.99.83 16509 (AMAZON-02)
4 13.224.196.71 16509 (AMAZON-02)
10 104.18.135.13 13335 (CLOUDFLAR...)
2 147.75.85.99 54825 (PACKET)
3 2606:4700:20:... 13335 (CLOUDFLAR...)
3 2606:4700::68... 13335 (CLOUDFLAR...)
1 2600:9000:215... 16509 (AMAZON-02)
4 34.232.243.86 14618 (AMAZON-AES)
2 2a03:2880:f01... 32934 (FACEBOOK)
1 2600:9000:20e... 16509 (AMAZON-02)
1 147.75.85.119 54825 (PACKET)
1 2600:1f18:624... 14618 (AMAZON-AES)
1 35.174.78.7 14618 (AMAZON-AES)
1 2606:4700::68... 13335 (CLOUDFLAR...)
1 143.204.101.12 16509 (AMAZON-02)
2 5 23.43.115.95 20940 (AKAMAI-ASN1)
1 35.201.93.216 15169 (GOOGLE)
2 54.68.89.141 16509 (AMAZON-02)
2 2a03:2880:f11... 32934 (FACEBOOK)
2 2 2a00:1450:400... 15169 (GOOGLE)
2 2 2a00:1450:400... 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
8 2.18.235.93 16625 (AKAMAI-AS)
1 13.224.196.15 16509 (AMAZON-02)
1 66.81.204.228 40034 (CONFLUENC...)
6 23.62.140.165 16625 (AKAMAI-AS)
9 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
15 172.217.16.194 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
14 199.166.0.26 7415 (ADSAFE-1)
4 2a00:1450:400... 15169 (GOOGLE)
1 52.208.212.211 16509 (AMAZON-02)
1 2600:9000:215... 16509 (AMAZON-02)
1 54.172.119.91 14618 (AMAZON-AES)
1 2600:9000:20e... 16509 (AMAZON-02)
2 52.50.81.152 16509 (AMAZON-02)
3 143.204.101.94 16509 (AMAZON-02)
16 2.18.235.40 16625 (AKAMAI-AS)
1 2 63.215.202.157 25751 (VALUECLICK)
1 23.37.49.134 16625 (AKAMAI-AS)
3 2.21.37.179 20940 (AKAMAI-ASN1)
1 1 3.9.224.64 16509 (AMAZON-02)
8 152.195.39.46 15133 (EDGECAST)
1 1 50.19.213.168 14618 (AMAZON-AES)
1 52.216.205.29 16509 (AMAZON-02)
8 2600:9000:215... 16509 (AMAZON-02)
1 136.243.25.80 24940 (HETZNER-AS)
2 3.9.56.242 16509 (AMAZON-02)
1 13.225.78.60 16509 (AMAZON-02)
8 199.166.0.32 7415 (ADSAFE-1)
4 13.225.78.2 16509 (AMAZON-02)
1 3.224.94.188 14618 (AMAZON-AES)
1 216.58.205.230 15169 (GOOGLE)
1 2a02:26f0:6c0... 20940 (AKAMAI-ASN1)
1 5 2.18.232.7 16625 (AKAMAI-AS)
7 18.210.116.191 14618 (AMAZON-AES)
4 2a00:1450:400... 15169 (GOOGLE)
2 143.204.101.67 16509 (AMAZON-02)
1 34.239.9.60 14618 (AMAZON-AES)
30 104.244.36.20 7415 (ADSAFE-1)
3 2.18.232.109 16625 (AKAMAI-AS)
1 213.254.244.22 36062 (DOUBLE-VE...)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
3 172.217.18.98 15169 (GOOGLE)
2 213.254.244.11 36062 (DOUBLE-VE...)
2 2a00:1450:400... 15169 (GOOGLE)
4 143.204.101.26 16509 (AMAZON-02)
2 24 34.95.120.147 15169 (GOOGLE)
4 104.16.87.26 13335 (CLOUDFLAR...)
7 208.100.17.190 32748 (STEADFAST)
4 104.16.39.14 13335 (CLOUDFLAR...)
2 54.164.3.90 14618 (AMAZON-AES)
3 208.100.17.181 32748 (STEADFAST)
7 37.252.173.22 29990 (ASN-APPNEXUS)
2 208.100.17.173 32748 (STEADFAST)
7 72.251.249.14 29791 (VOXEL-DOT...)
1 185.64.189.112 62713 (AS-PUBMATIC)
1 185.86.138.78 201081 (SMARTADSE...)
1 18.196.104.43 16509 (AMAZON-02)
4 6 152.199.21.89 15133 (EDGECAST)
1 8.41.222.100 26120 (RHYTHMONE)
1 2600:9000:215... 16509 (AMAZON-02)
349 91
Apex Domain
Subdomains
Transfer
53 adsafeprotected.com
cdn.adsafeprotected.com
pixel.adsafeprotected.com
static.adsafeprotected.com
dt.adsafeprotected.com
355 KB
24 openx.net
carambola-d.openx.net
eu-u.openx.net
33across-d.openx.net
367 KB
19 doubleclick.net
stats.g.doubleclick.net
securepubads.g.doubleclick.net
ad.doubleclick.net
googleads4.g.doubleclick.net
295 KB
18 carambo.la
route.carambo.la
cdata.carambo.la
logging.carambo.la
inimage.carambo.la
analytics.carambo.la
xtr.carambo.la
media.carambo.la
239 KB
17 reuters.com
www.reuters.com
static.reuters.com
wireapi.reuters.com
599 KB
16 evidon.com
c.evidon.com
iabmap.evidon.com
60 KB
14 tynt.com
cdn.tynt.com
sc.tynt.com
ic.tynt.com
de.tynt.com
15 KB
14 media.net
contextual.media.net
cdneast2-xch.media.net
151 KB
11 s-onetag.com
get.s-onetag.com
beacon.s-onetag.com
dfp-gateway.s-onetag.com
onetag-geo.s-onetag.com
24 KB
10 moatads.com
z.moatads.com
geo.moatads.com
px.moatads.com
399 KB
10 dianomi.com
www.dianomi.com
24 KB
9 googlesyndication.com
pagead2.googlesyndication.com
tpc.googlesyndication.com
ade.googlesyndication.com
71 KB
8 33across.com
cdn-sic.33across.com
sic.33across.com
ssc.33across.com
258 KB
8 moatpixel.com
reutersdfpcw319687550988.s.moatpixel.com
3 KB
8 teads.tv
a.teads.tv
t.teads.tv
sync.teads.tv
187 KB
8 brid.tv
services.brid.tv
p.brid.tv
stats-dev.brid.tv
92 KB
7 lijit.com
ap.lijit.com
40 KB
7 adnxs.com
ib.adnxs.com
5 KB
6 advertising.com
adserver-us.adtech.advertising.com
1 KB
6 doubleverify.com
cdn.doubleverify.com
cdn3.doubleverify.com
tps40.doubleverify.com
tps20228.doubleverify.com
72 KB
6 googletagservices.com
www.googletagservices.com
159 KB
6 google-analytics.com
www.google-analytics.com
64 KB
5 google.de
www.google.de
adservice.google.de
1 KB
5 google.com
www.google.com
adservice.google.com
1 KB
5 scorecardresearch.com
sb.scorecardresearch.com
3 KB
4 adlightning.com
tagan.adlightning.com
79 KB
4 googleapis.com
fonts.googleapis.com
4 KB
4 reutersmedia.net
s1.reutersmedia.net
s2.reutersmedia.net
static.reutersmedia.net
136 KB
4 betrad.com
l.betrad.com
480 B
3 mediaplex.com
altfarm.mediaplex.com
secure.img-cdn.mediaplex.com
img.mediaplex.com
5 KB
3 demdex.net
dpm.demdex.net
reuters.demdex.net
5 KB
3 consensu.org
vendorlist.consensu.org
evidon.mgr.consensu.org
cmp.teads.mgr.consensu.org
17 KB
3 tinypass.com
experience.tinypass.com
cdn.tinypass.com
118 KB
3 tru.am
tru.am
beacon.tru.am
13 KB
3 hotjar.com
static.hotjar.com
script.hotjar.com
vars.hotjar.com
76 KB
3 chartbeat.com
static.chartbeat.com
mab.chartbeat.com
31 KB
2 gstatic.com
fonts.gstatic.com
20 KB
2 2mdn.net
gcdn.2mdn.net
r4---sn-4g5e6nz7.c.2mdn.net
2 MB
2 facebook.com
www.facebook.com
347 B
2 segment.io
api.segment.io
282 B
2 facebook.net
connect.facebook.net
88 KB
2 reuters.tv
queso-cdn.prod.reuters.tv
sope.prod.reuters.tv
26 KB
1 1rx.io
tag.1rx.io
270 B
1 emxdgt.com
hb.emxdgt.com
307 B
1 smartadserver.com
prg.smartadserver.com
1 KB
1 pubmatic.com
hbopenbid.pubmatic.com
116 B
1 utoumine.net
utoumine.net
422 B
1 amazonaws.com
s3.amazonaws.com
2 KB
1 pixel.watch
pixel.watch
322 B
1 chartbeat.net
ping.chartbeat.net
168 B
1 mnet-ad.net
s.mnet-ad.net
356 B
1 globalwebindex.net
gwiqcdn.globalwebindex.net
15 KB
1 native.ai
cdn.native.ai
43 KB
1 cloudflare.com
cdnjs.cloudflare.com
2 KB
1 segment.com
cdn.segment.com
71 KB
1 admantx.com
async01.admantx.com
378 B
1 ytimg.com
s.ytimg.com
9 KB
1 youtube.com
www.youtube.com
1 KB
1 googletagmanager.com
www.googletagmanager.com
74 KB
1 bulletinhealthcare.com
mailview.bulletinhealthcare.com
439 B
349 60
Domain Requested by
30 dt.adsafeprotected.com
15 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.reuters.com
tagan.adlightning.com
15 c.evidon.com static.reuters.com
c.evidon.com
secure.img-cdn.mediaplex.com
www.reuters.com
14 pixel.adsafeprotected.com cdn.adsafeprotected.com
www.reuters.com
12 33across-d.openx.net tagan.adlightning.com
33across-d.openx.net
10 www.dianomi.com static.reuters.com
www.dianomi.com
www.reuters.com
10 static.reuters.com www.reuters.com
8 eu-u.openx.net 1 redirects tagan.adlightning.com
8 reutersdfpcw319687550988.s.moatpixel.com
8 static.adsafeprotected.com pixel.adsafeprotected.com
www.reuters.com
8 dfp-gateway.s-onetag.com get.s-onetag.com
8 contextual.media.net static.reuters.com
contextual.media.net
www.reuters.com
7 ap.lijit.com www.reuters.com
ap.lijit.com
7 ib.adnxs.com tagan.adlightning.com
www.reuters.com
7 ic.tynt.com
7 analytics.carambo.la cdata.carambo.la
6 adserver-us.adtech.advertising.com 4 redirects
6 www.googletagservices.com contextual.media.net
securepubads.g.doubleclick.net
6 cdneast2-xch.media.net www.reuters.com
6 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
www.reuters.com
5 sb.scorecardresearch.com 2 redirects www.reuters.com
4 cdn-sic.33across.com tagan.adlightning.com
4 carambola-d.openx.net 1 redirects cdata.carambo.la
www.reuters.com
4 tagan.adlightning.com cdata.carambo.la
4 fonts.googleapis.com cdata.carambo.la
4 stats-dev.brid.tv www.reuters.com
4 px.moatads.com
4 cdata.carambo.la www.reuters.com
cdata.carambo.la
4 z.moatads.com securepubads.g.doubleclick.net
4 tpc.googlesyndication.com securepubads.g.doubleclick.net
tagan.adlightning.com
4 l.betrad.com www.reuters.com
4 wireapi.reuters.com static.reuters.com
3 de.tynt.com cdn.tynt.com
3 media.carambo.la www.reuters.com
3 t.teads.tv
3 a.teads.tv www.reuters.com
a.teads.tv
3 services.brid.tv securepubads.g.doubleclick.net
services.brid.tv
3 pagead2.googlesyndication.com securepubads.g.doubleclick.net
3 adservice.google.com www.googletagservices.com
tagan.adlightning.com
3 adservice.google.de www.googletagservices.com
tagan.adlightning.com
3 www.reuters.com static.reuters.com
www.googletagmanager.com
2 ssc.33across.com cdn-sic.33across.com
2 sic.33across.com tagan.adlightning.com
2 sc.tynt.com tagan.adlightning.com
2 cdn.tynt.com tagan.adlightning.com
2 fonts.gstatic.com cdata.carambo.la
2 tps20228.doubleverify.com cdn.doubleverify.com
2 ade.googlesyndication.com
2 sync.teads.tv 1 redirects a.teads.tv
2 cdn.doubleverify.com secure.img-cdn.mediaplex.com
www.reuters.com
2 static.reutersmedia.net cdata.carambo.la
2 geo.moatads.com z.moatads.com
2 reuters.demdex.net www.reuters.com
2 www.google.de www.reuters.com
2 www.google.com 2 redirects
2 stats.g.doubleclick.net 2 redirects
2 www.facebook.com www.reuters.com
www.googletagmanager.com
2 api.segment.io cdn.segment.com
2 connect.facebook.net cdn.segment.com
connect.facebook.net
2 experience.tinypass.com www.reuters.com
cdn.tinypass.com
2 tru.am www.googletagmanager.com
tru.am
2 static.chartbeat.com www.reuters.com
1 onetag-geo.s-onetag.com beacon.s-onetag.com
1 tag.1rx.io www.reuters.com
1 hb.emxdgt.com www.reuters.com
1 prg.smartadserver.com www.reuters.com
1 hbopenbid.pubmatic.com www.reuters.com
1 googleads4.g.doubleclick.net
1 r4---sn-4g5e6nz7.c.2mdn.net
1 gcdn.2mdn.net 1 redirects
1 tps40.doubleverify.com cdn.doubleverify.com
1 cdn3.doubleverify.com cdn.doubleverify.com
1 img.mediaplex.com secure.img-cdn.mediaplex.com
1 xtr.carambo.la cdata.carambo.la
1 cmp.teads.mgr.consensu.org a.teads.tv
1 ad.doubleclick.net services.brid.tv
1 inimage.carambo.la cdata.carambo.la
1 logging.carambo.la cdata.carambo.la
1 p.brid.tv services.brid.tv
1 utoumine.net
1 s3.amazonaws.com www.reuters.com
1 pixel.watch 1 redirects
1 route.carambo.la 1 redirects
1 secure.img-cdn.mediaplex.com www.reuters.com
1 altfarm.mediaplex.com 1 redirects
1 s2.reutersmedia.net
1 beacon.s-onetag.com get.s-onetag.com
1 ping.chartbeat.net
1 get.s-onetag.com www.googletagmanager.com
1 dpm.demdex.net www.reuters.com
1 s.mnet-ad.net www.reuters.com
1 cdn.adsafeprotected.com contextual.media.net
1 s1.reutersmedia.net www.reuters.com
1 gwiqcdn.globalwebindex.net www.reuters.com
1 beacon.tru.am tru.am
1 cdn.native.ai www.reuters.com
1 cdn.tinypass.com experience.tinypass.com
1 cdnjs.cloudflare.com www.dianomi.com
1 vars.hotjar.com static.hotjar.com
1 evidon.mgr.consensu.org c.evidon.com
1 sope.prod.reuters.tv static.reuters.com
1 script.hotjar.com static.hotjar.com
1 vendorlist.consensu.org c.evidon.com
1 iabmap.evidon.com c.evidon.com
1 static.hotjar.com www.googletagmanager.com
1 cdn.segment.com www.reuters.com
1 async01.admantx.com static.reuters.com
1 s.ytimg.com www.youtube.com
1 mab.chartbeat.com static.chartbeat.com
1 www.youtube.com www.reuters.com
1 www.googletagmanager.com www.reuters.com
1 queso-cdn.prod.reuters.tv www.reuters.com
1 mailview.bulletinhealthcare.com 1 redirects
349 113
Subject Issuer Validity Valid
www.reuters.com
Amazon
2019-04-02 -
2020-05-02
a year crt.sh
static.reuters.com
Amazon
2018-11-28 -
2019-12-28
a year crt.sh
*.chartbeat.com
Gandi Standard SSL CA 2
2019-04-10 -
2020-04-10
a year crt.sh
*.prod.reuters.tv
Amazon
2019-01-28 -
2020-02-28
a year crt.sh
*.google-analytics.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.google.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
f6.shared.global.fastly.net
GlobalSign CloudSSL CA - SHA256 - G3
2019-10-17 -
2020-08-07
10 months crt.sh
*.admantx.com
SSL.com RSA SSL subCA
2019-03-29 -
2021-06-25
2 years crt.sh
*.evidon.com
DigiCert ECC Secure Server CA
2019-02-01 -
2020-05-02
a year crt.sh
*.segment.com
DigiCert SHA2 Secure Server CA
2019-06-24 -
2020-07-01
a year crt.sh
wireapi.reuters.com
Amazon
2019-01-01 -
2020-02-01
a year crt.sh
ssl424245.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-30 -
2020-03-07
6 months crt.sh
static.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
ssl389962.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-09-11 -
2020-03-19
6 months crt.sh
*.tinypass.com
DigiCert SHA2 Secure Server CA
2019-01-31 -
2020-03-20
a year crt.sh
l.betrad.com
Go Daddy Secure Certificate Authority - G2
2019-04-25 -
2021-06-24
2 years crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA
2019-09-22 -
2019-12-20
3 months crt.sh
vendorlist.consensu.org
Amazon
2019-03-06 -
2020-04-06
a year crt.sh
script.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
evidon.mgr.consensu.org
Amazon
2019-08-22 -
2020-09-22
a year crt.sh
vars.hotjar.com
Let's Encrypt Authority X3
2019-10-06 -
2020-01-04
3 months crt.sh
ssl412106.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2
2019-08-10 -
2020-02-16
6 months crt.sh
cdn.native.ai
Amazon
2019-08-26 -
2020-09-26
a year crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA
2018-11-28 -
2019-12-26
a year crt.sh
*.globalwebindex.net
RapidSSL RSA CA 2018
2017-12-13 -
2020-12-19
3 years crt.sh
www.google.de
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.media.net
DigiCert SHA2 Secure Server CA
2018-12-30 -
2020-03-30
a year crt.sh
*.adsafeprotected.com
COMODO RSA Domain Validation Secure Server CA
2018-08-20 -
2020-09-17
2 years crt.sh
*.mnet-ad.net
Sectigo RSA Domain Validation Secure Server CA
2019-04-04 -
2020-04-15
a year crt.sh
*.g.doubleclick.net
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.demdex.net
DigiCert SHA2 High Assurance Server CA
2018-01-09 -
2021-02-12
3 years crt.sh
*.s-onetag.com
Amazon
2019-06-25 -
2020-07-25
a year crt.sh
*.chartbeat.net
Thawte RSA CA 2018
2018-12-20 -
2020-01-01
a year crt.sh
*.brid.tv
Go Daddy Secure Certificate Authority - G2
2019-01-02 -
2020-03-03
a year crt.sh
moatads.com
DigiCert ECC Secure Server CA
2018-11-10 -
2020-02-09
a year crt.sh
www.mediaplex.com
GeoTrust RSA CA 2018
2018-11-26 -
2020-02-25
a year crt.sh
teads.tv
Let's Encrypt Authority X3
2019-08-22 -
2019-11-20
3 months crt.sh
*.carambo.la
DigiCert SHA2 Secure Server CA
2019-02-21 -
2021-02-25
2 years crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2
2019-09-06 -
2020-12-02
a year crt.sh
utoumine.net
Let's Encrypt Authority X3
2019-09-05 -
2019-12-04
3 months crt.sh
*.moatads.com
DigiCert SHA2 Secure Server CA
2019-03-12 -
2021-06-10
2 years crt.sh
*.doubleclick.net
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
teads.mgr.consensu.org
Let's Encrypt Authority X3
2019-09-23 -
2019-12-22
3 months crt.sh
*.googleapis.com
GTS CA 1O1
2019-10-03 -
2019-12-26
3 months crt.sh
*.mediaplex.com
GlobalSign Organization Validation CA - SHA256 - G2
2019-02-04 -
2021-03-25
2 years crt.sh
*.doubleverify.com
DigiCert ECC Secure Server CA
2019-01-22 -
2020-01-22
a year crt.sh
*.c.docs.google.com
GTS CA 1O1
2019-10-10 -
2019-12-19
2 months crt.sh
*.adlightning.com
Amazon
2019-08-19 -
2020-09-19
a year crt.sh
*.openx.net
GeoTrust RSA CA 2018
2018-01-04 -
2020-07-09
3 years crt.sh
*.tynt.com
Sectigo RSA Domain Validation Secure Server CA
2019-10-01 -
2021-09-30
2 years crt.sh
*.33across.com
Sectigo RSA Domain Validation Secure Server CA
2019-10-01 -
2021-09-30
2 years crt.sh
*.adnxs.com
DigiCert ECC Secure Server CA
2019-01-23 -
2021-03-08
2 years crt.sh
*.lijit.com
Go Daddy Secure Certificate Authority - G2
2019-03-11 -
2020-05-10
a year crt.sh
*.pubmatic.com
Sectigo RSA Organization Validation Secure Server CA
2019-02-22 -
2021-02-21
2 years crt.sh
*.smartadserver.com
Thawte RSA CA 2018
2018-09-07 -
2020-02-17
a year crt.sh
*.emxdgt.com
Go Daddy Secure Certificate Authority - G2
2019-07-17 -
2020-07-17
a year crt.sh
*.adtech.advertising.com
DigiCert SHA2 High Assurance Server CA
2018-05-22 -
2020-05-26
2 years crt.sh
*.1rx.io
Sectigo RSA Domain Validation Secure Server CA
2019-06-28 -
2021-06-27
2 years crt.sh

This page contains 45 frames:

Primary Page: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Frame ID: ED691D490660CA55763938A9B84CD6E5
Requests: 193 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-74dcf4e32eff343c96838bf3a780ac1d.html
Frame ID: 853575565A7C9B1DBC330EB75F2F7E23
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
Frame ID: 7D67C2921E5880E94C8DECA75F04DD2D
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
Frame ID: C642A49C4A86F33FC1868A0CE218BBC5
Requests: 1 HTTP requests in this frame

Frame: https://www.dianomi.com/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
Frame ID: AA66965CD033F5F54D279E2A8EC3D8F5
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: FA5359C9E61A465D0C5AA873FFBE1F36
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=26&https=1&gdpr=1&gdprconsent=0
Frame ID: FF40189EF030C71918E1F87B9A412893
Requests: 1 HTTP requests in this frame

Frame: https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=101&https=1&gdpr=1&gdprconsent=0
Frame ID: DB1097221791A8E8E0A97F725F077700
Requests: 1 HTTP requests in this frame

Frame: https://reuters.demdex.net/dest5.html?d_nsid=0
Frame ID: 01AD5BECFEDD22BBEC8677B018C4C49D
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvJM04CBeS-SIkY0iY8pRPDPVJ8gaAowozAbBIliXkvuEieYg2EavLfiQi2U_a7cTdA7S8NCLN3OgseFxbYvnBa03ps1xb_AJI53M83F-2ddOMILxLXgix9Hee9Tcq8WQOmE6ZqVGqgp9t6nQUgAYpPB8gPcKTr8F2YfWlvY2o-BJHEyXaV-uiM0kH89Gr52lONlX6fkV44K6y5FZAGhe6ElYqAeQpOFqVhA7MvpfLjpq9QxUn9Zt1-ykjjEdS-MY6KNRr3mUPu5mUWznq1tFcXNzqTjaBBe80B7A&sai=AMfl-YSF-p-x75MkkdqgzVHKSZ3DaRnqmkbuPme7xYCpy1bE3hz7WxwJmOAGowM1AlQMMrtK0OWAdnvgNt87zNm5LiBHq85zcynI4g3O2rZylw&sig=Cg0ArKJSzBeD0lIDw2yNEAE&urlfix=1&adurl=
Frame ID: 66C32573759F2D1A6B59578EA0C83739
Requests: 17 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvk2g3_IEUAIdTbwh4R8oZ8Z4YnvMm82NtHbMdCj1jttEZEC_haKVKFej7omWZtaHiXAgnZqOzARzil8vDEAqXGs3kh8vHylihpJ9TO4aSKXgc6pilrsMU9ylODgY6yPh_uhSyPhC0cmVf3o1LLrtowRqZV7LY8qaePjmB9UHPL-bAUh8COg80_RIc9gTnJw-I10JJm5dE7o_UgrGHzZgls4E2usvhRtxOguFBuWWQ7jCX_H4OP_8THcwqtuq-jrxcrLfCxdaCgga1KaAV-7d10NiyEkgvF7mlvsQ&sai=AMfl-YTG-SCCffvlybwo2lEnp_l5ygP-wFZA_n3ZZQJ5mxpmG6vYQb6FmPZ0Mppq8t5il98T6TanXPmY1uKunbJ8omzFvDwDR57QrWsgixQB_w&sig=Cg0ArKJSzPxH4xZSZqVwEAE&urlfix=1&adurl=
Frame ID: 8321B1523C7F60B33A9001D35F2CFF70
Requests: 16 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss-FFUSCvRYoRuccgZzI1O6GHZSt9tlzZBMoSt6trvIDIwiZJGQYmJ_7TWsOpu_4crARV5XKlR3-lYMdkYSUoUtnOTFeCFGQSwYrF-eBP0TiqT-cIIiILnHBWwy-kvVg9eOlx5A9ltublOdebQ0u-nt22Llc_-jGxKDZnqJHCObHmsRAUS2tqgMY3DaHwd4it-qkgJ-SjhJmRfUaihbvMyUQ-pzlE5Ix4LM3v9U2WfQoUWNJM5jtlQ7m0dz-ZR7Ayx49ZbtKdS5pRTFC0hTijQL5_tuzlgjzDtu&sai=AMfl-YScTWA6cS-Urnq0SFnBi0ioOEKpi6UH0YJNvhfwwIPUvUAX1W8HCqq6e-ktSoeEf3hw4wqezBWC73M5hHsDbr1KdDjDR1GV8LbntXUMUA&sig=Cg0ArKJSzLvlW118wwj3EAE&urlfix=1&adurl=
Frame ID: 5A321A932FBE73860EB3A6ADA4F7CE29
Requests: 5 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html
Frame ID: 81AD14EF3FB193AB7706EBE8936E0FBE
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssNu1y6Koh18DwFz4bPl_kzwmStxPJ6AZkeCsCOjW1o_mIpIT-lNq5A8k2MwjDO-paTr9aky33ViMxfOOqR-Y8HM9qtcBV2rsOk1ZsZ00-usJu3vRUv8I4OWqbjzbYnQHq1fB18VVCfBv4SoV0uKCbvNso4U4muZi5Yelf_CTpquEHiJ5oUe59_bX31zbkbZ31xvkt_pg21WZ5xErfid1DLU0sLzNqbA-R3eje_E1yyfBhoX_rt4mh6TJEgypdT7fqpcGZNWgLSXmECOU79h2-d3VhdENk&sai=AMfl-YSBWkSuR_74pWAnNaDuEZ81BXQOvPCxNaI7lpecRtSSzOPpyZTjEcyVhJLaqXmbqTG5UzVl-uJ4KtdoLT11r3tIKQhhG6WZkaMldzEqFw&sig=Cg0ArKJSzMZmj9GNUo18EAE&urlfix=1&adurl=
Frame ID: E8C99D049D5102FF12201C8A43E130F4
Requests: 37 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=610609812&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=0a7a4091-f417-11e9-9767-00259086cc16
Frame ID: AB076A2DF62DC661410179EEF3417F04
Requests: 2 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=37592232&placementId=4741317042&pubCreative=138206523841&pubOrder=2107429564&cb=614615616&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=0a7add7e-f417-11e9-8240-00259086cc1c
Frame ID: E665831DAEA21B813398A05032FA0F74
Requests: 2 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1759352134&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=0a79cbab-f417-11e9-aea2-382c4ac63189
Frame ID: AF22FD6E9B43A3DE0811E0DCD0006A1D
Requests: 2 HTTP requests in this frame

Frame: https://cmp.teads.mgr.consensu.org/index.html
Frame ID: 760B4F85C96E63236546EA5A4F14460D
Requests: 1 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: 5299EA6F2DA8F7D00B0AC40A63C96C92
Requests: 1 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: 3D7D6393486788AECD4185199FD55258
Requests: 1 HTTP requests in this frame

Frame: https://img.mediaplex.com/content/0/2399/250799/is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250/index.html?mpt=785004098&mpssl=1&mpck=altfarm.mediaplex.com%2Fad%2Fck%2F2399-250799-36431-8%3Fmpt%3D785004098%26mpcr%3D102570365%26mpcrset%3Droot&mpvc=https%3A%2F%2Fadclick.g.doubleclick.net%2Fpcs%2Fclick%253Fxai%253DAKAOjsvNzdnP88lAyGnZgjMT44dqfnXsopY89_Mel7mNBCCXtNc9A6vRdQUVrQl4u8bkqkT9AwYOvfLeCnVH4Vt99OaLhNLoMq2tsmeyuosnKMQ6xDwzRdacmLwNH44hDNWBHs45kjypr7RCSbZE2-09ZCKuSRx0iTsmtuLlepg2czmffP-9JKiRPx_axcTBfLS_tEX9as_9qv2mkAVXXkn2uctFSfBqRGu1qOzw2yTuADrYPl4zQbxLV6zYxZyi4A0SxmmD1xaPPoFXklJbJwmFVUse55x_WBAbOw%2526sai%253DAMfl-YTSbcFd6i_Mk2hT1RrXEBgmsC-Co5lXn4WIN4mR-xFab9qd2SVppve5Yogs_tw4cIG17O5ZClCU0U5OZoKIoNKfM4zFDyiu6BamKERaGw%2526sig%253DCg0ArKJSzFZyrc-oxWemEAE%2526urlfix%253D1%2526adurl%253D
Frame ID: 2E399EDD6711F82C18C03CA367E133E3
Requests: 1 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: 06AAB4C2187C7BF66A0D53997D67DBEB
Requests: 1 HTTP requests in this frame

Frame: https://pixel.adsafeprotected.com/jload?anId=10764&campId=970x250&pubId=63378192&chanId=37592232&placementId=5158696277&pubCreative=138285704442&pubOrder=2594181822&cb=1046498820&custom=leaderboard&custom2=&custom3=0&adsafe_par&impId=0a797dd8-f417-11e9-8572-00259086cbca
Frame ID: 0C042223A59ECCB55EF74A2B883F3BFD
Requests: 2 HTTP requests in this frame

Frame: https://cdn.doubleverify.com/dv-measurements289.js
Frame ID: A38F57DC78D6FE8152E7E5D3521F36AA
Requests: 4 HTTP requests in this frame

Frame: https://sync.teads.tv/iframe/redirect?pid=78293&userId=03cd9682-f756-4641-8c5f-a96589861161&gdprIab=%7B%22status%22:23,%22consent%22:%22%22,%22reason%22:230%7D&env=js-web&1571671542300
Frame ID: 23D5470F1607486006029A2A294D33C6
Requests: 1 HTTP requests in this frame

Frame: https://cdn3.doubleverify.com/t2tv7.html
Frame ID: F375FBA92C91BBDDF8B97639A5763590
Requests: 1 HTTP requests in this frame

Frame: https://static.adsafeprotected.com/sca.17.4.95.js
Frame ID: 18452C678AF1ED8B217976AB07207969
Requests: 1 HTTP requests in this frame

Frame: https://tagan.adlightning.com/carambola/blacklist_script.js
Frame ID: F709E1AB200082216784143C3BBF3B90
Requests: 14 HTTP requests in this frame

Frame: https://tagan.adlightning.com/carambola/blacklist_script.js
Frame ID: 18D7F272FABD8391611C6B953FF76DA2
Requests: 4 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
Frame ID: F41579BBB0B4017999A2313550E8432A
Requests: 1 HTTP requests in this frame

Frame: https://cdn.tynt.com/siab.js?0xTPOWkJpE&_ADTIME_&$RANDOM&%%CACHEBUSTER%%&
Frame ID: 200D041875AB99BA569C3FA7A1C814C3
Requests: 12 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Frame ID: 0378AB771AEF55BA176C9418D5C28C66
Requests: 7 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 3E0221B5335B0C554D83C7F4F684A554
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 38F4688D6CA78BF6A4A7CB466D1B2E13
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: D1F7A6E6F06E5AC6E0610D3E9C47CD94
Requests: 2 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Frame ID: 351ED78F83F4EB20DDE5BE14B6C483AE
Requests: 7 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: 1481EDF11035E602CBDD245AF97C2325
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: C0B3CE5501A20AD7F9E8581AFD01B20F
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: 8EC39BCC8D4F2667E59BD5A806F41089
Requests: 1 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 3272B35E21C30FA843271FD7C2D6652D
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: C5A5251D0127FA56471C402C8D838583
Requests: 2 HTTP requests in this frame

Frame: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Frame ID: 80722B976267F4ED706A6EF2D06071CF
Requests: 2 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: 7C0D5FAAB8011EB1BB0BA93664F0F2C7
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: 1253720FE9EE54F026A9073ABB33FEC8
Requests: 1 HTTP requests in this frame

Frame: https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Frame ID: 151BCC5DA1265F94E8272DDE080EEC16
Requests: 1 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102101ashp&r=9372293-f406&l=008-012&t=c HTTP 302
    https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-ra... Page URL

Detected technologies

Overall confidence: 50%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i

Overall confidence: 100%
Detected patterns
  • headers via /\(CloudFront\)$/i

Overall confidence: 50%
Detected patterns
  • url /\.aspx?(?:$|\?)/i

Overall confidence: 100%
Detected patterns
  • headers via /\(CloudFront\)$/i

Overall confidence: 100%
Detected patterns
  • script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i

Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i

Overall confidence: 100%
Detected patterns
  • script /googlesyndication\.com\//i

Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i

Overall confidence: 100%
Detected patterns
  • html /<!-- (?:End )?Google Tag Manager -->/i

Overall confidence: 100%
Detected patterns
  • script /^\/\/static\.hotjar\.com\/c\/hotjar-/i

Overall confidence: 100%
Detected patterns
  • script /cdn\.segment\.com\/analytics\.js/i

Overall confidence: 100%
Detected patterns
  • html /<iframe[^>]* (?:id="comscore"|scr=[^>]+comscore)|\.scorecardresearch\.com\/beacon\.js|COMSCORE\.beacon/i
  • script /\.scorecardresearch\.com\/beacon\.js|COMSCORE\.beacon/i

Page Statistics

349
Requests

100 %
HTTPS

32 %
IPv6

60
Domains

113
Subdomains

91
IPs

9
Countries

6753 kB
Transfer

16128 kB
Size

8
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102101ashp&r=9372293-f406&l=008-012&t=c HTTP 302
    https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 67
  • https://sb.scorecardresearch.com/b?c1=2&c2=6035630&ns__t=1571671538806&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571671538806&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&c9=
Request Chain 71
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=950467070.1571671538&jid=628450960&gjid=1574010316&_gid=1164471696.1571671538&_u=aGDAiEAjR~&z=1418887512 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=628450960&_v=j79&z=1418887512 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=628450960&_v=j79&z=1418887512&slf_rd=1&random=2587628130
Request Chain 113
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=950467070.1571671538&jid=1701441820&gjid=844310375&_gid=1164471696.1571671538&_u=aGDAiEAjR~&z=72485287 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=1701441820&_v=j79&z=72485287 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=1701441820&_v=j79&z=72485287&slf_rd=1&random=3078290154
Request Chain 125
  • https://altfarm.mediaplex.com/ad/js/2399-250799-36431-8?mpt=785004098&mpvc=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsvNzdnP88lAyGnZgjMT44dqfnXsopY89_Mel7mNBCCXtNc9A6vRdQUVrQl4u8bkqkT9AwYOvfLeCnVH4Vt99OaLhNLoMq2tsmeyuosnKMQ6xDwzRdacmLwNH44hDNWBHs45kjypr7RCSbZE2-09ZCKuSRx0iTsmtuLlepg2czmffP-9JKiRPx_axcTBfLS_tEX9as_9qv2mkAVXXkn2uctFSfBqRGu1qOzw2yTuADrYPl4zQbxLV6zYxZyi4A0SxmmD1xaPPoFXklJbJwmFVUse55x_WBAbOw%2526sai%253DAMfl-YTSbcFd6i_Mk2hT1RrXEBgmsC-Co5lXn4WIN4mR-xFab9qd2SVppve5Yogs_tw4cIG17O5ZClCU0U5OZoKIoNKfM4zFDyiu6BamKERaGw%2526sig%253DCg0ArKJSzFZyrc-oxWemEAE%2526urlfix%253D1%2526adurl%253D HTTP 302
  • https://secure.img-cdn.mediaplex.com/content/0/2399/250799/is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250.js?mpck=altfarm.mediaplex.com%2Fad%2Fck%2F2399-250799-36431-8%3Fmpt%3D785004098%26mpcr%3D102570365%26mpcrset%3Droot&mpjs=c.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B%20cdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpjsp=https%3A%2F%2Fc.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B%20https%3A%2F%2Fcdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpt=785004098&mpqs=mpt%3D785004098&mpssl=1&mpvc=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsvNzdnP88lAyGnZgjMT44dqfnXsopY89_Mel7mNBCCXtNc9A6vRdQUVrQl4u8bkqkT9AwYOvfLeCnVH4Vt99OaLhNLoMq2tsmeyuosnKMQ6xDwzRdacmLwNH44hDNWBHs45kjypr7RCSbZE2-09ZCKuSRx0iTsmtuLlepg2czmffP-9JKiRPx_axcTBfLS_tEX9as_9qv2mkAVXXkn2uctFSfBqRGu1qOzw2yTuADrYPl4zQbxLV6zYxZyi4A0SxmmD1xaPPoFXklJbJwmFVUse55x_WBAbOw%2526sai%253DAMfl-YTSbcFd6i_Mk2hT1RrXEBgmsC-Co5lXn4WIN4mR-xFab9qd2SVppve5Yogs_tw4cIG17O5ZClCU0U5OZoKIoNKfM4zFDyiu6BamKERaGw%2526sig%253DCg0ArKJSzFZyrc-oxWemEAE%2526urlfix%253D1%2526adurl%253D
Request Chain 134
  • https://route.carambo.la/inimage/getlayer?pid=thms97&did=112441&wid=3&rdn=[RANDOM_NUMBER] HTTP 302
  • https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Request Chain 137
  • https://pixel.watch/q4m9 HTTP 302
  • https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
Request Chain 173
  • https://sb.scorecardresearch.com/p?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571671541888&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=89722632&cs_ucfr=1 HTTP 302
  • https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571671541888&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=89722632&cs_ucfr=1
Request Chain 217
  • https://sync.teads.tv/iframe?pid=78293&userId=03cd9682-f756-4641-8c5f-a96589861161&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&env=js-web&1571671542300 HTTP 302
  • https://sync.teads.tv/iframe/redirect?pid=78293&userId=03cd9682-f756-4641-8c5f-a96589861161&gdprIab=%7B%22status%22:23,%22consent%22:%22%22,%22reason%22:230%7D&env=js-web&1571671542300
Request Chain 224
  • https://gcdn.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/id,itag,source,ctier,acao,ip,ipbits,expire/signature/8B7A8A1C69C9F732DE398CB9822694E23BF26F51.313C9ACCFFAABC44E1BDD3BEDA9B426C2A2904DD/key/ck2/file/file.mp4 HTTP 302
  • https://r4---sn-4g5e6nz7.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/56CEFBCBBA99E0CC4E9BC2BE8BC30BD86488E2A3.701BB800280C951808BFB9858487B1B852F0FC2E/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5e6nz7/ms/onc/mt/1571671475/mv/m/mvi/3/pl/41/file/file.mp4
Request Chain 274
  • https://carambola-d.openx.net/w/1.0/acj?ai=df0c5bbb-566c-42f0-88d3-3411842b0dea&o=8241388711&callback=OX_8241388711&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&jr=&auid=540746705&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=300x250&ifr=1&tws=1600x1200&mt=1 HTTP 302
  • https://carambola-d.openx.net/w/1.0/acj?cc=1&ai=df0c5bbb-566c-42f0-88d3-3411842b0dea&o=8241388711&callback=OX_8241388711&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&jr=&auid=540746705&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=300x250&ifr=1&tws=1600x1200&mt=1
Request Chain 275
  • https://eu-u.openx.net/w/1.0/pd?plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb HTTP 302
  • https://eu-u.openx.net/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
Request Chain 352
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;v=2;cmd=bid;cors=yes;alias=203c0db755d142e;misc=1571671550590;bidfloor=0.05; HTTP 302
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;cfp=1;rndc=1571671549;v=2;cmd=bid;cors=yes;alias=203c0db755d142e;misc=1571671550590;bidfloor=0.05 HTTP 302
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;apid=1A105e1166-f417-11e9-9ab7-1222202f268e;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=203c0db755d142e;misc=1571671550590;bidfloor=0.05
Request Chain 353
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;v=2;cmd=bid;cors=yes;alias=21d520127a7074e;misc=1571671550590;bidfloor=0.05; HTTP 302
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=21d520127a7074e;misc=1571671550590;bidfloor=0.05 HTTP 302
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;apid=1A105e1904-f417-11e9-9a7d-12e614795296;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=21d520127a7074e;misc=1571671550590;bidfloor=0.05

349 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
www.reuters.com/article/us-alexion-pharms-fda/
Redirect Chain
  • http://mailview.bulletinhealthcare.com/mailview.aspx?m=2019102101ashp&r=9372293-f406&l=008-012&t=c
  • https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
198 KB
53 KB
Document
General
Full URL
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.7 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-7.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
965d326c8b62c0011e4f2320e8dcf087a9b503c1369cec43519aedd706e5bb45

Request headers

:method
GET
:authority
www.reuters.com
:scheme
https
:path
/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
none
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
content-type
text/html;charset=UTF-8
access-control-allow-headers
Access-Control-Allow-Origin,charset
access-control-allow-origin
http://admin.reuters.com
channel-name
healthNews
content-encoding
gzip
date
Mon, 21 Oct 2019 15:25:38 GMT
expires
Mon, 21 Oct 2019 15:22:09 GMT
last-updateda
Sat, 19 Oct 2019 00:31:35 GMT
server
nginx
vary
Accept-Encoding
x-cache
Miss from cloudfront
via
1.1 df26103dc140569d7032449c70c3b141.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C2
x-amz-cf-id
2-3hyVw5KW46W_iGVrr-HOCsE4ziQ0oABnU3BW9ZuZ4PTI7uLr-ANg==

Redirect headers

Cache-Control
private
Content-Type
text/html; charset=utf-8
Location
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Server
Microsoft-IIS/10.0
Set-Cookie
ASP.NET_SessionId=eq51iles5zfk2l4qe3q5ir4f; path=/; HttpOnly
X-AspNet-Version
4.0.30319
X-BNN-Server
biapp1
Date
Mon, 21 Oct 2019 15:25:37 GMT
Content-Length
247
article.bundle.css
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
149 KB
16 KB
Stylesheet
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.css
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
27f08df1567ca0787d0e9bdfd6dc30cb6d250efdb932e0ac752abbb10cb87f19

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:08:18 GMT
content-encoding
gzip
age
1040
x-cache
Hit from cloudfront
status
200
content-length
16097
last-modified
Fri, 18 Oct 2019 18:58:47 GMT
server
nginx
vary
Accept-Encoding
content-type
text/css
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
a35b-6p_N_GenPDS1AeAV-NhJjaA9nLq9vJmtPzWD7kVkopjIomgSQ==
expires
Mon, 21 Oct 2019 17:03:19 GMT
common.bundle.css
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
480 KB
279 KB
Stylesheet
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.css
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
f789c9224c81ba9c39f3dd523c7d53b289574ecb6e3554bcc63f575ab45652c0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:08:18 GMT
content-encoding
gzip
last-modified
Fri, 18 Oct 2019 18:58:51 GMT
server
nginx
age
1040
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/css
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
6FxubLiJaw84vx8IUp7aG5DGW7kPIVjVJzkucoR2N5DcPEHens8MkA==
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
expires
Mon, 21 Oct 2019 17:02:06 GMT
chartbeat_mab.js
static.chartbeat.com/js/
19 KB
8 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat_mab.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200c:8800:18:1fcd:349:ca21 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
c1acfa727754dab58bedc79995a642e235c6fde6449824c4fba4318fc060c91c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:08:06 GMT
content-encoding
gzip
last-modified
Wed, 14 Aug 2019 01:44:12 GMT
server
nginx
age
1051
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA2
x-amz-cf-id
W3B-C0MOQYPCart32TlyTkQkVe-HaJ7wz-9YPIHv0IO2OcGeXeojhw==
via
1.1 1a483cde6df004748f3e5c80dc46df26.cloudfront.net (CloudFront)
expires
Mon, 21 Oct 2019 17:08:06 GMT
embedder.bundle.js
queso-cdn.prod.reuters.tv/new/assets/
50 KB
13 KB
Script
General
Full URL
https://queso-cdn.prod.reuters.tv/new/assets/embedder.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:21f3:a600:1e:ef1b:aa40:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx/1.14.0 (Ubuntu) /
Resource Hash
3ad6849c327eac0d747d48c9e8d0430e5599933b668c944154f8228ec48b19ac

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:22 GMT
content-encoding
gzip
x-origin
i-001de507f23474502.queso.prod.us.reuters.tv
age
16
x-cache
Hit from cloudfront
status
200
access-control-allow-origin
*
last-modified
Thu, 21 Mar 2019 19:00:31 GMT
server
nginx/1.14.0 (Ubuntu)
vary
Accept-Encoding
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
via
1.1 eb1a8c1b1275e33a016e623478052111.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C2
access-control-allow-headers
connection, range, accept-encoding, user-agent, referer, content-type
x-amz-cf-id
koPNqvE27tkW3nhS4_IUtN2AypoBQr_I4Bm1JzgZmQuLbDt6xQsn4Q==
gtm.js
www.googletagmanager.com/
286 KB
74 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
4babdbdb9df91fa9d25226c86d7b80502293ac0a3859e1eae43fe636caed4552
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
75395
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:38 GMT
3aae9fd5da3557fba61d6444cb943643.png
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
1 KB
2 KB
Image
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/3aae9fd5da3557fba61d6444cb943643.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
6346ee09058d555984eb04aac881775c926b5d9d4f73ca91493f7cb708ed90df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 19:05:34 GMT
content-encoding
gzip
age
73204
x-cache
Hit from cloudfront
status
200
content-length
1539
last-modified
Fri, 18 Oct 2019 18:58:44 GMT
server
nginx
vary
Accept-Encoding
content-type
image/png
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
AdjP5JYrJx-MMuAammwr5sG8YIc1hltnAGjVX-Hg5Ii3DV6TnHDwrg==
expires
Sat, 19 Oct 2019 19:05:11 GMT
common.bundle.js
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
731 KB
175 KB
Script
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
d62e1ce4a06c3bc837907935917e23462591f87162a171c0cdf5be61c7dcd04e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:08:18 GMT
content-encoding
gzip
last-modified
Fri, 18 Oct 2019 18:58:51 GMT
server
nginx
age
1040
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
SG5LAP0TcZdhMUNynjda_LyJ4Ij3pHwe3LXvPWty5Qil9vh455gedA==
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
expires
Fri, 18 Oct 2019 21:00:04 GMT
article.bundle.js
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
360 KB
52 KB
Script
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
c35c41a7ff7df6d6d0d3e1ba8382602098f32fe9018ee20c827d8b82f7d390e7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:08:10 GMT
content-encoding
gzip
age
1048
x-cache
Hit from cloudfront
status
200
content-length
52458
last-modified
Fri, 18 Oct 2019 18:58:47 GMT
server
nginx
vary
Accept-Encoding
content-type
application/javascript
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
cache-control
max-age=7200
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
ZhBcBmrrDoXhe9Uk8TbQyZzFVXgN-lbkG6-j6AQz5IQjI6vzaWINcA==
expires
Mon, 21 Oct 2019 17:05:45 GMT
analytics.js
www.google-analytics.com/
43 KB
18 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
5489
date
Mon, 21 Oct 2019 13:54:09 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
17803
expires
Mon, 21 Oct 2019 15:54:09 GMT
js
www.google-analytics.com/gtm/
60 KB
23 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-TBBXQQ&t=gtm1&cid=950467070.1571671538
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
9e223d43450fc3a047c5eb120c7b38d5ae9b3cf337ffb18352820727dff5dc33
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
last-modified
Mon, 21 Oct 2019 15:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
22753
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:38 GMT
iframe_api
www.youtube.com/
859 B
1 KB
Script
General
Full URL
https://www.youtube.com/iframe_api
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
YouTube Frontend Proxy /
Resource Hash
16dd54686a3ed4ca169cba44af157ea072d91930a6b5ad3690b4651820e5e0b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
x-content-type-options
nosniff
server
YouTube Frontend Proxy
content-type
application/javascript
status
200
cache-control
no-cache
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
859
x-xss-protection
0
expires
Tue, 27 Apr 1971 19:44:06 EST
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
f01d25f7a76e0682a7a43230c32bef653eaf28b8a6f7a683ebb88bf8c6aa4f50

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d7d62426c6b87d35cef5c2c873355aa44edffcf4a7f927f1c51b10694ea4f6ed

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
truncated
/
71 KB
71 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ee0768f9d2def8b13df284410776f5d755109e77b5c0ca17d8895f65b343a0cd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
/
mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/
197 B
483 B
XHR
General
Full URL
https://mab.chartbeat.com/mab_strategy/headline_testing/get_strategy/?host=reuters.com&domain=reuters.com&path=%2Farticle%2Fus-alexion-pharms-fda-idUSKBN1WY00B
Requested by
Host: static.chartbeat.com
URL: https://static.chartbeat.com/js/chartbeat_mab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a04:4e42:3::714 , Ascension Island, ASN54113 (FASTLY - Fastly, US),
Reverse DNS
Software
/
Resource Hash
f296ebafdde834f558f15f9db19063b68d6ee4eff02d3852ffd35fc7efa9fad5

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
age
806
x-cache
HIT
status
200
x-cache-hits
1
content-length
162
x-served-by
cache-fra19129-FRA
access-control-allow-origin
*
x-timer
S1571671538.292756,VS0,VE0
vary
Origin, Access-Control-Request-Headers, Access-Control-Request-Method, Accept-Encoding
content-type
application/json
via
1.1 varnish (Varnish/6.0), 1.1 varnish
cache-control
no-store, no-cache, must-revalidate, max-age=0, s-maxage=0
accept-ranges
bytes
expires
Sat, 19 Oct 2019 15:12:11 GMT
www-widgetapi.js
s.ytimg.com/yts/jsbin/www-widgetapi-vfloS5Wsk/
23 KB
9 KB
Script
General
Full URL
https://s.ytimg.com/yts/jsbin/www-widgetapi-vfloS5Wsk/www-widgetapi.js
Requested by
Host: www.youtube.com
URL: https://www.youtube.com/iframe_api
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
b631fccbe48b26dccef2b6eedeed2d6fb9020daf34dbc8010e587e280b6f498e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 06:21:03 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
32675
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
8680
x-xss-protection
0
last-modified
Sun, 20 Oct 2019 04:15:26 GMT
server
sffe
vary
Accept-Encoding, Origin
content-type
text/javascript
cache-control
public, max-age=691200
accept-ranges
bytes
timing-allow-origin
https://www.youtube.com
expires
Tue, 29 Oct 2019 06:21:03 GMT
service
async01.admantx.com/admantx/
182 B
378 B
Script
General
Full URL
https://async01.admantx.com/admantx/service?request=%7B%22key%22%3A%22234330834c41105ad5ed794fa036e085b40225c44f9228bb9e2692f427917605%22%2C%20%22decorator%22%3A%22template.reuters%22%2C%20%22filter%22%3A%5B%22default%22%5D%2C%20%22method%22%3A%22descriptor%22%2C%20%22mode%22%3A%22async%22%2C%20%22type%22%3A%22URL%22%2C%20%22body%22%3A%22https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-alexion-pharms-fda%252Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B%22%7D
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.217.204.244 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-217-204-244.eu-west-1.compute.amazonaws.com
Software
nginx/1.12.2 /
Resource Hash
92bdb5bb1cc3d230e148e51f40dfb5411d88d4637fb04012edc609193f2663fb

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Access-Control-Allow-Origin
*
Date
Mon, 21 Oct 2019 15:25:38 GMT
Server
nginx/1.12.2
Connection
keep-alive
Content-Length
182
Content-Type
text/plain; charset=UTF-8
evidon-sitenotice-tag.js
c.evidon.com/sitenotice/
44 KB
12 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
311f7c035bd8e2e36fdef1962231c004e48199087b73427a87499997210bfe16

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
11996
last-modified
Wed, 16 Oct 2019 16:58:44 GMT
server
AkamaiNetStorage
etag
"b42c671932dcdded523f9b56fb2dc206:1571245124"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 22 Oct 2019 15:25:38 GMT
country.js
c.evidon.com/geo/
260 B
512 B
Script
General
Full URL
https://c.evidon.com/geo/country.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
f9784f57729f84391b084eed9e944e048f771129d65e9b58f34095fdfba86473

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
last-modified
Wed, 30 May 2018 22:23:16 GMT
server
AkamaiNetStorage
status
200
etag
"c1e367d098d326049811561575dbda4a:1527718996"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
accept-ranges
bytes
access-control-allow-headers
*
content-length
260
snthemes.js
c.evidon.com/sitenotice/1237/
47 KB
4 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/snthemes.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
dc952b429f6066d7d94fece53fc84f3ae6ba7aba72841cc71ac88042c3228e64

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
3322
last-modified
Fri, 18 Oct 2019 18:12:29 GMT
server
AkamaiNetStorage
etag
"e13017a3fb41788e6e8dc706b5abef04:1571422349"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 22 Oct 2019 15:25:38 GMT
settings.js
c.evidon.com/sitenotice/1237/reuters/
6 KB
2 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/reuters/settings.js
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
2cccaa9b761c701b19383bf2c16794490c76879fa470dff36fd5052de5485546

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
1781
last-modified
Tue, 15 Oct 2019 18:06:46 GMT
server
AkamaiNetStorage
etag
"c572214fc967df0bb833134036bb5c13:1571162806"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 22 Oct 2019 15:25:38 GMT
analytics.min.js
cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/
332 KB
71 KB
Script
General
Full URL
https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.99.83 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-99-83.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
86bd33a6a74ca346c85dfb1763c2be1fd48b0e6444815428539fe8f47aee9047

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
V6jnK2IMprCtTkH_yqLSPHkVeogErYOs
content-encoding
gzip
etag
"b40b70f3ab0904e1d63cf46940e4c657"
x-amz-cf-pop
FRA50-C1
x-cache
Hit from cloudfront
status
200
x-amz-replication-status
COMPLETED
content-length
71912
access-control-allow-origin
*
last-modified
Fri, 18 Oct 2019 17:30:36 GMT
server
AmazonS3
date
Mon, 21 Oct 2019 15:25:38 GMT
access-control-max-age
3000
access-control-allow-methods
GET, HEAD
content-type
text/javascript; charset=utf-8
via
1.1 32e4d419823b7f8df8417a8b18c9602d.cloudfront.net (CloudFront)
cache-control
public, max-age=300
accept-ranges
bytes
x-amz-cf-id
161jqg2df8Xd1CAmEqRSsIbJXM2ifzAStmYqgRVVby4t0bOR2AwuYQ==
finance
wireapi.reuters.com/v7/feed/rcom/us/top-nav/
50 B
508 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.71 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-71.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:20:51 GMT
via
1.1 linkerd, 1.1 7a18a0a1d9929dae345690b88b08dd5e.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Mon, 21 Oct 2019 15:20:51 GMT
x-amz-cf-pop
FRA2-C1
x-amzn-requestid
425601e8-c063-46cd-a8c2-e4fca0df74bf
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B6zxAHfEoAMF9QQ=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
gXwYbSAX8nuUeLe-lymL18t4PyFoM2uTVzBwD029OIOVoYxmcT9VnA==
x-amzn-remapped-connection
keep-alive
markets
wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/
50 B
509 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/markets?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.71 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-71.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:20:51 GMT
via
1.1 linkerd, 1.1 7a18a0a1d9929dae345690b88b08dd5e.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Mon, 21 Oct 2019 15:20:51 GMT
x-amz-cf-pop
FRA2-C1
x-amzn-requestid
e7413015-f104-4081-8c13-b5cd76bfd4a2
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B6zw-FipjoEFozA=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
Ce_tSq0G5QWQeqwdqrB4u9LDXMfRsdEyEN6pSHLotWzVHJSDsKZCAw==
x-amzn-remapped-connection
keep-alive
world
wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/
50 B
507 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/world?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.71 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-71.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:20:50 GMT
via
1.1 linkerd, 1.1 7a18a0a1d9929dae345690b88b08dd5e.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Mon, 21 Oct 2019 15:20:50 GMT
x-amz-cf-pop
FRA2-C1
x-amzn-requestid
0b115fe8-012e-4e1b-8380-871e1300fbf0
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B6zw-FQnjoEF_4Q=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
UADdlvD9P0Odj733ibpUtZJveIuc3OgbMxTKDsXJ57VLmiR08F38rA==
x-amzn-remapped-connection
keep-alive
politics
wireapi.reuters.com/v7/feed/rcom/us/top-nav/
50 B
508 B
Fetch
General
Full URL
https://wireapi.reuters.com/v7/feed/rcom/us/top-nav/politics?count=7
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.71 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-71.fra2.r.cloudfront.net
Software
/
Resource Hash
eedaddf9c2b920f335c7c9830059d625f4251143e4b3fee53043f80c83663037

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:20:50 GMT
via
1.1 linkerd, 1.1 7a18a0a1d9929dae345690b88b08dd5e.cloudfront.net (CloudFront)
x-amzn-remapped-server
nginx
x-amzn-remapped-date
Mon, 21 Oct 2019 15:20:50 GMT
x-amz-cf-pop
FRA2-C1
x-amzn-requestid
9898c004-c0a8-402e-b02e-931ffc7633aa
x-cache
Error from cloudfront
status
404
l5d-success-class
1.0
x-amz-apigw-id
B6zw-FD7joEFZsA=
content-length
50
vary
Origin
content-type
application/json;charset=UTF-8
access-control-allow-origin
*
x-amz-cf-id
lLSvK3Eqdn-8X8cpPhvXHRJILoAZQCDoTt3V_65Xwu1Ur0jDsTnCBA==
x-amzn-remapped-connection
keep-alive
contextfeed.js
www.dianomi.com/js/
9 KB
3 KB
Script
General
Full URL
https://www.dianomi.com/js/contextfeed.js?
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
7a736b2f2091be24fcca895da408ed1bf5b0a66dbc3e27522864fe29652db3c8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
467
cf-polished
origSize=11527
status
200
x-xss-protection
1; mode=block
last-modified
Wed, 16 Oct 2019 11:34:07 GMT
server
cloudflare
etag
W/"2d07-595057a8e8736"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
expires
Mon, 21 Oct 2019 19:25:38 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
52943ecb5fa89abc-FRA
cf-bgj
minify
breakingNews
www.reuters.com/assets/
1 B
364 B
Fetch
General
Full URL
https://www.reuters.com/assets/breakingNews?view=json
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.7 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-7.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
01ba4719c80b6fe911b091a7c05124b64eeece964e09c058ef8f9805daca546b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
via
1.1 df26103dc140569d7032449c70c3b141.cloudfront.net (CloudFront)
server
nginx
x-amz-cf-pop
FRA2-C2
status
200
x-cache
Miss from cloudfront
content-type
application/json;charset=UTF-8
access-control-allow-origin
http://admin.reuters.com
access-control-allow-headers
Access-Control-Allow-Origin,charset
content-length
1
x-amz-cf-id
gM0AxW-Ha4dqhXUEAtztOjroPZ-fv9ekX7wQmuEnp13Skj9dtzYECQ==
expires
Mon, 21 Oct 2019 15:25:23 GMT
hotjar-65715.js
static.hotjar.com/c/
5 KB
3 KB
Script
General
Full URL
https://static.hotjar.com/c/hotjar-65715.js?sv=5
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.85.99 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
pkt-ams-k1-5
Software
openresty /
Resource Hash
3141a2340b088e23385902728f5a09d6109eadec6219233a56f0667812d4d4bd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
x-content-type-options
nosniff
section-io-tag
hotjar
age
27
status
200
section-io-cache
Hit
vary
Accept-Encoding
content-length
2393
server
openresty
cache-control
max-age=60
x-frame-options
SAMEORIGIN
etag
W/c289c39eef0af01497c7199d186d80dd
access-control-max-age
600
section-io-origin-status
304
access-control-allow-origin
*
x-cache-hit
1
section-io-origin-time-seconds
0.017
section-io-id
9360a4d59f39ef5ca8642a81c455a1df
accept-ranges
bytes
content-type
application/javascript
reuters.js
tru.am/scripts/custom/
1 KB
789 B
Script
General
Full URL
https://tru.am/scripts/custom/reuters.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6f23d93c9b8e3ca26f6fcc6be6a8d087e43a3f5795daa3c61017071642f66f3c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
cf-cache-status
REVALIDATED
last-modified
Thu, 14 Jun 2018 18:27:56 GMT
server
cloudflare
etag
W/"40b7d4de06dae04ec0d6537ef2f54db8"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=86400
cf-ray
52943ecb9bc6cbc4-VIE
expires
Tue, 22 Oct 2019 15:25:38 GMT
load
experience.tinypass.com/xbuilder/experience/
4 KB
1 KB
Script
General
Full URL
https://experience.tinypass.com/xbuilder/experience/load?aid=TIDovF4cqC
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4c33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
bd1dc64fac45e75fffefbd76f176c6ea118ab79b88b3efddc5642d4e7c76d4fe

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
cf-cache-status
EXPIRED
wn
prod-exp-10-0-1-208
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
accept-encoding
p3p
CP="NON DSP COR OUR IND"
status
200
cache-control
public, max-age=1800
x-forwarded-https
on
cf-ray
52943ecb7dcdcb9c-VIE
content-type
application/javascript;charset=utf-8
x-request-id
CqidqzpFC2N
expires
Mon, 21 Oct 2019 15:55:38 GMT
en.js
c.evidon.com/sitenotice/1237/translations/
55 KB
5 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/1237/translations/en.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
42ebce48f38ca99ec71f9cdc53e4555d4d0fbd8bdd1a0740e123e32d1b58502d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
4709
last-modified
Mon, 14 Oct 2019 18:54:07 GMT
server
AkamaiNetStorage
etag
"bcc188e94557debbc19be771b7b3cee8:1571079247"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 22 Oct 2019 15:25:38 GMT
iabevidonmapping.js
iabmap.evidon.com/
7 KB
7 KB
Script
General
Full URL
https://iabmap.evidon.com/iabevidonmapping.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:f600:10:27b4:f500:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a092021e174c55591059b1000001f762a8f9dfb2620a5ab7a402ded82046192b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 14:07:12 GMT
via
1.1 436c247027acc191b22ece964efbaeca.cloudfront.net (CloudFront)
last-modified
Tue, 08 Oct 2019 17:18:25 GMT
server
AmazonS3
age
69664
etag
"f15dbe32afb421812fe35ffb86f50f8d"
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
7122
x-amz-cf-id
H7gbts4oJOW9Njgk9BdNN3yP69F2QGFnRACQ3ruAjJE0A7OPVmEStg==
evidon-cmp.js
c.evidon.com/sitenotice/
23 KB
7 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-cmp.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
2c0255dc71491f7eb909fabf7c2a4111eb30b4373097086c5bf04e93804057dc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
6652
last-modified
Wed, 16 Oct 2019 16:58:46 GMT
server
AkamaiNetStorage
etag
"cf000373b0fd7b697588ee13bd7024a8:1571245126"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 22 Oct 2019 15:25:38 GMT
evidon-banner.js
c.evidon.com/sitenotice/
10 KB
3 KB
Script
General
Full URL
https://c.evidon.com/sitenotice/evidon-banner.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-sitenotice-tag.js
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
06d56458db165cd0ede7a6c23b441e81d0269feac7f8793d582253cc63e9db38

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
vary
Accept-Encoding
status
200
content-length
2958
last-modified
Wed, 16 Oct 2019 16:58:45 GMT
server
AkamaiNetStorage
etag
"119ff1c01eb744dc72c66e4d7f49b38b:1571245125"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
cache-control
max-age=86400, private;max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
expires
Tue, 22 Oct 2019 15:25:38 GMT
2
l.betrad.com/site/v3/1237/5669/3/1/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/1/2/2?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.232.243.86 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-232-243-86.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
61500
l.betrad.com/site/v3/1237/5669/3/1/2/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/1/2/2/61500?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.232.243.86 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-232-243-86.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
js
www.google-analytics.com/gtm/
60 KB
22 KB
Script
General
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-KBK7743&cid=950467070.1571671538
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
605b6328846dedec173402f4dadfaf7bc7fb60b8ae0087f2f9cc03fc44248219
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
last-modified
Mon, 21 Oct 2019 15:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
22752
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:38 GMT
linkid.js
www.google-analytics.com/plugins/ua/
2 KB
995 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 14:39:03 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
2795
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
856
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:39:03 GMT
fbevents.js
connect.facebook.net/en_US/
103 KB
23 KB
Script
General
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
9404cee30e4489a7ed4d6de2dd92aa8e4386fd5ff1c81ebcea77f581952eac31
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-23=":443"; ma=3600
content-length
22458
x-xss-protection
0
pragma
public
x-fb-debug
Vhq9AbZXR/74LwBeHgwvj6/5CpUGT821cI/2HIhZ9dOuLhSDEEuv7rRUxQ3JBXan9/NXhaX425JjeT8UyCP+Zw==
x-fb-trip-id
1850256238
x-frame-options
DENY
date
Mon, 21 Oct 2019 15:25:38 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
61500
l.betrad.com/site/v3/1237/5669/3/4/2/2/
0
120 B
Image
General
Full URL
https://l.betrad.com/site/v3/1237/5669/3/4/2/2/61500?consent=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.232.243.86 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-232-243-86.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
vendorlist.json
vendorlist.consensu.org/
88 KB
17 KB
XHR
General
Full URL
https://vendorlist.consensu.org/vendorlist.json
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-cmp.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20eb:3200:1:af78:4c0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3e25214e79eab3cf412ea2fec1eee887baf77be4448461d72f2af47ee093128a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
dDurJJk9w9s3FJNGQzpcI8tyg.M9IFSK
content-encoding
gzip
vary
Origin,Access-Control-Request-Headers,Access-Control-Request-Method
age
66918
x-cache
Hit from cloudfront
status
200
access-control-allow-origin
*
last-modified
Fri, 18 Oct 2019 08:50:37 GMT
server
AmazonS3
date
Sun, 20 Oct 2019 20:50:21 GMT
access-control-max-age
86400
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
via
1.1 dde0b4b1e223fa23670e93078a04c116.cloudfront.net (CloudFront)
cache-control
max-age=259200
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
b0SoUOV8K81VmNvO3aqzZLFhoedYGT8_SKPWa4jVYnoAR_d2xSRD7A==
context.pl
www.dianomi.com/cgi-bin/
2 KB
768 B
XHR
General
Full URL
https://www.dianomi.com/cgi-bin/context.pl?id=4&h=www.reuters.com
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
20a6d2b7cfb04122ea4af740a815984fc15ffe7cbde0f298d70301b04fe27ff0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
application/json; charset=ISO-8859-1
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=600
access-control-allow-credentials
true
cf-ray
52943ecbdc8abece-FRA
x-xss-protection
1; mode=block
expires
Mon, 21 Oct 2019 15:26:38 GMT
modules.9c427faaa7393368f30c.js
script.hotjar.com/
433 KB
73 KB
Script
General
Full URL
https://script.hotjar.com/modules.9c427faaa7393368f30c.js
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-65715.js?sv=5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.85.119 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
pkt-ams-k1-2
Software
/
Resource Hash
8f98d1e3eefb7d26d9a1fbe17b046769afb0335b4dccd5a0861fc77d7833db70

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
last-modified
Mon, 21 Oct 2019 09:50:58 GMT
status
200
etag
"1dbb6c845721a7274de1e15b07fb79e8"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
cache-control
max-age=31536000
section-io-origin-time-seconds
0.025
section-io-origin-status
200
accept-ranges
bytes
section-io-id
1f87e0696c1cc2dc3cdd8ff2fd75622e
content-length
74442
312961195854690
connect.facebook.net/signals/config/
280 KB
65 KB
Script
General
Full URL
https://connect.facebook.net/signals/config/312961195854690?v=2.9.5&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
f0accb42c769145b6d141864835eba045063021590a01aa8bcce348573ebb188
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
alt-svc
h3-23=":443"; ma=3600
content-length
66234
x-xss-protection
0
pragma
public
x-fb-debug
nQtBiclgWLvPrMI27qulHTN/2BG7oyCtVC32XlD/MBAJpZ2O1VX6HUkBS15oy6Cim2vEGkK7YvHf/l01+9ecGg==
x-fb-trip-id
1850256238
x-frame-options
DENY
date
Mon, 21 Oct 2019 15:25:38 GMT
vary
Accept-Encoding
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=1200
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
article-recirc
sope.prod.reuters.tv/program/rcom/v1/
13 KB
13 KB
Fetch
General
Full URL
https://sope.prod.reuters.tv/program/rcom/v1/article-recirc?edition=us&pageid=USKBN1WY00B&modules=rightrail,ribbon,bottom
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f18:624f:b000:4319:b1c8:f4e4:70ed Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
Software
nginx/1.14.0 (Ubuntu) /
Resource Hash
d0038a734c134523631a916db03fdb873f97f6eb1ea3ebd3b7cc60097c8a1eb0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
seq
ceff1a07-449e-48f2-a2bc-d3780b0ff9c6

Response headers

date
Mon, 21 Oct 2019 15:25:39 GMT
x-origin
i-059003315cf58724a.sope.prod.us.reuters.tv
server
nginx/1.14.0 (Ubuntu)
x-amzn-trace-id
Root=1-5dadcdf3-3280f080266912305a2ae228
status
200
content-type
application/json
access-control-allow-origin
*
access-control-allow-headers
connection, range, accept-encoding, user-agent, referer, seq
content-length
13352
getcookie
evidon.mgr.consensu.org/iab/
169 B
380 B
Script
General
Full URL
https://evidon.mgr.consensu.org/iab/getcookie
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/sitenotice/evidon-cmp.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.78.7 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-78-7.compute-1.amazonaws.com
Software
/
Resource Hash
9b133863146a5f391e8cee0842cafc7498ae89b6f79edbecfc842055342c1fe2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
x-amzn-requestid
4128f888-e20e-4922-99fe-063f3bd416b7
status
200
content-type
text/javascript
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5dadcdf2-0d3d25d49a296b18c75c7ff7;Sampled=0
x-amz-apigw-id
B60d-EpuIAMF9Yw=
content-length
169
box-74dcf4e32eff343c96838bf3a780ac1d.html
vars.hotjar.com/ Frame 8535
0
0
Document
General
Full URL
https://vars.hotjar.com/box-74dcf4e32eff343c96838bf3a780ac1d.html
Requested by
Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-65715.js?sv=5
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
147.75.85.99 Parsippany, United States, ASN54825 (PACKET - Packet Host, Inc., US),
Reverse DNS
pkt-ams-k1-5
Software
/
Resource Hash

Request headers

:method
GET
:authority
vars.hotjar.com
:scheme
https
:path
/box-74dcf4e32eff343c96838bf3a780ac1d.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
date
Mon, 21 Oct 2019 15:25:38 GMT
content-type
text/html
content-length
808
cache-control
max-age=31536000
content-encoding
br
last-modified
Thu, 17 Oct 2019 10:26:51 GMT
etag
"e97b43816dfbff056689db51ae5cdfc7"
section-io-origin-status
200
section-io-origin-time-seconds
0.025
vary
Accept-Encoding
accept-ranges
bytes
section-io-id
daa6891fda5021e6875e14d60b909c84
dianomi-context.css
www.dianomi.com/partner/dianomi/css/
169 B
246 B
Stylesheet
General
Full URL
https://www.dianomi.com/partner/dianomi/css/dianomi-context.css?v=1.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
99781410070a5dd4d753fdb8a46f4272082b5be64541dcfcb1b2d3c4aea09c6c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
1451
cf-polished
origSize=199
status
200
x-xss-protection
1; mode=block
last-modified
Mon, 21 Jan 2019 12:43:41 GMT
server
cloudflare
etag
W/"c7-57ff735e16ce7"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css; charset=utf-8
access-control-allow-origin
*
expires
Mon, 21 Oct 2019 19:25:38 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
52943ecc89509abc-FRA
cf-bgj
minify
smartads.epl
www.dianomi.com/ Frame 7D67
0
0
Document
General
Full URL
https://www.dianomi.com/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/smartads.epl?id=4728&num_ads=5&shuffle=0&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
__cfduid=df5fc73e0b86c329ea385f181b87ccc491571671538
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
date
Mon, 21 Oct 2019 15:25:38 GMT
content-type
text/html; charset=UTF-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
expires
now
pragma
no-cache
cache-control
no-cache,no-store,private
link
</img/a/pss/2649/23.css>;rel=preload;as=style
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
52943ecc89519abc-FRA
content-encoding
br
cf-h2-pushed
</img/a/pss/2649/23.css>
videofeed-combined.js
www.dianomi.com/js/
15 KB
4 KB
Script
General
Full URL
https://www.dianomi.com/js/videofeed-combined.js?id=33
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
d31b1f947a51cfdc97520d53eb6610e8abf104e48569fb8069e917ffe5c7a617
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
age
863
cf-polished
origSize=20718
status
200
x-xss-protection
1; mode=block
last-modified
Wed, 09 Oct 2019 10:58:47 GMT
server
cloudflare
etag
W/"50ee-594782b536c0d"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
access-control-allow-origin
*
expires
Mon, 21 Oct 2019 19:25:38 GMT
cache-control
public, max-age=14400
access-control-allow-credentials
true
cf-ray
52943ecc89539abc-FRA
cf-bgj
minify
recirculation.epl
www.dianomi.com/ Frame C642
0
0
Document
General
Full URL
https://www.dianomi.com/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/recirculation.epl?id=98&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
__cfduid=df5fc73e0b86c329ea385f181b87ccc491571671538
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
date
Mon, 21 Oct 2019 15:25:38 GMT
content-type
text/html; charset=utf-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
52943ecc89559abc-FRA
content-encoding
br
recirculation.epl
www.dianomi.com/ Frame AA66
0
0
Document
General
Full URL
https://www.dianomi.com/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.dianomi.com
:scheme
https
:path
/recirculation.epl?id=99&start=6&cf=545.4.Reuters%20v3.1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
__cfduid=df5fc73e0b86c329ea385f181b87ccc491571671538
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
date
Mon, 21 Oct 2019 15:25:38 GMT
content-type
text/html; charset=utf-8
x-content-type-options
nosniff
x-xss-protection
1; mode=block
access-control-allow-origin
*
access-control-allow-credentials
true
vary
Accept-Encoding, User-Agent
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
52943ecc995c9abc-FRA
content-encoding
br
lazyload.iife.min.js
cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/10.20.1/
5 KB
2 KB
Script
General
Full URL
https://cdnjs.cloudflare.com/ajax/libs/vanilla-lazyload/10.20.1/lazyload.iife.min.js
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/contextfeed.js?
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:c497 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
3c514d4fb8244af230a89d2203522c6a67a55a3f161cfd4fca9f53301c0588ff
Security Headers
Name Value
Strict-Transport-Security max-age=15780000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
vary
Accept-Encoding
cf-cache-status
HIT
age
16305392
status
200
served-in-seconds
0.028
timing-allow-origin
*
last-modified
Sun, 17 Feb 2019 22:45:49 GMT
server
cloudflare
etag
W/"5c69e41d-14cf"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=15780000; includeSubDomains
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
public, max-age=30672000
cf-ray
52943ecccc94cbb0-VIE
expires
Sat, 10 Oct 2020 15:25:38 GMT
dianomi-max-200x38.png
www.dianomi.com/img/
15 KB
15 KB
Image
General
Full URL
https://www.dianomi.com/img/dianomi-max-200x38.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
98c311aa7422fcd7e58a00b053de863d392168102280666046859146b7c27958
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
x-content-type-options
nosniff
cf-cache-status
HIT
age
2128155
cf-polished
origSize=31456
status
200
content-length
15624
x-xss-protection
1; mode=block
last-modified
Tue, 23 May 2017 10:48:47 GMT
server
cloudflare
etag
"7ae0-5502ebb78747a"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/png
access-control-allow-origin
*
expires
Thu, 21 Nov 2019 01:25:38 GMT
cache-control
public, max-age=2628000
access-control-allow-credentials
true
accept-ranges
bytes
cf-ray
52943ecc995e9abc-FRA
cf-bgj
imgq:100
pixeltrack.pl
www.dianomi.com/cgi-bin/
77 B
197 B
Image
General
Full URL
https://www.dianomi.com/cgi-bin/pixeltrack.pl?cf=545.4.Reuters%20v3.1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
d4fa79afcf5a5cc5a0f12dedaf825f11530e6397d723fe7044cd37ba3c248e57
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:38 GMT
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
image/gif; charset=ISO-8859-1
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
52943ecc995f9abc-FRA
content-length
77
x-xss-protection
1; mode=block
expires
Sun, 20 Oct 2019 15:25:38 GMT
truncated
/
49 KB
49 KB
Font
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
45610b21279531a97f9566b0f0f8a1d287a45ae4bc6bc545971af5cd7e393cc6

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Origin
https://www.reuters.com

Response headers

Content-Type
application/font-woff
tinypass.min.js
cdn.tinypass.com/api/
365 KB
116 KB
Script
General
Full URL
https://cdn.tinypass.com/api/tinypass.min.js
Requested by
Host: experience.tinypass.com
URL: https://experience.tinypass.com/xbuilder/experience/load?aid=TIDovF4cqC
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4c33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4a249c6a6ef8b5bd539edff6254da0fc3a8e12c12aac8fa31554e2159801753c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
cf-cache-status
HIT
age
298
p3p
CP="NON DSP COR OUR IND"
status
200
wn
prod-dash-10-0-1-142
last-modified
Fri, 18 Oct 2019 15:29:58 GMT
server
cloudflare
etag
W/"374221-1571412598000-gzip"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
cache-control
public, max-age=300
cf-ray
52943eccb9b2cb9c-VIE
expires
Mon, 21 Oct 2019 15:30:38 GMT
smartads_video_json.pl
www.dianomi.com/cgi-bin/
3 B
148 B
XHR
General
Full URL
https://www.dianomi.com/cgi-bin/smartads_video_json.pl?id=4729&cf=545.4.Reuters%20v3.1
Requested by
Host: www.dianomi.com
URL: https://www.dianomi.com/js/videofeed-combined.js?id=33
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.18.135.13 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
ca3d163bab055381827226140568f3bef7eaac187cebd76878e0b63e9e442356
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.reuters.com
cache-control
private, no-cache, no-store, must-revalidate, max-age=0, pre-check=0, post-check=0
access-control-allow-credentials
true
cf-ray
52943ecccdafbece-FRA
x-xss-protection
1; mode=block
truncated
/
38 B
38 B
Other
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
52dc24c0429ea6ccc5b579a6da8bb79bf41e471fe5108a62009f3c2e195551c0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/webp
execute
experience.tinypass.com/xbuilder/experience/
2 KB
1 KB
XHR
General
Full URL
https://experience.tinypass.com/xbuilder/experience/execute?aid=TIDovF4cqC
Requested by
Host: cdn.tinypass.com
URL: https://cdn.tinypass.com/api/tinypass.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:4c33 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
240fba7388a451ba49878499fed070f98ef07571b85140c931f6d38473e0f07b

Request headers

Accept
*/*
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
cf-cache-status
DYNAMIC
p3p
CP="NON DSP COR OUR IND"
status
200
x-forwarded-https
on
x-request-id
Cqidqzpfprk
pragma
no-cache
wn
prod-exp-10-0-1-74
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
access-control-allow-methods
POST, GET, OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cf-ray
52943ecd3b4ecb9c-VIE
expires
Thu, 01 Jan 1970 00:00:00 GMT
ta-pagesocial-sdk.js
tru.am/scripts/
35 KB
12 KB
Script
General
Full URL
https://tru.am/scripts/ta-pagesocial-sdk.js
Requested by
Host: tru.am
URL: https://tru.am/scripts/custom/reuters.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
2b8d8ef7fec86e16424f0c6be7f0471a0c29256e074e1336d92876ddb4bc09ff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Thu, 18 Apr 2019 03:51:14 GMT
server
cloudflare
age
4226
etag
W/"942d5ae1e512ccdf18813550428dd002"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=86400
cf-ray
52943ecd4910cbc4-VIE
expires
Tue, 22 Oct 2019 15:25:38 GMT
nativeai.js
cdn.native.ai/js/current/
130 KB
43 KB
Script
General
Full URL
https://cdn.native.ai/js/current/nativeai.js?1571270400000
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.12 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-12.fra50.r.cloudfront.net
Software
nginx / ASP.NET
Resource Hash
bfcea73208d9a1f1a1f89d306cdff89c8d4a8740f0e7ab8b84501c1b86f3fd94

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 14:58:21 GMT
Content-Encoding
gzip
Last-Modified
Fri, 12 Jul 2019 21:55:34 GMT
Server
nginx
X-Amz-Cf-Pop
FRA50-C1
X-Powered-By
ASP.NET
Vary
Accept-Encoding
X-Cache
RefreshHit from cloudfront
Content-Type
application/javascript
Via
1.1 479d15a99f4dd073131fba1516541469.cloudfront.net (CloudFront)
Cache-Control
max-age=0,must-revalidate
Transfer-Encoding
chunked
Connection
keep-alive
X-Amz-Cf-Id
Fc15qN_yaqYOCb1HZwG7pwKJU-X2P_o_QaMeLh8lqOzY-gajXXM8vw==
ads.js
www.reuters.com/
112 B
516 B
Script
General
Full URL
https://www.reuters.com/ads.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.7 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-7.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
7464555aae6d8d87b77f7170fba1698ff64f7454ded58627ca1819246e9a9969

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:38 GMT
content-encoding
gzip
server
nginx
x-amz-cf-pop
FRA2-C2
status
200
vary
Accept-Encoding
x-cache
Miss from cloudfront
content-type
text/javascript;charset=UTF-8
access-control-allow-origin
http://admin.reuters.com
access-control-allow-headers
Access-Control-Allow-Origin,charset
content-length
116
via
1.1 df26103dc140569d7032449c70c3b141.cloudfront.net (CloudFront)
x-amz-cf-id
5E7FpFrdUK1gWeNfhcV3EjnZSHM-t4hE95Ba6ZMDSOvUxJHCz5X05A==
expires
Mon, 21 Oct 2019 15:25:32 GMT
beacon
beacon.tru.am/
0
352 B
Fetch
General
Full URL
https://beacon.tru.am/beacon
Requested by
Host: tru.am
URL: https://tru.am/scripts/ta-pagesocial-sdk.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:a322 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded;charset=UTF-8

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:38 GMT
via
1.1 google
cf-cache-status
DYNAMIC
server
cloudflare
status
200
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Origin
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, private, max-age=0
cf-ray
52943ecdbf5fcbc0-VIE
content-length
0
expires
Thu, 01 Jan 1970 00:00:00 UTC
beacon.js
sb.scorecardresearch.com/
1 KB
1 KB
Script
General
Full URL
https://sb.scorecardresearch.com/beacon.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.43.115.95 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-43-115-95.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
76c393f564f53c19e795307e622edc8657a603f7a816c2646385697286d11313

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:38 GMT
Content-Encoding
gzip
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=86400
Connection
keep-alive
Content-Length
902
Expires
Tue, 22 Oct 2019 15:25:38 GMT
gwiq.js
gwiqcdn.globalwebindex.net/gwiq/
14 KB
15 KB
Script
General
Full URL
https://gwiqcdn.globalwebindex.net/gwiq/gwiq.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.201.93.216 , Ascension Island, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
216.93.201.35.bc.googleusercontent.com
Software
UploadServer /
Resource Hash
2f78a9f3d1d4b5078213d39c3f51ea1f5b72d91793a9e3fa14612e9d1add543d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:15:19 GMT
age
619
x-guploader-uploadid
AEnB2UqXFQJkIR4tJNJPfJfAe7_D4BVozKU4X1DgG06Vl4IBJlNSEysxBE0YGCJwsNq7UVLwmOaqwXFO6dOFyfE0wbOuy6q4Xw
x-goog-storage-class
MULTI_REGIONAL
status
200
x-goog-metageneration
3
x-goog-stored-content-encoding
identity
alt-svc
clear
content-length
14561
last-modified
Fri, 22 Mar 2019 17:21:14 GMT
server
UploadServer
etag
"7bb2a0f8543ca52adc2740318f3b8331"
x-goog-hash
crc32c=CMb65Q==, md5=e7Kg+FQ8pSrcJ0AxjzuDMQ==
x-goog-generation
1553275274038866
cache-control
public, max-age=3600
x-goog-stored-content-length
14561
accept-ranges
bytes
content-type
application/javascript
expires
Mon, 21 Oct 2019 16:15:19 GMT
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=6035630&ns__t=1571671538806&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease%20-%20Reuters&c7=https...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571671538806&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease%20-%20Reuters&c7=http...
0
248 B
Image
General
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571671538806&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&c9=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.43.115.95 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-43-115-95.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:38 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=6035630&ns__t=1571671538806&ns_c=UTF-8&cv=3.1e&c8=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease%20-%20Reuters&c7=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&c9=
Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:38 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
p
api.segment.io/v1/
21 B
141 B
XHR
General
Full URL
https://api.segment.io/v1/p
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.68.89.141 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-68-89-141.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

status
200
date
Mon, 21 Oct 2019 15:25:39 GMT
access-control-allow-origin
https://www.reuters.com
content-length
21
vary
Origin
content-type
application/json
/
www.facebook.com/tr/
44 B
347 B
Image
General
Full URL
https://www.facebook.com/tr/?id=312961195854690&ev=PageView&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&rl=&if=false&ts=1571671539094&sw=1600&sh=1200&v=2.9.5&r=stable&a=seg&ec=0&o=30&fbp=fb.1.1571671539093.1938823473&it=1571671538531&coo=false&rqm=GET
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:39 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
alt-svc
h3-23=":443"; ma=3600
content-length
44
expires
Mon, 21 Oct 2019 15:25:39 GMT
collect
www.google-analytics.com/
35 B
133 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=1083546234&t=pageview&_s=1&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&dp=%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&ul=en-us&de=UTF-8&dt=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAiEAjR~&jid=628450960&gjid=1574010316&cid=950467070.1571671538&tid=UA-24152976-22&_gid=1164471696.1571671538&cd2=Homepage&cd11=us-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease&cd4=News&cd8=0&cd10=False&cd9=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&cd19=Page%20Load&cd7=Desktop&cd14=USKBN1WY00B&cd6=U.S.&cd5=Article&cd17=Reuters%20Editorial&cd3=Homepage%20-%20Homepage&cd1=Homepage&cd13=401&cd18=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease&z=1972348068
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 08 Oct 2019 18:03:13 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
1113746
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=950467070.1571671538&jid=628450960&gjid=1574010316&_gid=1164471696.1571671538&_u=aGDAiEAjR~&z=1418887512
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=628450960&_v=j79&z=1418887512
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=628450960&_v=j79&z=1418887512&slf_rd=1&random=2587628130
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=628450960&_v=j79&z=1418887512&slf_rd=1&random=2587628130
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:39 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:39 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=628450960&_v=j79&z=1418887512&slf_rd=1&random=2587628130
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
0b9ae0631dc9cb1d12dd2eb240ef07bb.png
static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/
22 KB
9 KB
Image
General
Full URL
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/0b9ae0631dc9cb1d12dd2eb240ef07bb.png
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
9f9104dee58871cdb561e4f139fcf095a2fc1fcb0a7778a964975e6b12059c6a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/article.bundle.css
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 19:00:31 GMT
content-encoding
gzip
age
73508
x-cache
Hit from cloudfront
status
200
content-length
9050
last-modified
Fri, 18 Oct 2019 18:58:43 GMT
server
nginx
vary
Accept-Encoding
content-type
image/png
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
mDN_1nz1yZaZVDj54CPNwYemkFSE81JBNPixVopXdUwJa0h0jYs10w==
expires
Mon, 21 Oct 2019 19:00:24 GMT
/
static.reuters.com/resources/r/
2 KB
2 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191021&t=2&i=1443309572&r=LYNXMPEF9K0O2&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
0cc9a65e6796a338995b77f195f6fe62ac4fbceb148bc859748ab517a754b102

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 10:36:28 GMT
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 10:36:12 GMT
server
nginx
age
17316
etag
"a4086eba2f12a0644e7f0606dcb3a060"
x-cache
Hit from cloudfront
x-amz-version-id
iPD74NC9v1UM8wE_DMT0wTkXnsxCMWAd
status
200
x-amz-cf-pop
FRA50-C1
content-type
image/jpeg
content-length
1724
x-amz-cf-id
TzizrPNyrHlv-sNFZYqXonPDzM9p5POkij9AOLmPiUnbJyCdpkEBtA==
/
static.reuters.com/resources/r/
3 KB
3 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191021&t=2&i=1443290154&r=LYNXMPEF9K0KA&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
c0fe1cf5472ab2f1c0b37b01d3d6d271d8ed0cf2e3d2e8e77ead33f79e806e1e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 09:25:47 GMT
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 09:19:58 GMT
server
nginx
age
21552
etag
"8ad1f5ec86290cbcc5606b9f0fcb98b2"
x-cache
Hit from cloudfront
x-amz-version-id
.utVozmDdCYjlWfXzo.ykA7gvOVKOIR0
status
200
x-amz-cf-pop
FRA50-C1
content-type
image/jpeg
content-length
2887
x-amz-cf-id
rMObu70sQpqSVkzRsuj1UxRAfmxMdpo52N9a0zbEkSv18_9sekO0EQ==
/
static.reuters.com/resources/r/
2 KB
3 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191020&t=2&i=1443144129&r=LYNXMPEF9J0JH&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
41c79a4ac81fc9fbb189704addf085ebdf7dc9a8c4897d29e76764bc3454f6ce

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 23:29:42 GMT
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Wed, 20 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Sun, 20 Oct 2019 23:29:20 GMT
server
nginx
age
56888
etag
"4db6457cc9e61adeb403f29afc2db7f2"
x-cache
Hit from cloudfront
x-amz-version-id
0AvxWncbmMmt5XiNdoWJlC0L1cblArFo
status
200
x-amz-cf-pop
FRA50-C1
content-type
image/jpeg
content-length
2329
x-amz-cf-id
2zNAyuXGHYSM8bSt0wSVCb_aL8EMEjQAKtQ7s67Ff4Hb3Spjb0ZWMg==
/
static.reuters.com/resources/r/
2 KB
3 KB
Image
General
Full URL
https://static.reuters.com/resources/r/?m=02&d=20191021&t=2&i=1443347677&r=LYNXMPEF9K0UI&w=120
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
622ec04b104420e2991daf464131e00606e4d291361fa662ebb68235c14b90b7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 12:49:49 GMT
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
x-amz-expiration
expiry-date="Thu, 21 Nov 2019 00:00:00 GMT", rule-id="ExpiraIn30Days"
last-modified
Mon, 21 Oct 2019 12:41:26 GMT
server
nginx
age
9233
etag
"961e417c87525d7170678921952a7abf"
x-cache
Hit from cloudfront
x-amz-version-id
gLRQBNK67LjByzRYZwGv7XXsnxUZR3Zz
status
200
x-amz-cf-pop
FRA50-C1
content-type
image/jpeg
content-length
2350
x-amz-cf-id
b394HnJe98aCtTSV9wwiRDqCkZRcGl6Z5GIPmC1oOimR8H8RZRRFnA==
1566521167044.jpg
s1.reutersmedia.net/resources/images/at/
88 KB
87 KB
Image
General
Full URL
https://s1.reutersmedia.net/resources/images/at/1566521167044.jpg
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
670a6bd86461985226f5ca30eae0ec5f7acc533fe1a04d78f96df82efa73d79d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 04:47:19 GMT
content-encoding
gzip
last-modified
Fri, 23 Aug 2019 00:46:07 GMT
server
nginx
age
38300
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
image/jpeg
status
200
cache-control
max-age=86400
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
MRYECC19elyL6122knWvXXCjsdPBknlqq9KE8yXs9yUMFvrbfqFbyA==
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
expires
Tue, 22 Oct 2019 01:44:00 GMT
/
www.facebook.com/tr/ Frame FA53
0
0
Document
General
Full URL
https://www.facebook.com/tr/
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
2849
pragma
no-cache
cache-control
no-cache
origin
https://www.reuters.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
fr=0ZmGbplnOOep6X80T..Bdrc3z...1.0.Bdrc3z.
Origin
https://www.reuters.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
alt-svc
h3-23=":443"; ma=3600
date
Mon, 21 Oct 2019 15:25:39 GMT
bidexchange.js
contextual.media.net/
397 KB
113 KB
Script
General
Full URL
https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Requested by
Host: static.reuters.com
URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
08b775e343645d10b097820e2f0a5c79cee24f09804731d8acf5d893fb62f614

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=1800
expires
Mon, 21 Oct 2019 15:55:40 GMT
iasPET.1.js
cdn.adsafeprotected.com/
18 KB
6 KB
Script
General
Full URL
https://cdn.adsafeprotected.com/iasPET.1.js
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.224.196.15 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-224-196-15.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
12c030f8ade953607bbcff2764f71cc9bba2a907cda26ebb943c928569cab2c2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 07 Oct 2019 18:17:47 GMT
Content-Encoding
gzip
Connection
keep-alive
Last-Modified
Mon, 07 Oct 2019 18:17:44 GMT
Server
AmazonS3
Age
594467
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/javascript
Via
1.1 96ab38d99b79d57e5c7e9b8a07c0fad3.cloudfront.net (CloudFront)
Cache-Control
max-age=604800
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA2-C1
X-Amz-Cf-Id
Z4pxHIq2L9tA_aPVjqoEXazP7B_gQgXUvPwugifWq_KqKPUCg7omLQ==
tc.js
contextual.media.net/
12 KB
7 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=TB4M82W&size=300x250&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
5d23dafa2c443b2dfaeb848fea20fdfacf73479fa6c6070c01c7f713c40311bd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
6675
expires
Wed, 23 Oct 2019 15:25:40 GMT
tc.js
contextual.media.net/
13 KB
7 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=T645KQG&size=728x90&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
61880e6272da762d94c13369e078e5b16d940c992f64debc61bd56a027cb2638

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
7433
expires
Wed, 23 Oct 2019 15:25:40 GMT
checksync.php
contextual.media.net/ Frame FF40
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=26&https=1&gdpr=1&gdprconsent=0
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
contextual.media.net
:scheme
https
:path
/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=26&https=1&gdpr=1&gdprconsent=0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
gdpr_status=1
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
server
Apache
content-type
text/html; charset=UTF-8
set-cookie
gdpr_status=1; Expires=Thu, 23 Apr 2020 15:25:40 GMT; domain=.media.net; Path=/;
x-mnet-hl2
E
vary
Accept-Encoding
content-encoding
gzip
cache-control
max-age=318631
expires
Fri, 25 Oct 2019 07:56:11 GMT
date
Mon, 21 Oct 2019 15:25:40 GMT
content-length
4593
hmmaster.js
contextual.media.net/
19 KB
7 KB
Script
General
Full URL
https://contextual.media.net/hmmaster.js?cid=8CUF1VN4G&p=hb&v=3.1.3&https=1&adt=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cc11628ee489395e239bc94ea6dc8d5b1908e6b957cc5c9a9e05a64793f77e28

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=1800
content-length
7348
expires
Mon, 21 Oct 2019 15:55:40 GMT
px.gif
contextual.media.net/
43 B
193 B
Image
General
Full URL
https://contextual.media.net/px.gif?&ch=1&vn=1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:40 GMT
last-modified
Wed, 19 Jul 2017 10:11:12 GMT
server
Apache
content-type
image/gif
status
200
cache-control
max-age=1209600
accept-ranges
bytes
content-length
43
expires
Mon, 04 Nov 2019 15:25:40 GMT
px.gif
s.mnet-ad.net/
43 B
356 B
Image
General
Full URL
https://s.mnet-ad.net/px.gif?&ch=2&vn=1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
66.81.204.228 , Virgin Islands (British), ASN40034 (CONFLUENCE-NETWORK-INC - Confluence Networks Inc, VG),
Reverse DNS
o1-66-81-204-228.static.o1.com
Software
Apache /
Resource Hash
8ac1703c1c34b2be426deda409d39258f82fae17f13e645f377f337a954aedde

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
Last-Modified
Wed, 19 Jul 2017 10:11:12 GMT
Server
Apache
Content-Type
image/gif
Cache-Control
max-age=1209600
Connection
Keep-Alive
Accept-Ranges
bytes
Keep-Alive
timeout=2, max=104
Content-Length
43
Expires
Mon, 04 Nov 2019 15:25:41 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
42 KB
3 KB
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=267235141*4%7C300x250%7C8CUD609M7%7C976846895%40267235141*29%7C300x250%7C11384%7C31484_232454_15%40267235141*38%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40267235141*51%7C300x250%7C973973%7C11084976%7C0.07%40267235141*59%7C300x250%7C8CUF1VN4G%7C_112891%7C0.07%40267235141*74%7C300x250%7C1113800%7C12209124%40267235141*97%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40267235141*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40267235141*145%7C300x250%7C100600%7C147215%40267235141*172%7C300x250%7C8CUF1VN4G%7C15331955%7C0.06%40267235141*175%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%7C0.01%40267235141*178%7C300x250%7C8CUF1VN4G%7C267235141_8CUF1VN4G%40313743496*4%7C728x90%7C8CUD609M7%7C536231532%40313743496*29%7C728x90~970x250%7C11384%7C31484_232454_2~31484_232454_57%40313743496*38%7C970x250~728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G~313743496_8CUF1VN4G%40313743496*51%7C728x90%7C973973%7C11084975%7C0.69%40313743496*59%7C728x90~970x250%7C8CUF1VN4G%7C_112891~_112891%7C0.07%40313743496*74%7C728x90~970x250%7C1113800%7C12209125~12209125%40313743496*97%7C728x90~970x250%7C8CUF1VN4G%7C313743496_8CUF1VN4G~313743496_8CUF1VN4G%40313743496*122%7C728x90%7C8CUF1VN4G%7C8CUF1VN4G_LKbKv9hpus2aba7C923hUsFj%7C1.22%40313743496*145%7C970x250~728x90%7C100600%7C147214~147214%40313743496*172%7C728x90~970x250%7C8CUF1VN4G%7C15303527~15303527%7C0.06%40313743496*175%7C728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G%7C0.01%40313743496*178%7C728x90%7C8CUF1VN4G%7C313743496_8CUF1VN4G%40391166652*4%7C160x600%7C8CUD609M7%7C712281133%40391166652*29%7C300x250~160x600~300x600%7C11384%7C31484_232454_15~31484_232454_9~31484_232454_10%40391166652*38%7C300x600~160x600~300x250%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40391166652*51%7C300x250~160x600~300x600%7C973973%7C11084976~11084976~11084976%7C0.07%40391166652*59%7C300x250~160x600~300x600%7C8CUF1VN4G%7C_112891~_112891~_112891%7C0.07%40391166652*74%7C300x250~300x600%7C1113800%7C12209124~12209124%40391166652*97%7C300x250~300x600~160x600%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40391166652*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40391166652*145%7C300x600~160x600~300x250%7C100600%7C147215~147215~147215%40391166652*172%7C160x600~300x250~300x600%7C8CUF1VN4G%7C15331955~15331955~15331955%7C0.06%40391166652*175%7C300x600~160x600~300x250%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%7C0.01%40391166652*178%7C300x600~300x250~160x600%7C8CUF1VN4G%7C391166652_8CUF1VN4G~391166652_8CUF1VN4G~391166652_8CUF1VN4G%40451439109*4%7C300x250%7C8CUD609M7%7C155187763%40451439109*29%7C300x250%7C11384%7C31484_123998_15%40451439109*38%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40451439109*51%7C300x250%7C973973%7C11084979%7C0.07%40451439109*59%7C300x250%7C8CUF1VN4G%7C_112891%7C0.07%40451439109*97%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40451439109*122%7C300x250%7C8CUF1VN4G%7C8CUF1VN4G_fFuYfaVC4aA86N9xVFo929Yk%7C1.22%40451439109*145%7C300x250%7C100600%7C147218%40451439109*172%7C300x250%7C8CUF1VN4G%7C15331958%7C0.06%40451439109*175%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%7C0.01%40451439109*178%7C300x250%7C8CUF1VN4G%7C451439109_8CUF1VN4G%40612341223*4%7C728x90%7C8CUD609M7%7C813012502%40612341223*29%7C728x90~970x250%7C11384%7C31484_232454_2~31484_232454_57%40612341223*38%7C970x250~728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G~612341223_8CUF1VN4G%40612341223*51%7C728x90%7C973973%7C11084975%7C0.69%40612341223*59%7C728x90~970x250%7C8CUF1VN4G%7C_112891~_112891%7C0.07%40612341223*74%7C728x90~970x250%7C1113800%7C12209125~12209125%40612341223*97%7C728x90~970x250%7C8CUF1VN4G%7C612341223_8CUF1VN4G~612341223_8CUF1VN4G%40612341223*122%7C728x90%7C8CUF1VN4G%7C8CUF1VN4G_LKbKv9hpus2aba7C923hUsFj%7C1.22%40612341223*145%7C728x90~970x250%7C100600%7C147214~147214%40612341223*172%7C728x90~970x250%7C8CUF1VN4G%7C15303527~15303527%7C0.06%40612341223*175%7C728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G%7C0.01%40612341223*178%7C728x90%7C8CUF1VN4G%7C612341223_8CUF1VN4G&crid=267235141%2C313743496%2C391166652%2C451439109%2C612341223&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=105192268419723221571671540618&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.05284177306368676&ndec=1&scrsize=1600x1200&taginfo=%7B%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A5830%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&prid=8PRVCXX19&wo=1&isRefresh=0&switch=1&cc=DE&rc=HE&ct=FRANKFURT
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
b94b2ae7a325dd1cd83950d6c13d8a44e4c88143b77615187c995fac0e54ea06

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Mon, 21 Oct 2019 15:25:40 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
3 KB
1 KB
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=267235141*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C267235141%40313743496*84%7C1x1_T645KQG_1%7C8CUF1VN4G%7C313743496%40391166652*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C391166652%40451439109*84%7C1x1_TB4M82W_1%7C8CUF1VN4G%7C451439109%40612341223*84%7C1x1_T645KQG_1%7C8CUF1VN4G%7C612341223&crid=267235141%2C313743496%2C391166652%2C451439109%2C612341223&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=169273224557705141571671540621&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.5105854648901802&ndec=1&scrsize=1600x1200&taginfo=%7B%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A5830%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&at=3&prid=8PRVCXX19&wo=1&cc=DE&rc=HE&ct=FRANKFURT
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
221815e91037871d9f3972c836ee883b6dc5dbee270bb58a11baa9116f548872

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Mon, 21 Oct 2019 15:25:40 GMT
checksync.php
contextual.media.net/ Frame DB10
0
0
Document
General
Full URL
https://contextual.media.net/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=101&https=1&gdpr=1&gdprconsent=0
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash

Request headers

:method
GET
:authority
contextual.media.net
:scheme
https
:path
/checksync.php?&vsSync=1&cs=1&hb=1&cv=37&ndec=1&cid=8CUF1VN4G&prvid=3%2C23%2C28%2C29%2C33%2C38%2C41%2C51%2C54%2C56%2C59%2C69%2C72%2C74%2C76%2C77%2C80%2C82%2C84%2C97%2C106%2C108%2C109%2C113%2C117%2C118%2C122%2C126%2C138%2C139%2C141%2C145%2C147%2C159%2C172%2C173%2C174%2C175%2C178%2C182%2C3004%2C3007%2C3010&rtime=101&https=1&gdpr=1&gdprconsent=0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
gdpr_status=1
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
server
Apache
content-type
text/html; charset=UTF-8
set-cookie
gdpr_status=1; Expires=Thu, 23 Apr 2020 15:25:40 GMT; domain=.media.net; Path=/;
x-mnet-hl2
E
vary
Accept-Encoding
content-encoding
gzip
cache-control
max-age=318631
expires
Fri, 25 Oct 2019 07:56:11 GMT
date
Mon, 21 Oct 2019 15:25:40 GMT
content-length
4593
gpt.js
www.googletagservices.com/tag/js/
46 KB
15 KB
Script
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f89fcb038aae8bf3e1723e73c705348add5a889d87ac1cc6be57377ccde8b96f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"313 / 589 of 1000 / last-modified: 1571666774"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14723
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:40 GMT
integrator.js
adservice.google.de/adsid/
109 B
656 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
109 B
717 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019101401.js
securepubads.g.doubleclick.net/gpt/
156 KB
58 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
f8800772f0dd827877029d9d634a170a156ff82b6b6bdf251b62c750b73cfe93
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58589
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:40 GMT
show_companion_ad.js
pagead2.googlesyndication.com/pagead/
188 KB
70 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/show_companion_ad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
229cbd9a75d3e1025f7ff4c1e218e69139e07db35e8b1b7bc5101600bce9cb80
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 14:29:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
3377
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
71217
x-xss-protection
0
server
cafe
etag
6945173793245176937
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=3600
timing-allow-origin
*
expires
Mon, 21 Oct 2019 15:29:23 GMT
pub
pixel.adsafeprotected.com/services/
325 B
710 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_mpu_13379540_USKBN1WY00B,s:300.250,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=03f41b7e-15d8-b9e8-6671-b2eef410d8f5&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-alexion-pharms-fda%252Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
2922ee71c655084ea00f9498e73abe32a4398ec616ef34f564850dca0a2ac9f7

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:40 GMT
X-Server-Name
app01ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
326 B
711 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:canvas_leaderboard_6185826132144441_USKBN1WY00B,s:728.90,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=03f41b7e-15d8-b9e8-6671-b2eef410d8f5&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-alexion-pharms-fda%252Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
64ff744ae4e5e5679c57ac7967e8624b97c09628702faf6205ba31e3711507ed

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:40 GMT
X-Server-Name
app23ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
tc.js
contextual.media.net/
15 KB
8 KB
Script
General
Full URL
https://contextual.media.net/tc.js?&tpkey=TF6129H&size=2x2&v=17&nat=1&https=1
Requested by
Host: contextual.media.net
URL: https://contextual.media.net/bidexchange.js?cid=8CUF1VN4G&dn=www.reuters.com&version=4.1&https=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.235.93 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-93.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
1c5f973eb7e9ce2290f6feaeacfaa58f5cf3821175316bba1d3adcb24d133a11

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache
vary
Accept-Encoding
x-mnet-h
E
content-type
text/javascript; charset=utf-8
status
200
cache-control
max-age=172800
content-length
8074
expires
Wed, 23 Oct 2019 15:25:40 GMT
pub
pixel.adsafeprotected.com/services/
312 B
697 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_canvas_4278898_USKBN1WY00B,s:2.2,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=03f41b7e-15d8-b9e8-6671-b2eef410d8f5&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-alexion-pharms-fda%252Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
9ec0227357eec7b61091216fc4f21f59e217fdb320afec68efd76cb3da81a6da

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:40 GMT
X-Server-Name
app03ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
313 B
698 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_native_16084939_USKBN1WY00B,s:2.2,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=03f41b7e-15d8-b9e8-6671-b2eef410d8f5&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-alexion-pharms-fda%252Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
f612ad98f7531eebcd51bb0cfeb7ec7b6186ea8d4eefa0c43485baccd7951a16

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:40 GMT
X-Server-Name
app21ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
314 B
699 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_connatix_2446208_USKBN1WY00B,s:1100.420,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=03f41b7e-15d8-b9e8-6671-b2eef410d8f5&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-alexion-pharms-fda%252Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
79f8a0bd0da5a2ac0656002a389cfdc1057bb3444fe5f68515907990cdd4ba80

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:40 GMT
X-Server-Name
app05ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
pub
pixel.adsafeprotected.com/services/
309 B
694 B
XHR
General
Full URL
https://pixel.adsafeprotected.com/services/pub?anId=10764&slot=%7Bid:dpslot_bizdev_article_rr2_7657068_USKBN1WY00B,s:300.280,p:/4735792/us.reuters/life/health/article,t:display%7D&wr=1600.1200&sr=1600.1200&sessionId=03f41b7e-15d8-b9e8-6671-b2eef410d8f5&url=https%253A%252F%252Fwww.reuters.com%252Farticle%252Fus-alexion-pharms-fda%252Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Requested by
Host: cdn.adsafeprotected.com
URL: https://cdn.adsafeprotected.com/iasPET.1.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
844839c24a374b0db8fb1a1384862e280b6cb3ef4e831639eb06072bdee5d763

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:40 GMT
X-Server-Name
app56ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/json;charset=UTF-8
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Expose-Headers
X-Server-Name
Access-Control-Allow-Credentials
true
Connection
keep-alive
Timing-Allow-Origin
*
Server
nginx
rtbsspub
cdneast2-xch.media.net/AdExchange/
985 B
914 B
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=105651588*141%7C1x1_TF6129H_1%7C8CUF1VN4G%7C105651588_8CUF1VN4G&crid=105651588&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=541538886055396791571671540828&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.6320033551874555&ndec=1&scrsize=1600x1200&taginfo=%7B%22105651588%22%3A%7B%22xps%22%3A634.5%2C%22yps%22%3A1187%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A5830%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&at=3&prid=8PRVCXX19&wo=1&cc=DE&rc=HE&ct=FRANKFURT
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
c1fa04c33086b1c29a8bf12c0b0a63ff063d44221cdaf9bee1ec1bf413e87e6a

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Mon, 21 Oct 2019 15:25:40 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
1 KB
939 B
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=105651588*4%7C2x2%7C8CUD609M7%7C638433813&crid=105651588&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=268721927175520351571671540829&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.8590791402872762&ndec=1&scrsize=1600x1200&taginfo=%7B%22105651588%22%3A%7B%22xps%22%3A634.5%2C%22yps%22%3A1187%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A5830%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&prid=8PRVCXX19&wo=1&isRefresh=0&cc=DE&rc=HE&ct=FRANKFURT
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
a15e4048380049af589ab4d217f7189b59e94fe969f1b7cbbc82e83f0329c0ce

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Mon, 21 Oct 2019 15:25:40 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
984 B
914 B
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=279381844*141%7C1x1_TF6129H_1%7C8CUF1VN4G%7C279381844_8CUF1VN4G&crid=279381844&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=117716068136057911571671540831&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.5189544132022572&ndec=1&scrsize=1600x1200&taginfo=%7B%22279381844%22%3A%7B%22xps%22%3A634.5%2C%22yps%22%3A1601%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A5830%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&at=3&prid=8PRVCXX19&wo=1&cc=DE&rc=HE&ct=FRANKFURT
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
d9a1249fecd202d6d03696c4e8af35b96b41cff692277bc0704cce216a34b169

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Mon, 21 Oct 2019 15:25:40 GMT
rtbsspub
cdneast2-xch.media.net/AdExchange/
1 KB
941 B
EventSource
General
Full URL
https://cdneast2-xch.media.net/AdExchange/rtbsspub?&gdpr=1&gdprconsent=0&cid=8CUF1VN4G&region=nv&ptrid=8PRL4E7N3&requestString=279381844*4%7C2x2%7C8CUD609M7%7C799230533&crid=279381844&sd=1&requrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&bl=1&rt=5&dn=https://www.reuters.com&https=1&act=headerBid&prvReqId=130000696317307561571671540831&erTr=0&hlt=1&ugd=4&adt=desktop&tr=0.11616244657170127&ndec=1&scrsize=1600x1200&taginfo=%7B%22279381844%22%3A%7B%22xps%22%3A634.5%2C%22yps%22%3A1601%7D%7D&pageinfo=%7B%22vw%22%3A1585%2C%22vh%22%3A1200%2C%22ph%22%3A5830%7D&itype=HB&sid=8973&scc=1&tmt=200&section=us.reuters%2Flife%2Fhealth%2Farticle&prid=8PRVCXX19&wo=1&isRefresh=0&cc=DE&rc=HE&ct=FRANKFURT
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.62.140.165 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-62-140-165.deploy.static.akamaitechnologies.com
Software
Apache-Coyote/1.1 /
Resource Hash
2fae9f8a6fc488c3957da5e9c8a73212fdc3538ed10f541db4e3c512f885533b

Request headers

Accept
text/event-stream
Cache-Control
no-cache
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:40 GMT
content-encoding
gzip
server
Apache-Coyote/1.1
status
200
vary
Accept-Encoding
content-type
text/event-stream;charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
timing-allow-origin
*, *
expires
Mon, 21 Oct 2019 15:25:40 GMT
ads
securepubads.g.doubleclick.net/gampad/
40 KB
10 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2148869679590698&correlator=3906276697438908&output=ldjh&impl=fifs&adsid=NT&eid=21062420%2C21062796&vrg=2019101401&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20191021&iu_parts=4735792%2Cus.reuters%2Clife%2Chealth%2Carticle&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4%2C%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250%7C300x600%7C1x1%2C728x90%7C970x250%7C970x90%7C1100x100%7C1100x90%7C1100x250%7C1x1%2C320x50%7C2x2%7C1x1%7C1100x375%2C320x50%7C2x2%7C1x1%7C1100x375%7C3020x375%2C320x50%7C1100x420%7C1100x400%2C300x280&fluid=0%2C0%2Cheight%2Cheight%2Cheight%2C0&prev_scp=type%3Dmpu%26div_id%3D13379540%26pixel_distance%3D400%26articleID%3DUSKBN1WY00B%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253Bcompanies-mrch%253BeverythingNews%253BhealthNews%253Bdrug-pricing1%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D14%26asset%3Dnone%26id%3D0a7a4091-f417-11e9-9767-00259086cc16%26vw%3D40%2C50%2C60%2C70%2C80%26grm%3D40%2C50%2C60%2C70%2C80%26pub%3D40%2C50%2C60%2C70%2C80%26mnetDNB%3D1%26mnetPageID%3D1%26mnetCV%3D3%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dleaderboard%26div_id%3D6185826132144441%26articleID%3DUSKBN1WY00B%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253Bcompanies-mrch%253BeverythingNews%253BhealthNews%253Bdrug-pricing1%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D14%26asset%3Dnone%26id%3D0a797dd8-f417-11e9-8572-00259086cbca%26vw%3D40%2C50%2C60%2C70%26grm%3D40%2C50%2C60%2C70%26pub%3D40%2C50%2C60%2C70%26mnetDNB%3D1%26mnetPageID%3D2%26mnetCV%3D3%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dcanvas%26div_id%3D4278898%26pixel_distance%3D400%26articleID%3DUSKBN1WY00B%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253Bcompanies-mrch%253BeverythingNews%253BhealthNews%253Bdrug-pricing1%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D14%26asset%3Dnone%26id%3D0a7add7e-f417-11e9-8240-00259086cc1c%26vw%3D40%2C50%2C60%2C70%26grm%3D40%2C50%2C60%2C70%26pub%3D40%2C50%2C60%2C70%26mnetDNB%3D1%26mnetPageID%3D6%26mnetCV%3D3%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dnative%26div_id%3D16084939%26pixel_distance%3D400%26articleID%3DUSKBN1WY00B%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253Bcompanies-mrch%253BeverythingNews%253BhealthNews%253Bdrug-pricing1%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D14%26asset%3Dnone%26id%3D0a7c3ce1-f417-11e9-819f-00259086ccde%26vw%3D40%2C50%2C60%2C70%26grm%3D40%2C50%2C60%2C70%26pub%3D40%2C50%2C60%2C70%26mnetDNB%3D1%26mnetPageID%3D7%26mnetCV%3D3%26mnetCC%3DDE%26mnetUGD%3D4%7Ctype%3Dconnatix%26div_id%3D2446208%26pixel_distance%3D20000%26articleID%3DUSKBN1WY00B%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253Bcompanies-mrch%253BeverythingNews%253BhealthNews%253Bdrug-pricing1%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D14%26asset%3Dnone%26id%3D0a7b5293-f417-11e9-9d73-00259086ca74%26vw%3D40%2C50%2C60%2C70%26grm%3D40%2C50%2C60%2C70%26pub%3D40%2C50%2C60%2C70%7Ctype%3Dbizdev_article_rr2%26div_id%3D7657068%26pixel_distance%3D20000%26articleID%3DUSKBN1WY00B%26storychannel%3Dhealthcare-upclose%253Bmedical-research%253Bcompanies-phar%253Bcompanies-mrch%253BeverythingNews%253BhealthNews%253Bdrug-pricing1%253Bconsolidated-business%26story%3D0%26template%3Darticle%26p_count%3D14%26asset%3Dnone%26id%3D0a79cbab-f417-11e9-aea2-382c4ac63189%26vw%3D40%2C50%2C60%26grm%3D40%2C50%2C60%26pub%3D40%2C50%2C60&cust_params=bidxc%3D1%26ntvPlacement%3D1093478%26admant%3DBarclays%252CExxon_Negative%252CFacebook_Neg%252CIBM%252CJLR_Negative%252CJPMorgan_Neg%252CMSFT_Neg%252CNomura_Negative%252CWorkdayPG_Neg%26fr%3Dtrue%26adt%3DveryLow%26alc%3DveryLow%26dlm%3DveryLow%26drg%3DveryLow%26hat%3DveryLow%26off%3DveryLow%26vio%3Dlow&cookie_enabled=1&bc=31&abxe=1&lmt=1571671541&dt=1571671541010&dlt=1571671538061&idt=2752&frm=20&biw=1585&bih=1200&oid=3&adxs=-12245933%2C-12245933%2C-12245933%2C-12245933%2C-12245933%2C-12245933&adys=-12245933%2C-12245933%2C-12245933%2C-12245933%2C-12245933%2C-12245933&adks=545836891%2C249291572%2C286138360%2C3082663687%2C662180068%2C2897712150&ucis=1%7C2%7C3%7C4%7C5%7C6&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&dssz=71&icsg=176160960&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x-1%7C0x-1%7C754x0%7C754x0%7C754x0%7C300x-1&msz=300x-1%7C0x-1%7C2x2%7C2x2%7C1100x420%7C300x-1&ga_vid=497700489.1571671541&ga_sid=1571671541&ga_hid=1083546234&fws=132%2C132%2C132%2C132%2C132%2C132&ohw=1585%2C1585%2C1585%2C1585%2C1585%2C1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3888436b1dce95558cac93425483d9a05363e58ea968e73e933e792407f3c1b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
9485
x-xss-protection
0
google-lineitem-id
5189420777,5158696277,4741317042,5153856862,-2,139199112
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138289622787,138285704442,138206523841,138291019025,-2,138204787707
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019101401.js
securepubads.g.doubleclick.net/gpt/
64 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
f123fae1ceff20dea7ee2ff8895276a22cddecc8e0ef503b5e95419e76909a54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24836
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:41 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

chartbeat_video.js
static.chartbeat.com/js/
66 KB
23 KB
Script
General
Full URL
https://static.chartbeat.com/js/chartbeat_video.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:200c:8800:18:1fcd:349:ca21 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
nginx /
Resource Hash
88762480fb084c0725cf9c3abde10e540ebf64884fd50a86789b5eb661c38cdd

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:13:34 GMT
content-encoding
gzip
last-modified
Thu, 01 Aug 2019 01:36:07 GMT
server
nginx
age
726
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/x-javascript
status
200
cache-control
max-age=7200
x-amz-cf-pop
FRA2
x-amz-cf-id
el6orN72AbQZy_v6wOnLEUN36C0JmIZga1AdGELOKDrUjtt8r1JoMg==
via
1.1 1a483cde6df004748f3e5c80dc46df26.cloudfront.net (CloudFront)
expires
Mon, 21 Oct 2019 17:13:34 GMT
id
dpm.demdex.net/
3 KB
2 KB
XHR
General
Full URL
https://dpm.demdex.net/id?d_visid_ver=4.4.0&d_fieldgroup=MC&d_rtbd=json&d_ver=2&d_orgid=4579BF7A580A3C6A0A495DAF%40AdobeOrg&d_nsid=0&ts=1571671541113
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.208.212.211 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-208-212-211.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
e9811ab474b5f52421a1ea428743eed4b964b7f0e88fe8efcd748729b59ffd6d
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

DCS
dcs-prod-irl1-v048-0b73edff1.edge-irl1.demdex.com 5.61.0.20191015084456 3ms (+0ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
Content-Encoding
gzip
X-TID
ypRC0IYxQzM=
Vary
Origin, Accept-Encoding, User-Agent
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json;charset=utf-8
Content-Length
963
Expires
Thu, 01 Jan 1970 00:00:00 GMT
tag.min.js
get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/
41 KB
13 KB
Script
General
Full URL
https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-W9SLGS
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:8400:1f:287:d20a:ce1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
a5537aed93100c34cdea277b5b092c37b6de90f11339384634a76a035030f7f0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
B0GnU21j5XMDwAuNEC12S2upHRxtcWd0
content-encoding
gzip
last-modified
Mon, 09 Sep 2019 10:39:51 GMT
server
AmazonS3
age
2759
date
Mon, 21 Oct 2019 14:39:43 GMT
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
text/javascript
status
200
cache-control
max-age=3600
x-amz-cf-pop
FRA50-C1
x-amz-cf-id
DwaU1rMAlX645OsX-CGiPZyo00tWJV1L9FcTxyoVljO8sAQc3aP21g==
via
1.1 436c247027acc191b22ece964efbaeca.cloudfront.net (CloudFront)
collect
www.google-analytics.com/
35 B
99 B
Image
General
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=1083546234&t=timing&_s=2&dl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&dp=%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&ul=en-us&de=UTF-8&dt=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&plt=3367&pdt=6&dns=1&rrt=198&srt=115&tcp=15&dit=661&clt=661&_gst=472&_gbt=482&_cst=338&_cbt=465&_u=aGDAiEAjR~&jid=1701441820&gjid=844310375&cid=950467070.1571671538&tid=UA-24152976-22&_gid=1164471696.1571671538&cd2=Homepage&cd11=us-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease&cd4=News&cd8=0&cd10=False&cd9=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&cd19=Page%20Load&cd7=Desktop&cd14=USKBN1WY00B&cd6=U.S.&cd5=Article&cd17=Reuters%20Editorial&cd3=Homepage%20-%20Homepage&cd1=Homepage&cd13=401&cd18=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease&z=1971365195
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 08 Oct 2019 18:03:13 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
1113748
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://stats.g.doubleclick.net/r/collect?t=dc&aip=1&_r=3&v=1&_v=j79&tid=UA-24152976-22&cid=950467070.1571671538&jid=1701441820&gjid=844310375&_gid=1164471696.1571671538&_u=aGDAiEAjR~&z=72485287
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=1701441820&_v=j79&z=72485287
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=1701441820&_v=j79&z=72485287&slf_rd=1&random=3078290154
42 B
109 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=1701441820&_v=j79&z=72485287&slf_rd=1&random=3078290154
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81a::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:41 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:41 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-24152976-22&cid=950467070.1571671538&jid=1701441820&_v=j79&z=72485287&slf_rd=1&random=3078290154
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
i
api.segment.io/v1/
21 B
141 B
XHR
General
Full URL
https://api.segment.io/v1/i
Requested by
Host: cdn.segment.com
URL: https://cdn.segment.com/analytics.js/v1/IEWBqQ8VWHijTQxb7lEBGFGS9uIJzigZ/analytics.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.68.89.141 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-68-89-141.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
12f71cb993958eefc4bdb41d7dbbda490779a9c7aba448f7be52bb63912e0254

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

status
200
date
Mon, 21 Oct 2019 15:25:41 GMT
access-control-allow-origin
https://www.reuters.com
content-length
21
vary
Origin
content-type
application/json
ping
ping.chartbeat.net/
43 B
168 B
Image
General
Full URL
https://ping.chartbeat.net/ping?h=reuters.com&p=reuters.com%2Farticle%2Fus-alexion-pharms-fda-idUSKBN1WY00B&u=CW69NUD-8zUxCeeoq-&d=reuters.com&g=52639&g0=Homepage&g1=Reuters%20Editorial&g4=Article&n=1&f=00001&c=0&x=0&m=0&y=5830&o=1600&w=1200&j=45&R=1&W=0&I=0&E=0&e=0&r=&b=3367&t=BbGopGDsV9SgBdwqn_BvI5C6CXihY1&V=116&i=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease%20-%20Reuters&tz=-120&sn=1&sv=DAShHbk-WELnA4YTDFdi25hpR9I&sd=1&im=06679cf0&_
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.172.119.91 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-172-119-91.compute-1.amazonaws.com
Software
/
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Mon, 21 Oct 2019 15:25:41 GMT
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
content-length
43
expires
0
beacon.min.js
beacon.s-onetag.com/
18 KB
6 KB
Script
General
Full URL
https://beacon.s-onetag.com/beacon.min.js
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:20eb:a800:5:9a4c:9b00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
662fa6bcdf71d8f92e29010d3e2e270e0071e5d19b1d14ce205654a78aa0a7a9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
dQ2IPgbwW_sArXQW0CBb3eN5W57SqoQ0
content-encoding
gzip
last-modified
Thu, 04 Apr 2019 09:35:05 GMT
server
AmazonS3
age
954
date
Mon, 21 Oct 2019 15:09:48 GMT
vary
Accept-Encoding
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=3600
x-amz-cf-pop
FRA2-C1
x-amz-cf-id
m3P2w_4RsTNhp8_wiCwSOztVkQ2bxR96UHfzyaKIPoGnHSqgNrNM-g==
via
1.1 69f13f852a135432abb1b7bfc5a8b421.cloudfront.net (CloudFront)
Cookie set dest5.html
reuters.demdex.net/ Frame 01AD
0
0
Document
General
Full URL
https://reuters.demdex.net/dest5.html?d_nsid=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.50.81.152 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-50-81-152.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Host
reuters.demdex.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Accept-Encoding
gzip, deflate, br
Cookie
demdex=34444282460734288412765687447184465210
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

Accept-Ranges
bytes
Cache-Control
max-age=21600
Content-Encoding
gzip
Content-Type
text/html
Expires
Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified
Wed, 16 Oct 2019 08:53:19 GMT
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Pragma
no-cache
Set-Cookie
demdex=34444282460734288412765687447184465210;Path=/;Domain=.demdex.net;Expires=Sat, 18-Apr-2020 15:25:41 GMT;Max-Age=15552000
Strict-Transport-Security
max-age=31536000; includeSubDomains
Vary
Accept-Encoding, User-Agent
X-TID
/KrmhwsjRuY=
Content-Length
2764
Connection
keep-alive
/
s2.reutersmedia.net/resources/r/
68 B
458 B
Image
General
Full URL
https://s2.reutersmedia.net/resources/r/?c=15&m=15&d=20180622&t=9&i=4679615073&w=001&r=UQYFYPY3ykYVh
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.92 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-92.fra50.r.cloudfront.net
Software
ADFCDN/5.2.3 / AdDefend GmbH
Resource Hash
adfa0c7de03bc3bea3de80b4a4514881c8b6296568f43a5acd5cd7a16fffd1c9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:41 GMT
via
1.1 009e5e3e32afcd1d135a7234c9da5521.cloudfront.net (CloudFront)
server
ADFCDN/5.2.3
x-amz-cf-pop
FRA50-C1
x-powered-by
AdDefend GmbH
x-cache
Miss from cloudfront
content-type
image/png
status
200
cache-control
max-age=0, max-stale=0, must-revalidate, no-cache, no-store, no-transform, post-check=0, pre-check=0, private
accept-ranges
bytes
content-length
68
x-amz-cf-id
so_pHZ0OHn-RAnpbj54A0xlg56Ad7VNl3SkORKVIG_y80s3AhjPuqw==
expires
0
view
securepubads.g.doubleclick.net/pcs/ Frame 66C3
0
274 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvJM04CBeS-SIkY0iY8pRPDPVJ8gaAowozAbBIliXkvuEieYg2EavLfiQi2U_a7cTdA7S8NCLN3OgseFxbYvnBa03ps1xb_AJI53M83F-2ddOMILxLXgix9Hee9Tcq8WQOmE6ZqVGqgp9t6nQUgAYpPB8gPcKTr8F2YfWlvY2o-BJHEyXaV-uiM0kH89Gr52lONlX6fkV44K6y5FZAGhe6ElYqAeQpOFqVhA7MvpfLjpq9QxUn9Zt1-ykjjEdS-MY6KNRr3mUPu5mUWznq1tFcXNzqTjaBBe80B7A&sai=AMfl-YSF-p-x75MkkdqgzVHKSZ3DaRnqmkbuPme7xYCpy1bE3hz7WxwJmOAGowM1AlQMMrtK0OWAdnvgNt87zNm5LiBHq85zcynI4g3O2rZylw&sig=Cg0ArKJSzBeD0lIDw2yNEAE&urlfix=1&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:41 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:41 GMT
brid.outstream.min.js
services.brid.tv/player/build/ Frame 66C3
234 KB
65 KB
Script
General
Full URL
https://services.brid.tv/player/build/brid.outstream.min.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.94 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-94.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
bc5f742466b9fcf58a4150040c84e13ed3bbd140c765f807668ac8024609f54a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:13:59 GMT
content-encoding
gzip
last-modified
Thu, 17 Oct 2019 07:22:59 GMT
server
AmazonS3
age
1543
etag
"b42d13920955da19215e0453f0909d30"
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=1200, public
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
65964
via
1.1 9ab847fabb8c9edbd39cff57c2a2f4c0.cloudfront.net (CloudFront)
x-amz-cf-id
iw5RSPauIvUr6Z6K7pqhcSQk9ZPqTfLQuHIJVRFICJiwDXkcOhhcKg==
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 66C3
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f820f689e79fe927155372514936423b30eb400c1d2b87b6503d1398f6d352c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571051767941600"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29551
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:41 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame 66C3
297 KB
99 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
6b173d87763629cab6332e13f5fce375f0656baff43c8696995f6e42d8470565

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Last-Modified
Sat, 19 Oct 2019 00:56:56 GMT
Server
AmazonS3
x-amz-request-id
CC87214EF5D132A9
ETag
"2187b9aaeaf01529cfc067f12de264d2"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=15313
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101024
x-amz-id-2
WqW+qP2m7ZeBhE7hIFQ+9pkKpIDMNnHK/BJxvlVvj3DHUMNJH9XzSe054NVTgzkA
osd.js
www.googletagservices.com/activeview/js/current/
77 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f425f66d90f1150499b36ab47b56fa6fb1a68136e4f42befca20a920ff85306b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571051767941600"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29055
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:41 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame 8321
0
255 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvk2g3_IEUAIdTbwh4R8oZ8Z4YnvMm82NtHbMdCj1jttEZEC_haKVKFej7omWZtaHiXAgnZqOzARzil8vDEAqXGs3kh8vHylihpJ9TO4aSKXgc6pilrsMU9ylODgY6yPh_uhSyPhC0cmVf3o1LLrtowRqZV7LY8qaePjmB9UHPL-bAUh8COg80_RIc9gTnJw-I10JJm5dE7o_UgrGHzZgls4E2usvhRtxOguFBuWWQ7jCX_H4OP_8THcwqtuq-jrxcrLfCxdaCgga1KaAV-7d10NiyEkgvF7mlvsQ&sai=AMfl-YTG-SCCffvlybwo2lEnp_l5ygP-wFZA_n3ZZQJ5mxpmG6vYQb6FmPZ0Mppq8t5il98T6TanXPmY1uKunbJ8omzFvDwDR57QrWsgixQB_w&sig=Cg0ArKJSzPxH4xZSZqVwEAE&urlfix=1&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:41 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:41 GMT
is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250.js
secure.img-cdn.mediaplex.com/content/0/2399/250799/ Frame 8321
Redirect Chain
  • https://altfarm.mediaplex.com/ad/js/2399-250799-36431-8?mpt=785004098&mpvc=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsvNzdnP88lAyGnZgjMT44dqfnXsopY89_Mel7mNBCCXtNc9A6vRdQUVrQl4u8...
  • https://secure.img-cdn.mediaplex.com/content/0/2399/250799/is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250.js?mpck=altfarm.mediaplex.com%2Fad%2Fck%2F2399-250799-36431-8%3Fmpt%3D785004098%26m...
4 KB
2 KB
Script
General
Full URL
https://secure.img-cdn.mediaplex.com/content/0/2399/250799/is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250.js?mpck=altfarm.mediaplex.com%2Fad%2Fck%2F2399-250799-36431-8%3Fmpt%3D785004098%26mpcr%3D102570365%26mpcrset%3Droot&mpjs=c.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B%20cdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpjsp=https%3A%2F%2Fc.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B%20https%3A%2F%2Fcdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpt=785004098&mpqs=mpt%3D785004098&mpssl=1&mpvc=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsvNzdnP88lAyGnZgjMT44dqfnXsopY89_Mel7mNBCCXtNc9A6vRdQUVrQl4u8bkqkT9AwYOvfLeCnVH4Vt99OaLhNLoMq2tsmeyuosnKMQ6xDwzRdacmLwNH44hDNWBHs45kjypr7RCSbZE2-09ZCKuSRx0iTsmtuLlepg2czmffP-9JKiRPx_axcTBfLS_tEX9as_9qv2mkAVXXkn2uctFSfBqRGu1qOzw2yTuADrYPl4zQbxLV6zYxZyi4A0SxmmD1xaPPoFXklJbJwmFVUse55x_WBAbOw%2526sai%253DAMfl-YTSbcFd6i_Mk2hT1RrXEBgmsC-Co5lXn4WIN4mR-xFab9qd2SVppve5Yogs_tw4cIG17O5ZClCU0U5OZoKIoNKfM4zFDyiu6BamKERaGw%2526sig%253DCg0ArKJSzFZyrc-oxWemEAE%2526urlfix%253D1%2526adurl%253D
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.37.49.134 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-37-49-134.deploy.static.akamaitechnologies.com
Software
nginx /
Resource Hash
1fed3bdd9a5a57e0e1d7099fc1e1014c68ec2667831a0a6503f2a0b8a6b33605

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Last-Modified
Tue, 20 Aug 2019 15:59:16 GMT
Server
nginx
ETag
W/"1a4789d-c75-5908e89de9ac2"
Vary
Accept-Encoding
Content-Type
text/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
1904
Expires
Mon, 21 Oct 2019 15:25:41 GMT

Redirect headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Server
nginx
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR PSAo PSDo OUR IND UNI COM NAV"
Location
https://secure.img-cdn.mediaplex.com/content/0/2399/250799/is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250.js?mpck=altfarm.mediaplex.com%2Fad%2Fck%2F2399-250799-36431-8%3Fmpt%3D785004098%26mpcr%3D102570365%26mpcrset%3Droot&mpjs=c.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B cdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpjsp=https%3A%2F%2Fc.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B https%3A%2F%2Fcdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpt=785004098&mpqs=mpt%3D785004098&mpssl=1&mpvc=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsvNzdnP88lAyGnZgjMT44dqfnXsopY89_Mel7mNBCCXtNc9A6vRdQUVrQl4u8bkqkT9AwYOvfLeCnVH4Vt99OaLhNLoMq2tsmeyuosnKMQ6xDwzRdacmLwNH44hDNWBHs45kjypr7RCSbZE2-09ZCKuSRx0iTsmtuLlepg2czmffP-9JKiRPx_axcTBfLS_tEX9as_9qv2mkAVXXkn2uctFSfBqRGu1qOzw2yTuADrYPl4zQbxLV6zYxZyi4A0SxmmD1xaPPoFXklJbJwmFVUse55x_WBAbOw%2526sai%253DAMfl-YTSbcFd6i_Mk2hT1RrXEBgmsC-Co5lXn4WIN4mR-xFab9qd2SVppve5Yogs_tw4cIG17O5ZClCU0U5OZoKIoNKfM4zFDyiu6BamKERaGw%2526sig%253DCg0ArKJSzFZyrc-oxWemEAE%2526urlfix%253D1%2526adurl%253D
Cache-Control
no-store
Connection
keep-alive
Content-Length
0
Expires
0
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 8321
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f820f689e79fe927155372514936423b30eb400c1d2b87b6503d1398f6d352c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571051767941600"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29551
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:41 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame 8321
297 KB
99 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
6b173d87763629cab6332e13f5fce375f0656baff43c8696995f6e42d8470565

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Last-Modified
Sat, 19 Oct 2019 00:56:56 GMT
Server
AmazonS3
x-amz-request-id
CC87214EF5D132A9
ETag
"2187b9aaeaf01529cfc067f12de264d2"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=15313
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101024
x-amz-id-2
WqW+qP2m7ZeBhE7hIFQ+9pkKpIDMNnHK/BJxvlVvj3DHUMNJH9XzSe054NVTgzkA
view
securepubads.g.doubleclick.net/pcs/ Frame 5A32
0
57 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjss-FFUSCvRYoRuccgZzI1O6GHZSt9tlzZBMoSt6trvIDIwiZJGQYmJ_7TWsOpu_4crARV5XKlR3-lYMdkYSUoUtnOTFeCFGQSwYrF-eBP0TiqT-cIIiILnHBWwy-kvVg9eOlx5A9ltublOdebQ0u-nt22Llc_-jGxKDZnqJHCObHmsRAUS2tqgMY3DaHwd4it-qkgJ-SjhJmRfUaihbvMyUQ-pzlE5Ix4LM3v9U2WfQoUWNJM5jtlQ7m0dz-ZR7Ayx49ZbtKdS5pRTFC0hTijQL5_tuzlgjzDtu&sai=AMfl-YScTWA6cS-Urnq0SFnBi0ioOEKpi6UH0YJNvhfwwIPUvUAX1W8HCqq6e-ktSoeEf3hw4wqezBWC73M5hHsDbr1KdDjDR1GV8LbntXUMUA&sig=Cg0ArKJSzLvlW118wwj3EAE&urlfix=1&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:41 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
tag
a.teads.tv/page/46561/ Frame 5A32
3 KB
1 KB
Script
General
Full URL
https://a.teads.tv/page/46561/tag
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.179 , France, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-21-37-179.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
59463000704c1188d8429a1d74ba978634e70fc8fd0bd146e9ce21948cae6c39

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
gzip
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, must-revalidate, max-age=3600
access-control-allow-credentials
true
content-length
994
expires
Mon, 21 Oct 2019 16:25:41 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 5A32
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f820f689e79fe927155372514936423b30eb400c1d2b87b6503d1398f6d352c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571051767941600"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29551
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:41 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame 5A32
297 KB
99 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
6b173d87763629cab6332e13f5fce375f0656baff43c8696995f6e42d8470565

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Last-Modified
Sat, 19 Oct 2019 00:56:56 GMT
Server
AmazonS3
x-amz-request-id
CC87214EF5D132A9
ETag
"2187b9aaeaf01529cfc067f12de264d2"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=15313
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101024
x-amz-id-2
WqW+qP2m7ZeBhE7hIFQ+9pkKpIDMNnHK/BJxvlVvj3DHUMNJH9XzSe054NVTgzkA
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/ Frame 81AD
0
0
Document
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
tpc.googlesyndication.com
:scheme
https
:path
/safeframe/1-0-35/html/container.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
timing-allow-origin
*
content-length
3491
date
Mon, 21 Oct 2019 14:56:47 GMT
expires
Tue, 20 Oct 2020 14:56:47 GMT
last-modified
Fri, 21 Jun 2019 14:35:26 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, immutable, max-age=31536000
age
1734
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
view
securepubads.g.doubleclick.net/pcs/ Frame E8C9
0
57 B
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssNu1y6Koh18DwFz4bPl_kzwmStxPJ6AZkeCsCOjW1o_mIpIT-lNq5A8k2MwjDO-paTr9aky33ViMxfOOqR-Y8HM9qtcBV2rsOk1ZsZ00-usJu3vRUv8I4OWqbjzbYnQHq1fB18VVCfBv4SoV0uKCbvNso4U4muZi5Yelf_CTpquEHiJ5oUe59_bX31zbkbZ31xvkt_pg21WZ5xErfid1DLU0sLzNqbA-R3eje_E1yyfBhoX_rt4mh6TJEgypdT7fqpcGZNWgLSXmECOU79h2-d3VhdENk&sai=AMfl-YSBWkSuR_74pWAnNaDuEZ81BXQOvPCxNaI7lpecRtSSzOPpyZTjEcyVhJLaqXmbqTG5UzVl-uJ4KtdoLT11r3tIKQhhG6WZkaMldzEqFw&sig=Cg0ArKJSzMZmj9GNUo18EAE&urlfix=1&adurl=
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:41 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
Carambola_layer_152.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/ Frame E8C9
Redirect Chain
  • https://route.carambo.la/inimage/getlayer?pid=thms97&did=112441&wid=3&rdn=[RANDOM_NUMBER]
  • https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
445 KB
112 KB
Script
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40D8) /
Resource Hash
35ecea6b7f7b94fb88fd898d4af61f64aa7b353fbc8aafafd03a5f3f11fb7204

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
153409E1BF7FEBEE
x-cache
HIT
status
200
content-length
113841
x-amz-id-2
V865sMdx3k/t3D5lrABPDE+/WuUUQ/8AKIupBflK34tUpj/Ukbfq0kicUK0ioNi4ZtvpZDfsX9I=
last-modified
Mon, 12 Aug 2019 09:30:10 GMT
server
ECS (fcn/40D8)
etag
"e54fd03b3325e7a3cefa8816a52dbd14"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes

Redirect headers

Location
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Date
Mon, 21 Oct 2019 15:25:41 GMT
Server
nginx/1.14.1
Connection
keep-alive
X-Powered-By
Express
Content-Length
0
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame E8C9
77 KB
29 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
f820f689e79fe927155372514936423b30eb400c1d2b87b6503d1398f6d352c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1571051767941600"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
29551
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:41 GMT
moatad.js
z.moatads.com/reutersdfpcw319687550988/ Frame E8C9
297 KB
99 KB
Script
General
Full URL
https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
AmazonS3 /
Resource Hash
6b173d87763629cab6332e13f5fce375f0656baff43c8696995f6e42d8470565

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Last-Modified
Sat, 19 Oct 2019 00:56:56 GMT
Server
AmazonS3
x-amz-request-id
CC87214EF5D132A9
ETag
"2187b9aaeaf01529cfc067f12de264d2"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
max-age=15313
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
101024
x-amz-id-2
WqW+qP2m7ZeBhE7hIFQ+9pkKpIDMNnHK/BJxvlVvj3DHUMNJH9XzSe054NVTgzkA
pixelNew.js
s3.amazonaws.com/scripts-clickmeter-com/js/ Frame E8C9
Redirect Chain
  • https://pixel.watch/q4m9
  • https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
2 KB
2 KB
Image
General
Full URL
https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.205.29 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:43 GMT
Last-Modified
Wed, 17 Dec 2014 10:04:21 GMT
Server
AmazonS3
x-amz-request-id
904F713E059927CC
ETag
"5ecfcd6d8fa19e88256687ff922f77d0"
Content-Type
application/x-javascript
x-amz-storage-class
REDUCED_REDUNDANCY
Accept-Ranges
bytes
Content-Length
2271
x-amz-id-2
s3juXHUFqR/GEx5y1EAWb9amkGuUpnWQ+83bYVyV2s8nAX0GYZSzsKR/kV9x6bRE6MgNyT8eLjk=

Redirect headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
X-Rate-Limit-Limit
20s
X-Rate-Limit-Remaining
299
Location
https://s3.amazonaws.com/scripts-clickmeter-com/js/pixelNew.js
X-Rate-Limit-Reset
2019-10-21T15:26:01.8093710Z
Engine
clickmeter.redirect, version 2.0
Connection
keep-alive
Content-Length
0
5189420777
dfp-gateway.s-onetag.com/1/4735792/
112 B
569 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/5189420777
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:9e00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
8a4d12e5be972c41fafa90e374ff50d36d59f1a0d15af42e0083ef7b0ed0e25b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 14:30:58 GMT
via
1.1 c55f09a9188f77960d35c97bad15e1b2.cloudfront.net (CloudFront), 1.1 a09186728c1bcdf0a561aedd92656804.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2, FRA50-C1
x-amzn-requestid
101bf56a-6212-4f3e-b6d7-da2c1b5e21e5
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5dadc122-1fcdfc512b1cf3697b8680de;Sampled=0
x-amz-apigw-id
B6sdeECCyK4Fm2g=
content-length
112
x-amz-cf-id
Whkyx7vEpyEQfPg4gDRWZQlY_DiZoMSRj4rR4-Ueai41lTiKRj_EjA==
5158696277
dfp-gateway.s-onetag.com/1/4735792/
112 B
573 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/5158696277
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:9e00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
9bb325b1075835a9fb5317344971b933cb6762b32ba15533e07c9505b6d4f2c7

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
via
1.1 850ccace60916919bf31313cb9176e01.cloudfront.net (CloudFront), 1.1 a09186728c1bcdf0a561aedd92656804.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA53-C1, FRA50-C1
x-amzn-requestid
1b11f699-6dfa-4c54-b610-78adbe854959
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5dadcdf5-7756925aa7b9f53c1870b858;Sampled=0
x-amz-apigw-id
B60ecFMrSK4FlMQ=
content-length
112
x-amz-cf-id
4SjkrvqgQn6NRCsSk6d8lEeHmz_g-DDW5Ch89Hm8OftgGa3qw6k9gw==
4741317042
dfp-gateway.s-onetag.com/1/4735792/
119 B
580 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/4741317042
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:9e00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
1469ce4dab8ec9f7506ac192f45056e1b3e6ef639247db13752046e111d723c6

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 14:48:32 GMT
via
1.1 3b02f73dccc5077f1ad544a27a475ed6.cloudfront.net (CloudFront), 1.1 a09186728c1bcdf0a561aedd92656804.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1, FRA50-C1
x-amzn-requestid
cc3b24b5-d097-4396-b3cd-403e9bd23e64
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5dadc540-1484f1a0f984e35d093d49ed;Sampled=0
x-amz-apigw-id
B6vCDGDqyK4Fkug=
content-length
119
x-amz-cf-id
1TG1ycXaknFdTOmQFYREYISKPIyXQkkhKaOzkuajoyAtxruIOiwmiA==
5153856862
dfp-gateway.s-onetag.com/1/4735792/
112 B
572 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/5153856862
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:9e00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
31788c18070c89ef7fd5d07c6f1fc171df082bb17915f92f149ec5f58ce59b10

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:02:14 GMT
via
1.1 3bf3e75bcb9a86b3eb343a1d4392a6df.cloudfront.net (CloudFront), 1.1 a09186728c1bcdf0a561aedd92656804.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1, FRA50-C1
x-amzn-requestid
955feabb-6332-42e0-81c8-d7faba3a2ffe
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5dadc876-a452043876171cd879697c60;Sampled=0
x-amz-apigw-id
B6xClEJsyK4FiSw=
content-length
112
x-amz-cf-id
wWBtaCdmt_gKzV66Oya20IWUQ_WSZzVODzvAxBOWPXaLKC3RB7H7CQ==
139199112
dfp-gateway.s-onetag.com/1/4735792/
114 B
577 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/139199112
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:9e00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
58d94b06f15b9a1ea02b26e3a0454a7921cda64a5769657e333cba9d9a0bb485

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:23 GMT
via
1.1 edfd22ec6695cdc9d7ac634220af1315.cloudfront.net (CloudFront), 1.1 a09186728c1bcdf0a561aedd92656804.cloudfront.net (CloudFront)
age
18
x-amzn-requestid
809a4821-c678-4bde-8f08-f2310706f03b
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5dadcde3-052e4ac06e5f574011eca600;Sampled=0
x-amz-cf-pop
FRA2-C2, FRA50-C1
x-amz-apigw-id
B60bfExNSK4Fn3A=
content-length
114
x-amz-cf-id
HwNLAkQ0E2sVmr-khn8DqceoW4SgG_2-3CfeDXzxEadKaod1dunRUg==
/
utoumine.net/s/ad-time/
68 B
422 B
Image
General
Full URL
https://utoumine.net/s/ad-time/?e=15&m=19&d=20170522&t=9&i=7208423087&w=001&r=VIJGSPY3ykYVh.jpg
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
136.243.25.80 , Germany, ASN24940 (HETZNER-AS, DE),
Reverse DNS
api.addefend.com
Software
ADFCDN/5.2.3 / AdDefend GmbH
Resource Hash
adfa0c7de03bc3bea3de80b4a4514881c8b6296568f43a5acd5cd7a16fffd1c9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Server
ADFCDN/5.2.3
X-Powered-By
AdDefend GmbH
Content-Type
image/png
Cache-Control
max-age=0, max-stale=0, must-revalidate, no-cache, no-store, no-transform, post-check=0, pre-check=0, private
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
68
Expires
0
adunit.js
services.brid.tv/player/build/plugins/ Frame 66C3
30 B
430 B
Script
General
Full URL
https://services.brid.tv/player/build/plugins/adunit.js
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.94 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-94.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
9c25c4e240bd28a308851f487711c88680072496bf9865fb73a258dff5ca3fd9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 02:34:45 GMT
content-encoding
gzip
last-modified
Wed, 06 Jun 2018 07:10:50 GMT
server
AmazonS3
age
46257
etag
"00472f99064e3d4328bd208da8c0b958"
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
public, max-age=31536000
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
content-length
50
via
1.1 9ab847fabb8c9edbd39cff57c2a2f4c0.cloudfront.net (CloudFront)
x-amz-cf-id
QeHUbvfEz54CQl6LafZEpCTdSPvBs9-PC234cMRyoc29g6h0E1YmYA==
truncated
/ Frame 66C3
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
c963723522ef96a48fe7ab1846e55e7fa3681b1d03be41b59cfe14271353a0d0

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame AB07
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=610609812&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=0a7a4091-f417-11e9-9767-00259086cc16
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
d516a71643a785858469e7133d84eed0502f914b4abd8afbddf8192c67cdef5c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
X-Server-Name
app50ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
11615.json
services.brid.tv/services/unit/ Frame 66C3
2 KB
1 KB
XHR
General
Full URL
https://services.brid.tv/services/unit/11615.json
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.94 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-94.fra50.r.cloudfront.net
Software
Apache /
Resource Hash
fb2c8395640565b0f734e404d34f7f8d7246bf847a96d0d0ef83f265e6844771

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:16:32 GMT
content-encoding
gzip
age
516
x-cache
Hit from cloudfront
status
200
content-length
825
x-served-by
media-lb-3
access-control-allow-origin
*
server
Apache
vary
Accept-Encoding
access-control-allow-methods
GET, OPTIONS
content-type
application/json; charset=UTF-8
via
1.1 f6c241b75ae7d21ac836339454ab90b8.cloudfront.net (CloudFront)
cache-control
no-store, no-cache, must-revalidate, post-check=0, pre-check=0
x-amz-cf-pop
FRA50-C1
access-control-allow-headers
origin, x-requested-with, content-type, accept
x-amz-cf-id
5GAL6A57lcekE8el2X6OXt8n4ewmSu1lbmensZLWaOHnDZdNhMshqg==
truncated
/ Frame 5A32
212 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
cc83c80b5df3a2598005c0b5f37238d5ab0a8bc14ee31a1009c2f8a37147065c

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame E665
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=37592232&placementId=4741317042&pubCreative=138206523841&pubOrder=2107429564&cb=614615616&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=0a7add7e-f417-11e9-8240-00259086cc1c
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
9f9966e9fd3614e1cbf07d26eea1f447491137cb4cb60971d09788401c5d1781

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
X-Server-Name
app50ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
truncated
/ Frame E8C9
211 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5f5e5522b4d70619f36859f604530e9baf6252c27abd109f3c85b9efd7bd2f10

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame AF22
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1759352134&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=0a79cbab-f417-11e9-aea2-382c4ac63189
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
7d8058d3d6a9d9cffdaf94bbe002e9b1956b5519cb064c51eddfe3f33d65e530

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
X-Server-Name
app14ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
n.js
geo.moatads.com/
110 B
285 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%7DGH%3Ch%2Cqkc!p!ny%7BiY81%22ASYUby%3D(tN%23V.x%3Bm_Qrw5.W%2F84VKp%40i6AKx!f%3EUYoo813_xB%2CN%7CDoD%3DhA&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBny6BsNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF6GfC6Jn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=%25Gv%3CS*hN%3BR&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=REUTERSDFPCW3&hp=1&wf=1&vb=6&cm=6&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571671541590&de=659252311504&m=0&ar=6907c9d928-clean&iw=6919a0a&q=2&cb=0&ym=0&cu=1571671541590&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4789302609%3A2599246982%3A5189420777%3A138289622787&zMoatTP=mpu&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=37592232&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=37592232&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=37592232&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&id=1&zMoatBlacklist=true&bo=3735912&bd=37592232&dfp=0%2C1&la=37592232&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=173050&na=565254401&cs=0&callback=DOMlessLLDcallback_51917965
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.9.56.242 London, United Kingdom, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-3-9-56-242.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
10d0c3672483f1ba461c0601bb4efcd0751a63f5df5ecb2a22ca805e1cf0f9fb

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
server
TornadoServer/4.5.3
etag
"df6a71fd1a5353fe45e3b91907b5fdb922033bbf"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
110
n.js
geo.moatads.com/
113 B
287 B
Script
General
Full URL
https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!Z.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%7DGH%3Ch%2Cqkc!p!ny%7BiY81%22ASYUby%3D(tN%23V.x%3Bm_Qrw5.W%2F84VKp%40i6AKx!f%3EUYoo813_xB%2CN%7CDoD%3DhA&qp=00000&is=hBBnjB7GsBpBBBPY2CEBsCybBqw776Kqi7gBooCvBOCiCOB6sCqGBgiBBs0fW0glMfcxnBBBkB0BYBny6BsNBmB0ziw7pCr6yC6rO24xXmYyBdfEC2BBBBBjzmBktCP97GBBBGwRmmEBBBBBBBBBBBnaBW35CeFaBBBpx0OFiBBBT5392tavKc5KCdzzFs7nBBBBBBBBRcQyRBBBCpjOBBBBBBBBBTLF6GfC6Jn7O0EYkCBB0IofRfBBPCxB7UBbjtBbBBC0dL9TRhq8K55G96Lo0eIRTzBiqeuSBBBBBB&iv=7&qt=0&gz=0&hh=0&hn=0&tw=%25Gv%3CS*hN%3BR&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=REUTERSDFPCW3&hp=1&wf=1&vb=6&cm=6&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571671541590&de=659252311504&m=0&ar=6907c9d928-clean&iw=6919a0a&q=3&cb=0&ym=0&cu=1571671541590&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4789302609%3A2599246982%3A5189420777%3A138289622787&zMoatTP=mpu&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=37592232&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=37592232&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=37592232&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&id=1&zMoatBlacklist=true&bo=3735912&bd=37592232&dfp=0%2C1&la=37592232&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=173050&na=1560431202&cs=0&callback=MoatDataJsonpRequest_51917965
Requested by
Host: z.moatads.com
URL: https://z.moatads.com/reutersdfpcw319687550988/moatad.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.9.56.242 London, United Kingdom, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-3-9-56-242.eu-west-2.compute.amazonaws.com
Software
TornadoServer/4.5.3 /
Resource Hash
33b0e1ba1b0c4207be36cf03a354643cbbf5567beb09f884db7f96de7f17bbb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
server
TornadoServer/4.5.3
etag
"3bc5be1bb9cad8f3af2490914a72b58a59838ca7"
content-type
text/html; charset=UTF-8
status
200
cache-control
max-age=900
timing-allow-origin
*
content-length
113
pixel.gif
px.moatads.com/
43 B
409 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=17&i=REUTERSDFPCW3&hp=1&wf=1&vb=6&cm=6&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571671541590&de=659252311504&m=0&ar=6907c9d928-clean&iw=6919a0a&q=4&cb=0&ym=0&cu=1571671541590&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4789302609%3A2599246982%3A5189420777%3A138289622787&zMoatTP=mpu&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=37592232&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=37592232&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=37592232&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&id=1&zMoatBlacklist=true&bo=3735912&bd=37592232&dfp=0%2C1&la=37592232&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=173050&na=13222517&cs=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:41 GMT
5189420777
dfp-gateway.s-onetag.com/1/4735792/
112 B
567 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/5189420777
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:9e00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
8a4d12e5be972c41fafa90e374ff50d36d59f1a0d15af42e0083ef7b0ed0e25b

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 14:30:58 GMT
via
1.1 c55f09a9188f77960d35c97bad15e1b2.cloudfront.net (CloudFront), 1.1 a09186728c1bcdf0a561aedd92656804.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2, FRA50-C1
x-amzn-requestid
101bf56a-6212-4f3e-b6d7-da2c1b5e21e5
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5dadc122-1fcdfc512b1cf3697b8680de;Sampled=0
x-amz-apigw-id
B6sdeECCyK4Fm2g=
content-length
112
x-amz-cf-id
Ut6K0h5z2GbEdMUv80jpVCMhsLVBVtdxsbj1J3u6Ljomnw3jWAtilA==
5153856862
dfp-gateway.s-onetag.com/1/4735792/
112 B
572 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/5153856862
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:9e00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
31788c18070c89ef7fd5d07c6f1fc171df082bb17915f92f149ec5f58ce59b10

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:02:14 GMT
via
1.1 3bf3e75bcb9a86b3eb343a1d4392a6df.cloudfront.net (CloudFront), 1.1 a09186728c1bcdf0a561aedd92656804.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA2-C1, FRA50-C1
x-amzn-requestid
955feabb-6332-42e0-81c8-d7faba3a2ffe
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5dadc876-a452043876171cd879697c60;Sampled=0
x-amz-apigw-id
B6xClEJsyK4FiSw=
content-length
112
x-amz-cf-id
mXyy7Jmrlk1BOnJC2cgR7lKDEdEBqT4a8o7HSHcpWJQYR5DDg4gQPw==
139199112
dfp-gateway.s-onetag.com/1/4735792/
114 B
578 B
XHR
General
Full URL
https://dfp-gateway.s-onetag.com/1/4735792/139199112
Requested by
Host: get.s-onetag.com
URL: https://get.s-onetag.com/4ed1416f-67eb-4d50-8a45-916a5921fee8/tag.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:9e00:a:52eb:a100:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
58d94b06f15b9a1ea02b26e3a0454a7921cda64a5769657e333cba9d9a0bb485

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:23 GMT
via
1.1 edfd22ec6695cdc9d7ac634220af1315.cloudfront.net (CloudFront), 1.1 a09186728c1bcdf0a561aedd92656804.cloudfront.net (CloudFront)
age
18
x-amzn-requestid
809a4821-c678-4bde-8f08-f2310706f03b
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600, public
x-amzn-trace-id
Root=1-5dadcde3-052e4ac06e5f574011eca600;Sampled=0
x-amz-cf-pop
FRA2-C2, FRA50-C1
x-amz-apigw-id
B60bfExNSK4Fn3A=
content-length
114
x-amz-cf-id
pQpL-4Qglb3fCx3H_oNlovpkfe4myt88FSC9fIRwnQpeuRQYTEviUQ==
brid.parser.min.js
p.brid.tv/player/build/plugins/parser/1.1.42/ Frame 66C3
83 KB
24 KB
Script
General
Full URL
https://p.brid.tv/player/build/plugins/parser/1.1.42/brid.parser.min.js
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.60 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-60.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
37642757d1d414dac352b8cc0869fa65b771300432e518e0e6ac6551b55181d5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 27 Sep 2019 08:25:58 GMT
content-encoding
gzip
last-modified
Fri, 27 Sep 2019 08:25:48 GMT
server
AmazonS3
age
25068
etag
"b79fb9eed71dd061b0ed7d88150263de"
x-cache
Hit from cloudfront
content-type
application/javascript
status
200
cache-control
max-age=31536000, public, immutable
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
content-length
24072
via
1.1 57d93b321db68494cc6755a0d3fb29cd.cloudfront.net (CloudFront)
x-amz-cf-id
dMm6jahKfb16wCPiI46F7I9NVPAnqmmoWbyEN0gzTHd2chYQPEnX4A==
event
reuters.demdex.net/
3 KB
3 KB
XHR
General
Full URL
https://reuters.demdex.net/event?d_dil_ver=9.3&_ts=1571671541677
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.50.81.152 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-50-81-152.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
d8af0af9beba52e5155c2d8d4622b69e0e137627983cdac8b74453a75005e5a0
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded

Response headers

DCS
dcs-prod-irl1-v048-0fc41c29f.edge-irl1.demdex.com 5.61.0.20191015084456 4ms (+1ms)
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
X-TID
O3JD9szuRqo=
Vary
Origin
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json;charset=utf-8
Content-Length
2670
Expires
Thu, 01 Jan 1970 00:00:00 GMT
teads-format.min.js
a.teads.tv/media/format/v3/
708 KB
184 KB
Script
General
Full URL
https://a.teads.tv/media/format/v3/teads-format.min.js
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/page/46561/tag
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.179 , France, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-21-37-179.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
a3685f15406c8ccf53f6d1c1c08df2d34ea3abf369b8ac1b425e6a6b400fae1b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
gzip
last-modified
Mon, 21 Oct 2019 08:02:22 GMT
x-amz-request-id
AD8E232A1E87E3FB
etag
"7eb3eebc3691aadfcdf8a3b5910edecf"
vary
Accept-Encoding
content-type
text/javascript;charset=utf-8
status
200
cache-control
private, must-revalidate, max-age=600
x-bucket
8
accept-ranges
bytes
content-length
187953
x-amz-id-2
bxxjNigxFgW/ROULE9eJukYOGCXunFNyXx8k29vI+aFy8i5T3UnuZoxTldcRKKeiZKWWJ1Lc22U=
expires
Mon, 21 Oct 2019 15:35:41 GMT
main.19.8.22.js
static.adsafeprotected.com/ Frame AB07
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=610609812&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=0a7a4091-f417-11e9-9767-00259086cc16
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app40ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
main.19.8.22.js
static.adsafeprotected.com/ Frame AF22
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1759352134&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=0a79cbab-f417-11e9-aea2-382c4ac63189
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app11ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
main.19.8.22.js
static.adsafeprotected.com/ Frame E665
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=2x2&pubId=54423312&chanId=37592232&placementId=4741317042&pubCreative=138206523841&pubOrder=2107429564&cb=614615616&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=0a7add7e-f417-11e9-8240-00259086cc1c
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app03ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
pixel.gif
px.moatads.com/
43 B
409 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=17&i=REUTERSDFPCW3&hp=1&wf=1&vb=6&cm=3&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1571671541652&de=17994133587&m=0&ar=6907c9d928-clean&iw=6919a0a&q=9&cb=0&ym=0&cu=1571671541652&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=54423312%3A2107429564%3A4741317042%3A138206523841&zMoatTP=canvas&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=37592232&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=37592232&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=37592232&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&id=1&zMoatBlacklist=true&bo=3735912&bd=37592232&dfp=0%2C1&la=37592232&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=173050&na=352168448&cs=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:41 GMT
truncated
/
2 KB
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
9d02d662da8a47fb5fb610b545007507b6017028043dbb63cd09ec897d3b9627

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
truncated
/
715 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
5a3f1dd74233f605e511f1b5b244bedf85ac88ba264caf4d6401bc7ec2017dcd

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
ping.gif
stats-dev.brid.tv/ Frame 66C3
0
347 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&apa=0&df=1&os=l&m=0&ow=14120&e=l
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.2 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-2.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 20:32:20 GMT
via
1.1 df26103dc140569d7032449c70c3b141.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
68064
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
content-length
0
x-amz-cf-id
7fvP8L85jUuaFNRqOOTjKh5lYtRJU8ozb98dFwlSY53ZC4Hpq7W-4w==
ping.gif
stats-dev.brid.tv/ Frame 66C3
0
346 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&os=l&m=0&apa=0&df=1&ow=14120&pub=p&e=r&aid=9261&par=b&wp=0&at=0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.2 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-2.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 20:32:20 GMT
via
1.1 df26103dc140569d7032449c70c3b141.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
68064
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
content-length
0
x-amz-cf-id
NpumZRexSspoIttxCldVPU3BWvilUbV7YdU5W583HktTdDSRtHQmRQ==
AddLogs
logging.carambo.la/ Frame E8C9
0
176 B
XHR
General
Full URL
https://logging.carambo.la/AddLogs
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.224.94.188 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-224-94-188.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/x-www-form-urlencoded

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:40 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
b960e43a872261771882a5e456a7acc1_cbe39601368556c2166fa9ec0a7ff09457fe52d3_incontent_unified_3.json
inimage.carambo.la/1/thms97/112441/ Frame E8C9
3 KB
1 KB
XHR
General
Full URL
https://inimage.carambo.la/1/thms97/112441/b960e43a872261771882a5e456a7acc1_cbe39601368556c2166fa9ec0a7ff09457fe52d3_incontent_unified_3.json
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40E4) /
Resource Hash
3967d055a26418e2631a0f70d1ed3e831788ade14cffe65ce4f19caef16f31c0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
D2FF74C7523082BB
x-cache
HIT
status
200
content-length
1057
x-amz-id-2
msSn7RXnifYiMpnbs02r3UukqGH6DiZucO7s/bPWlwUReFqIs5mi0uCKm9zPYU8mIg1O9HPSOrA=
x-amz-expiration
expiry-date="Wed, 23 Oct 2019 00:00:00 GMT", rule-id="delete files after 24 hours"
last-modified
Mon, 21 Oct 2019 04:25:21 GMT
server
ECS (fcn/40E4)
etag
"dfbf6ef17f170ec734664e50d3b771f1"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=0, s-maxage=14400
accept-ranges
bytes
xml;dc_sdk_apis=[APIFRAMEWORKS];dc_omid_p=[OMIDPARTNER]
ad.doubleclick.net/ddm/pfadx/N1181610.3639REUTERS.COM/B23276979.256194050;sz=0x0;ord=1571671541785;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;dcmt=text/ Frame 66C3
32 KB
9 KB
XHR
General
Full URL
https://ad.doubleclick.net/ddm/pfadx/N1181610.3639REUTERS.COM/B23276979.256194050;sz=0x0;ord=1571671541785;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;dcmt=text/xml;dc_sdk_apis=[APIFRAMEWORKS];dc_omid_p=[OMIDPARTNER]
Requested by
Host: services.brid.tv
URL: https://services.brid.tv/player/build/brid.outstream.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
216.58.205.230 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s24-in-f230.1e100.net
Software
cafe /
Resource Hash
37ca327304686096d3334f12eae7efd7ce632a0168707214da2726e7ff2b5024
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
8904
x-xss-protection
0
pragma
no-cache
server
cafe
content-type
text/xml; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
index.html
cmp.teads.mgr.consensu.org/ Frame 760B
0
0
Document
General
Full URL
https://cmp.teads.mgr.consensu.org/index.html
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2a02:26f0:6c00:292::2c92 , Ascension Island, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
Software
AmazonS3 /
Resource Hash

Request headers

Host
cmp.teads.mgr.consensu.org
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

x-amz-id-2
eP74N5mDf2mwuUwz6E0m831egGDvXvr6HEIydDhB20yVDuv4ZE6ina8YQaGiXGlfbz2w11Bw+zo=
x-amz-request-id
93A9209AF986CF84
Last-Modified
Fri, 14 Sep 2018 07:42:32 GMT
ETag
"e7d6c2974a38b7ff77a560e83789f66a"
Accept-Ranges
bytes
Content-Type
text/html
Content-Length
583
Server
AmazonS3
Cache-Control
max-age=300
Expires
Mon, 21 Oct 2019 15:30:41 GMT
Date
Mon, 21 Oct 2019 15:25:41 GMT
Connection
keep-alive
p2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/p?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571671541888&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_s...
  • https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571671541888&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_...
43 B
309 B
Image
General
Full URL
https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571671541888&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=89722632&cs_ucfr=1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.43.115.95 , Netherlands, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a23-43-115-95.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
24e480e4659fbae818853a38f8a3036f529f539024dc3e772c0b594ce02ea9db

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/p2?c1=2&c2=17198971&ns_ap_sv=2.1511.10&ns_type=hidden&ns_st_it=a&ns_st_sv=4.0.0&ns_st_ad=1&ns_st_sq=1&ns_st_id=1571671541888&ns_st_ec=1&ns_st_cn=1&ns_st_ev=play&ns_st_ct=va00&ns_st_cl=0&ns_st_pt=0&c3=*null&c4=*null&c6=*null&ns_ts=89722632&cs_ucfr=1
Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=placementCall&ts=1571671541885&pageId=46561&pid=78293&env=js-web&pfid=[pfid]&f=1&fv=undefined-master
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Mon, 21 Oct 2019 15:25:41 GMT
cache-control
max-age=0, no-cache, no-store
expires
Mon, 21 Oct 2019 15:25:41 GMT
content-length
23
content-type
image/gif
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=slotAvailable&ts=1571671541885&pageId=46561&pid=78293&env=js-web&pfid=[pfid]&f=1&slot=native&fv=undefined-master
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Mon, 21 Oct 2019 15:25:41 GMT
cache-control
max-age=0, no-cache, no-store
expires
Mon, 21 Oct 2019 15:25:41 GMT
content-length
23
content-type
image/gif
sca.17.4.95.js
static.adsafeprotected.com/ Frame 5299
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app03ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=300x250&pubId=4789302609&chanId=37592232&placementId=5189420777&pubCreative=138289622787&pubOrder=2599246982&cb=610609812&custom=mpu&custom2=400&custom3=0&adsafe_par&impId=0a7a4091-f417-11e9-9767-00259086cc16&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&adsafe_type=abdfq&adsafe_jsinfo=,id:39ee33eb-fb9f-7ece-5a9a-6235abb6c0f5,c:rHe9tN,sl:inView,em:true,fr:true,mn:app50ami,pt:1-5-15,wc:0.0.1600.1200,ac:1140.686.300.250,am:i,cc:1140.686.300.250,piv:100,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d|1e1|1f1|1f2|1f3|1g1|1h|1i,idMap:1c*,pl:,rend:1,renddet:DIV.qs.sn,rmeas:1,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:261,oid:0ae64986-f417-11e9-8f6c-382c4ac630f9,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
X-Server-Name
app14ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
sca.17.4.95.js
static.adsafeprotected.com/ Frame 3D7D
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app37ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=300x280&pubId=20159232&chanId=37592232&placementId=139199112&pubCreative=138204787707&pubOrder=277213512&cb=1759352134&custom=bizdev_article_rr2&custom2=20000&custom3=0&adsafe_par&impId=0a79cbab-f417-11e9-aea2-382c4ac63189&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&adsafe_type=abdfq&adsafe_jsinfo=,id:3b44d41f-d553-031c-b3d6-035bd71ea353,c:rHe9u4,sl:outOfView,em:true,fr:true,mn:app14ami,pt:1-5-15,wc:0.0.1600.1200,ac:1140.3326.300.280,am:i,cc:1140.3326.300.280,piv:0,obst:0,th:0,reas:l,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFy5Cr2+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d|1e1|1f1|1f2|1f3|1g*.10764|1g1|1h|1i,idMap:1g*,pl:,rend:1,renddet:DIV.qs.sn,rmeas:1,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:272,oid:0ae9cbf2-f417-11e9-9814-0025908827f0,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
X-Server-Name
app50ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
SetPageRequestGeo
analytics.carambo.la/ Frame E8C9
35 B
332 B
Fetch
General
Full URL
https://analytics.carambo.la/SetPageRequestGeo
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.210.116.191 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-210-116-191.compute-1.amazonaws.com
Software
/
Resource Hash
a3b59cf3c15a5896f4224c367d24e647fe14e411b8024dcc87aa37783e0cf110

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
35
Expires
-1
css
fonts.googleapis.com/ Frame E8C9
9 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
33e2656713e8648323bd5193b2e314db7df61f4d37d5df4ce22ad72b04a1166a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 21 Oct 2019 15:25:42 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Mon, 21 Oct 2019 15:25:42 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:42 GMT
css
fonts.googleapis.com/
9 KB
734 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
33e2656713e8648323bd5193b2e314db7df61f4d37d5df4ce22ad72b04a1166a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 21 Oct 2019 15:25:42 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Mon, 21 Oct 2019 15:25:42 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:42 GMT
css
fonts.googleapis.com/ Frame E8C9
24 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
0a733c9a259685cf9a9816145434c0087227f35400e16208e7e63e58ccd44538
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 21 Oct 2019 15:25:42 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Mon, 21 Oct 2019 15:25:42 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:42 GMT
css
fonts.googleapis.com/
24 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
0a733c9a259685cf9a9816145434c0087227f35400e16208e7e63e58ccd44538
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Mon, 21 Oct 2019 15:25:42 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Mon, 21 Oct 2019 15:25:42 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:42 GMT
Knowledge-Medium.woff
static.reutersmedia.net/resources_v2/fonts/ Frame E8C9
24 KB
24 KB
Font
General
Full URL
https://static.reutersmedia.net/resources_v2/fonts/Knowledge-Medium.woff
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.67 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-67.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
ae62fb7dca96004b13d628bf9deaa48d592259489d50369e6998929cfafe590f

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 01:32:31 GMT
content-encoding
gzip
age
136391
x-cache
Hit from cloudfront
status
200
content-length
24497
access-control-allow-origin
*
last-modified
Wed, 29 Mar 2017 00:52:23 GMT
server
nginx
vary
Accept-Encoding
content-type
application/x-font-woff
via
1.1 d55780b776b171387055eca956ae29a9.cloudfront.net (CloudFront)
cache-control
max-age=604800
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
clvwwxAoflEkK-HXO2gXLknkWfl0dOckhoUyU1J9VdfL3n9mdaY71A==
expires
Tue, 08 Oct 2019 18:56:35 GMT
Knowledge-Regular.woff
static.reutersmedia.net/resources_v2/fonts/ Frame E8C9
24 KB
24 KB
Font
General
Full URL
https://static.reutersmedia.net/resources_v2/fonts/Knowledge-Regular.woff
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.67 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-67.fra50.r.cloudfront.net
Software
nginx /
Resource Hash
4e75f5bbf505e72bd2fc760536a94e16ee82202ec60757a8815a0273dc5ae85d

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 00:25:05 GMT
content-encoding
gzip
age
140437
x-cache
Hit from cloudfront
status
200
content-length
24249
access-control-allow-origin
*
last-modified
Wed, 29 Mar 2017 00:52:26 GMT
server
nginx
vary
Accept-Encoding
content-type
application/x-font-woff
via
1.1 d55780b776b171387055eca956ae29a9.cloudfront.net (CloudFront)
cache-control
max-age=604800
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
opbt0aNJq8Dc99E_lxYnCujxL_VqdHl7uHsUzgaTUzgxM6XHk_mC7A==
expires
Fri, 25 Oct 2019 19:41:43 GMT
cbolaIcons.woff
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/css/fonts/ Frame E8C9
4 KB
4 KB
Font
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/css/fonts/cbolaIcons.woff?phtwnv
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40DA) /
Resource Hash
c85a8e7c2d1d0583578b2afd3a1ce469797bfa5c9d5598cba25f51f839348ec8

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
last-modified
Mon, 12 Aug 2019 09:30:07 GMT
server
ECS (fcn/40DA)
x-amz-request-id
EB7763FE05F63708
status
200
etag
"dae3eb8c820d3bbb16a17610dece1c88"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
application/octet-stream
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
x-cache
HIT
accept-ranges
bytes
content-length
3832
x-amz-id-2
7MUht4mVKz4ngR9jgyvmir1wZGEjO9QI/rIZ/srGx3xO9UJu61r4NOknLMNQ46mu1ltfrbqjbSk=
SetPageElementsRequestNew
analytics.carambo.la/ Frame E8C9
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetPageElementsRequestNew
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.210.116.191 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-210-116-191.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
GetAds
xtr.carambo.la/ Frame E8C9
10 KB
2 KB
Fetch
General
Full URL
https://xtr.carambo.la/GetAds
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.239.9.60 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-239-9-60.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
1299e53ba1649682c4f25d89297450860f282b07a71388be8509635f4b991f2d

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
deflate
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Connection
keep-alive
Content-Length
2198
Expires
-1
28634_3_10.jpg
media.carambo.la/Images/ Frame E8C9
15 KB
15 KB
Image
General
Full URL
https://media.carambo.la/Images/28634_3_10.jpg
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/41AE) /
Resource Hash
2c23375288cbdd49313713cab32cd1846f2d3435658c9809b865cad5dd2ca021

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
last-modified
Sun, 19 May 2019 09:15:33 GMT
server
ECS (fcn/41AE)
x-amz-request-id
FEDA265519C40264
status
200
etag
"8e65d85bf5b54be8007159521eda7902"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
x-cache
HIT
accept-ranges
bytes
content-length
15382
x-amz-id-2
iYqmC5usQ5Vr1PTpAVMH29ynbbw1QGYNtQXtz8ONSF7e5GutyKxo2+oy+Yei09I+TcsbFxJ3YB4=
4717_3_10.jpg
media.carambo.la/Images/ Frame E8C9
7 KB
7 KB
Image
General
Full URL
https://media.carambo.la/Images/4717_3_10.jpg
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40E4) /
Resource Hash
ed30c27a0c5befd0ddef3cc24cd36c184dd022545942ee62585fd1bda9cf3084

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
last-modified
Thu, 11 May 2017 11:05:15 GMT
server
ECS (fcn/40E4)
x-amz-request-id
C4E33D75B66C3D63
status
200
etag
"0d8852d6d000972120b6bbf9f63a34de"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
7227
x-amz-id-2
LCNFAL83kzmrOjnAQrKzUniMDn+g5nAZpuYTPWp+j2WAxRCRl3qS1MI8EtPo0o/EtTGE9WP79IE=
3415_3_10.jpg
media.carambo.la/Images/ Frame E8C9
10 KB
10 KB
Image
General
Full URL
https://media.carambo.la/Images/3415_3_10.jpg
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/418E) /
Resource Hash
d90447454adfbf82f4bdcbc33cdf640da16766bf839d2cf197248bbbc63d58cf

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:47 GMT
last-modified
Thu, 11 May 2017 11:05:47 GMT
server
ECS (fcn/418E)
x-amz-request-id
F28BF5BD0DC1E29D
status
200
etag
"3d50a2cdd82d8488c71722a411c5a962"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
image/jpeg
access-control-allow-origin
*
x-cache
HIT
accept-ranges
bytes
content-length
9857
x-amz-id-2
V7w6gGh/OfryVQho7CtuFnqzYTtqC+CW7jjgAzLHjuQz5cVy82cR8BsdLCaUxNAKnnWsWk+v1vw=
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=39ee33eb-fb9f-7ece-5a9a-6235abb6c0f5&tv={c:rHe9vC,pingTime:0,time:373,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:260}],es:0,sc:1,ha:1,gm:1,slTimes:{i:373,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:260,wc:0.0.1600.1200,ac:1140.686.300.250,am:i,cc:1140.686.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[130~100],as:[130~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d|1e1|1f1|1f2|1f3|1g1|1h|1i,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt44.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
index.html
img.mediaplex.com/content/0/2399/250799/is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250/ Frame 2E39
0
0
Document
General
Full URL
https://img.mediaplex.com/content/0/2399/250799/is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250/index.html?mpt=785004098&mpssl=1&mpck=altfarm.mediaplex.com%2Fad%2Fck%2F2399-250799-36431-8%3Fmpt%3D785004098%26mpcr%3D102570365%26mpcrset%3Droot&mpvc=https%3A%2F%2Fadclick.g.doubleclick.net%2Fpcs%2Fclick%253Fxai%253DAKAOjsvNzdnP88lAyGnZgjMT44dqfnXsopY89_Mel7mNBCCXtNc9A6vRdQUVrQl4u8bkqkT9AwYOvfLeCnVH4Vt99OaLhNLoMq2tsmeyuosnKMQ6xDwzRdacmLwNH44hDNWBHs45kjypr7RCSbZE2-09ZCKuSRx0iTsmtuLlepg2czmffP-9JKiRPx_axcTBfLS_tEX9as_9qv2mkAVXXkn2uctFSfBqRGu1qOzw2yTuADrYPl4zQbxLV6zYxZyi4A0SxmmD1xaPPoFXklJbJwmFVUse55x_WBAbOw%2526sai%253DAMfl-YTSbcFd6i_Mk2hT1RrXEBgmsC-Co5lXn4WIN4mR-xFab9qd2SVppve5Yogs_tw4cIG17O5ZClCU0U5OZoKIoNKfM4zFDyiu6BamKERaGw%2526sig%253DCg0ArKJSzFZyrc-oxWemEAE%2526urlfix%253D1%2526adurl%253D
Requested by
Host: secure.img-cdn.mediaplex.com
URL: https://secure.img-cdn.mediaplex.com/content/0/2399/250799/is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250.js?mpck=altfarm.mediaplex.com%2Fad%2Fck%2F2399-250799-36431-8%3Fmpt%3D785004098%26mpcr%3D102570365%26mpcrset%3Droot&mpjs=c.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B%20cdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpjsp=https%3A%2F%2Fc.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B%20https%3A%2F%2Fcdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpt=785004098&mpqs=mpt%3D785004098&mpssl=1&mpvc=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsvNzdnP88lAyGnZgjMT44dqfnXsopY89_Mel7mNBCCXtNc9A6vRdQUVrQl4u8bkqkT9AwYOvfLeCnVH4Vt99OaLhNLoMq2tsmeyuosnKMQ6xDwzRdacmLwNH44hDNWBHs45kjypr7RCSbZE2-09ZCKuSRx0iTsmtuLlepg2czmffP-9JKiRPx_axcTBfLS_tEX9as_9qv2mkAVXXkn2uctFSfBqRGu1qOzw2yTuADrYPl4zQbxLV6zYxZyi4A0SxmmD1xaPPoFXklJbJwmFVUse55x_WBAbOw%2526sai%253DAMfl-YTSbcFd6i_Mk2hT1RrXEBgmsC-Co5lXn4WIN4mR-xFab9qd2SVppve5Yogs_tw4cIG17O5ZClCU0U5OZoKIoNKfM4zFDyiu6BamKERaGw%2526sig%253DCg0ArKJSzFZyrc-oxWemEAE%2526urlfix%253D1%2526adurl%253D
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
63.215.202.157 Amsterdam, Netherlands, ASN25751 (VALUECLICK - Conversant, Inc., US),
Reverse DNS
157.vip.crm-node1.ams5.cnvr.net
Software
nginx /
Resource Hash

Request headers

Host
img.mediaplex.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Accept-Encoding
gzip, deflate, br
Cookie
svid=410605155634020814; mojo3=2399:36431
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

Server
nginx
Date
Mon, 21 Oct 2019 15:25:42 GMT
Content-Type
text/html; charset=ISO-8859-1
Transfer-Encoding
chunked
Connection
keep-alive
Last-Modified
Tue, 20 Aug 2019 15:59:14 GMT
ETag
W/"16ebf00-1414-5908e89ba5880"
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
Content-Encoding
br
durly.js
c.evidon.com/ Frame 8321
4 KB
2 KB
Script
General
Full URL
https://c.evidon.com/durly.js?;coid=6250;nid=142330;ad_w=300;ad_h=250;check_container=true;
Requested by
Host: secure.img-cdn.mediaplex.com
URL: https://secure.img-cdn.mediaplex.com/content/0/2399/250799/is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250.js?mpck=altfarm.mediaplex.com%2Fad%2Fck%2F2399-250799-36431-8%3Fmpt%3D785004098%26mpcr%3D102570365%26mpcrset%3Droot&mpjs=c.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B%20cdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpjsp=https%3A%2F%2Fc.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B%20https%3A%2F%2Fcdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpt=785004098&mpqs=mpt%3D785004098&mpssl=1&mpvc=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsvNzdnP88lAyGnZgjMT44dqfnXsopY89_Mel7mNBCCXtNc9A6vRdQUVrQl4u8bkqkT9AwYOvfLeCnVH4Vt99OaLhNLoMq2tsmeyuosnKMQ6xDwzRdacmLwNH44hDNWBHs45kjypr7RCSbZE2-09ZCKuSRx0iTsmtuLlepg2czmffP-9JKiRPx_axcTBfLS_tEX9as_9qv2mkAVXXkn2uctFSfBqRGu1qOzw2yTuADrYPl4zQbxLV6zYxZyi4A0SxmmD1xaPPoFXklJbJwmFVUse55x_WBAbOw%2526sai%253DAMfl-YTSbcFd6i_Mk2hT1RrXEBgmsC-Co5lXn4WIN4mR-xFab9qd2SVppve5Yogs_tw4cIG17O5ZClCU0U5OZoKIoNKfM4zFDyiu6BamKERaGw%2526sig%253DCg0ArKJSzFZyrc-oxWemEAE%2526urlfix%253D1%2526adurl%253D
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
06f777ff38a8dd1b7583e8323755ef6ed1c5ab41107894ed98792553e82097ba

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
content-encoding
gzip
last-modified
Wed, 14 Nov 2018 17:30:33 GMT
server
AkamaiNetStorage
status
200
etag
"2dfa8070bee860ca86deb1779cf87d3e:1542216642"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
access-control-max-age
86400
accept-ranges
bytes
access-control-allow-headers
*
content-length
1605
dvtp_src.js
cdn.doubleverify.com/ Frame 8321
18 KB
6 KB
Script
General
Full URL
https://cdn.doubleverify.com/dvtp_src.js?ctx=3758893&cmp=250799&sid=36431&plc=2399250799364318&num=&adid=&advid=1498131&adsrv=8&region=40&btreg=2399250799364318&btadsrv=mediaplex&crt=102570365&dvp_plcd=2399-250799-36431-8&crtname=&chnl=&unit=&pid=&uid=&tagtype=&dvtagver=6.1.src
Requested by
Host: secure.img-cdn.mediaplex.com
URL: https://secure.img-cdn.mediaplex.com/content/0/2399/250799/is2001g0008_021_313045_de_li_dir_fy20q2_itt_oa_970x250.js?mpck=altfarm.mediaplex.com%2Fad%2Fck%2F2399-250799-36431-8%3Fmpt%3D785004098%26mpcr%3D102570365%26mpcrset%3Droot&mpjs=c.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B%20cdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpjsp=https%3A%2F%2Fc.evidon.com%2Fdurly.js%3F%3Bcoid%3D6250%3Bnid%3D142330%3Bad_w%3D300%3Bad_h%3D250%3Bcheck_container%3Dtrue%3B%20https%3A%2F%2Fcdn.doubleverify.com%2Fdvtp_src.js%3Fctx%3D3758893%26cmp%3D250799%26sid%3D36431%26plc%3D2399250799364318%26num%3D%26adid%3D%26advid%3D1498131%26adsrv%3D8%26region%3D40%26btreg%3D2399250799364318%26btadsrv%3Dmediaplex%26crt%3D102570365%26dvp_plcd%3D2399-250799-36431-8%26crtname%3D%26chnl%3D%26unit%3D%26pid%3D%26uid%3D%26tagtype%3D%26dvtagver%3D6.1.src&mpt=785004098&mpqs=mpt%3D785004098&mpssl=1&mpvc=https://adclick.g.doubleclick.net/pcs/click%253Fxai%253DAKAOjsvNzdnP88lAyGnZgjMT44dqfnXsopY89_Mel7mNBCCXtNc9A6vRdQUVrQl4u8bkqkT9AwYOvfLeCnVH4Vt99OaLhNLoMq2tsmeyuosnKMQ6xDwzRdacmLwNH44hDNWBHs45kjypr7RCSbZE2-09ZCKuSRx0iTsmtuLlepg2czmffP-9JKiRPx_axcTBfLS_tEX9as_9qv2mkAVXXkn2uctFSfBqRGu1qOzw2yTuADrYPl4zQbxLV6zYxZyi4A0SxmmD1xaPPoFXklJbJwmFVUse55x_WBAbOw%2526sai%253DAMfl-YTSbcFd6i_Mk2hT1RrXEBgmsC-Co5lXn4WIN4mR-xFab9qd2SVppve5Yogs_tw4cIG17O5ZClCU0U5OZoKIoNKfM4zFDyiu6BamKERaGw%2526sig%253DCg0ArKJSzFZyrc-oxWemEAE%2526urlfix%253D1%2526adurl%253D
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.232.109 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-109.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 /
Resource Hash
ec9f555293783e1fc77da97dbabfb27b29c2495be2bf735229482e2a0f14766f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:42 GMT
Content-Encoding
gzip
Last-Modified
Mon, 07 Oct 2019 18:19:34 GMT
Server
Microsoft-IIS/10.0
ETag
W/"0fffc53b7dd51:0"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
max-age=54008
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
5776
SetEvent
analytics.carambo.la/ Frame E8C9
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetEvent
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.210.116.191 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-210-116-191.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
sca.17.4.95.js
static.adsafeprotected.com/ Frame 06AA
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:42 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app37ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=2x2&pubId=54423312&chanId=37592232&placementId=4741317042&pubCreative=138206523841&pubOrder=2107429564&cb=614615616&custom=canvas&custom2=400&custom3=0&adsafe_par&impId=0a7add7e-f417-11e9-8240-00259086cc1c&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&adsafe_type=abdfq&adsafe_jsinfo=,id:fa97b592-b696-3c82-280b-b681a483dc6b,c:rHe9w0,sl:inView,em:true,fr:true,mn:app50ami,pt:1-5-15,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFy5Cr5+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d1|1e*.10764|1e1|1f1|1f2|1f3|1g1|1g2|1h|1i,idMap:1e*,pl:,rend:0,renddet:WINDOW,rmeas:0,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:389,oid:0ae907e8-f417-11e9-b82d-382c4ac630f9,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
app50ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=39ee33eb-fb9f-7ece-5a9a-6235abb6c0f5&tv={c:rHe9wU,pingTime:-2,time:453,type:a,im:{sf:0,pom:1,prf:{beA:136,beZ:137,mfA:376,cmA:377,inA:377,inZ:381,prA:381,prZ:391,si:397,poA:397,poZ:403,cmZ:403,mfZ:403,loA:510,loZ:512,ltA:589,ltZ:589,mdA:137,mdZ:174}},sca:{dfp:{df:4,sz:300.250,dom:div}},env:{gca:1},clog:[{piv:100,vs:i,r:,w:300,h:250,t:260}],es:0,sc:1,ha:1,gm:1,slTimes:{i:453,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:260,wc:0.0.1600.1200,ac:1140.686.300.250,am:i,cc:1140.686.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[210~100],as:[210~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d|1e1|1f1|1f2|1f3|1g.10764|1g1|1h|1i,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1,slid:[google_ads_iframe_/4735792/us.reuters/life/health/article_0,google_ads_iframe_/4735792/us.reuters/life/health/article_0__container__,dpslot_mpu_13379540_USKBN1WY00B,USKBN1WY00B],sinceFw:191,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt14.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=3b44d41f-d553-031c-b3d6-035bd71ea353&tv={c:rHe9x5,pingTime:-2,time:459,type:a,im:{sf:0,pom:1,prf:{beA:108,beZ:110,mfA:371,cmA:371,inA:371,inZ:375,prA:375,prZ:378,si:380,poA:380,poZ:384,cmZ:384,mfZ:384,loA:481,loZ:482,ltA:566,ltZ:566,mdA:110,mdZ:165}},sca:{dfp:{df:4,sz:300.280,dom:body}},env:{gca:1},clog:[{piv:0,vs:o,r:l,w:300,h:280,t:272}],es:0,sc:1,ha:1,gm:1,slTimes:{i:0,o:459,n:0,pp:0,pm:0},slEvents:[{sl:o,t:272,wc:0.0.1600.1200,ac:1140.3326.300.280,am:i,cc:1140.3326.300.280,piv:0,obst:0,th:0,reas:l,bkn:{piv:[195~0],as:[195~300.280]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d|1e1|1f1|1f2|1f3|1g*.10764|1g1|1h|1i,idMap:1g*,rend:1,renddet:DIV.qs.sn,rmeas:1,slid:[google_ads_iframe_/4735792/us.reuters/life/health/article_5,google_ads_iframe_/4735792/us.reuters/life/health/article_5__container__,dpslot_bizdev_article_rr2_7657068_USKBN1WY00B,USKBN1WY00B],sinceFw:186,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt44.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
truncated
/ Frame 8321
217 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ea1f335e22593429c66601058b233a01f74ac410b999dc79c6c67524661f1906

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
jload
pixel.adsafeprotected.com/ Frame 0C04
45 KB
13 KB
Script
General
Full URL
https://pixel.adsafeprotected.com/jload?anId=10764&campId=970x250&pubId=63378192&chanId=37592232&placementId=5158696277&pubCreative=138285704442&pubOrder=2594181822&cb=1046498820&custom=leaderboard&custom2=&custom3=0&adsafe_par&impId=0a797dd8-f417-11e9-8572-00259086cbca
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
865e393d0207481f06c1f34cb78efeb06ae63b8ab4b53294487a1d9d9ac8037e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
Content-Encoding
gzip
X-Server-Name
app50ami.ami.303net.pvt
Transfer-Encoding
chunked
Content-Type
application/javascript;charset=utf-8
Access-Control-Allow-Origin
pixel.adsafeprotected.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
keep-alive
Server
nginx
Expires
Wed, 31 Dec 1969 23:59:59 GMT
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=fa97b592-b696-3c82-280b-b681a483dc6b&tv={c:rHe9xl,pingTime:0,time:472,type:pf,im:{pBlk:394},clog:[{piv:100,vs:i,r:,w:2,h:2,t:389}],es:0,sc:1,ha:1,gm:1,slTimes:{i:472,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:389,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[94~100],as:[94~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFy5Cr5+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d1|1e*.10764|1e1|1f1|1f2|1f3|1g1|1g2|1h|1i,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt46.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
ad
a.teads.tv/page/46561/
118 B
335 B
XHR
General
Full URL
https://a.teads.tv/page/46561/ad?windowWidth=1600&windowHeight=1200&windowDepth=1&windowReferrerUrl=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&page=%7B%22id%22%3A46561%2C%22placements%22%3A%5B%7B%22id%22%3A78293%2C%22validity%22%3A%7B%22status%22%3Atrue%2C%22reasons%22%3A%5B%5D%7D%2C%22player%22%3A%7B%22width%22%3A755%2C%22height%22%3A425%7D%2C%22slotType%22%3A%22native%22%7D%5D%2C%22gdpr_iab%22%3A%7B%22status%22%3A23%2C%22consent%22%3A%22%22%2C%22reason%22%3A230%7D%7D&userId=03cd9682-f756-4641-8c5f-a96589861161&formatVersion=2.22.61&env=js-web&netBw=9&ttfb=116
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.37.179 , France, ASN20940 (AKAMAI-ASN1, US),
Reverse DNS
a2-21-37-179.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
f50167bee40cd7fdd6c623efb794e0edddec7de87ef71f48c8b1b1413e1dfc4a

Request headers

Accept
application/json; charset=UTF-8
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:42 GMT
content-encoding
gzip
status
200
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
https://www.reuters.com
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
129
expires
Mon, 21 Oct 2019 15:25:42 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=176&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=37592232&ord=1571671541661&r=744065408032&t=meas&bedc=1&q=1&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:42 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=176&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=37592232&ord=1571671541661&r=744065408032&t=nht&bedc=1&q=2&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:42 GMT
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=fa97b592-b696-3c82-280b-b681a483dc6b&tv={c:rHe9ym,pingTime:-2,time:535,type:a,im:{sf:0,pom:1,prf:{beA:117,beZ:119,mfA:495,cmA:495,inA:495,inZ:497,prA:497,prZ:505,si:507,poA:507,bl:512,poZ:512,cmZ:512,mfZ:512,loA:590,loZ:592,ltA:652,ltZ:652,mdA:119,mdZ:188}},sca:{dfp:{df:4,sz:100.100,dom:div},ha1:{res1:1,ps:1,ts:1571671542169,psfr:1}},env:{gca:1},clog:[{piv:100,vs:i,r:,w:2,h:2,t:389}],es:0,sc:1,ha:1,gm:1,slTimes:{i:535,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:389,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[157~100],as:[157~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFy5Cr5+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d1|1e*.10764|1e1|1f1|1f2|1f3|1g1|1g2|1h|1i,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0,slid:[google_ads_iframe_/4735792/us.reuters/life/health/article_2,google_ads_iframe_/4735792/us.reuters/life/health/article_2__container__,dpslot_canvas_4278898_USKBN1WY00B,USKBN1WY00B],sinceFw:145,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt14.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=3&fi=1&apd=6&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=reuters.com&L1id=63378192&L2id=2594181822&L3id=5158696277&L4id=138285704442&S1id=3735912&S2id=37592232&ord=1571671542232&r=705334989317&t=meas&bedc=1&q=1&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:42 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=3&fi=1&apd=6&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=reuters.com&L1id=63378192&L2id=2594181822&L3id=5158696277&L4id=138285704442&S1id=3735912&S2id=37592232&ord=1571671542232&r=705334989317&t=fv&bedc=1&q=2&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:42 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=3&fi=1&apd=6&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=reuters.com&L1id=63378192&L2id=2594181822&L3id=5158696277&L4id=138285704442&S1id=3735912&S2id=37592232&ord=1571671542232&r=705334989317&t=nht&bedc=1&q=3&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:42 GMT
ba.js
c.evidon.com/geo/ Frame 8321
41 KB
12 KB
Script
General
Full URL
https://c.evidon.com/geo/ba.js?r181114
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/durly.js?;coid=6250;nid=142330;ad_w=300;ad_h=250;check_container=true;
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
72bd223dadfcc3fe7e65d1d107fe61d98649ad7cf9f220a869c2e048b0aeab1a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
content-encoding
gzip
last-modified
Wed, 14 Nov 2018 17:29:11 GMT
server
AkamaiNetStorage
status
200
etag
"b5d7c697ff1dc525401c112149d1a74f:1542216553"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
access-control-max-age
86400
cache-control
max-age=86400
accept-ranges
bytes
access-control-allow-headers
*
content-length
12438
4.gif
c.evidon.com/a/ Frame 8321
43 B
297 B
Image
General
Full URL
https://c.evidon.com/a/4.gif
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
de3a7ca2f8ae592aae2652335b755b0d0b65df663dda8776387cae7339b76d64

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
last-modified
Thu, 15 Apr 2010 17:07:29 GMT
server
AkamaiNetStorage
status
200
etag
"65786c291a4603aa5150a1884452838d:1271351254"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
image/gif
access-control-allow-origin
cache-control
max-age=172800
accept-ranges
bytes
access-control-allow-headers
*
content-length
43
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=0&fi=0&apd=239&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=1&d=reuters.com&L1id=20159232&L2id=277213512&L3id=139199112&L4id=138204787707&S1id=3735912&S2id=37592232&ord=1571671541661&r=744065408032&t=hdn&bedc=1&q=3&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:42 GMT
dv-measurements289.js
cdn.doubleverify.com/ Frame A38F
270 KB
63 KB
Script
General
Full URL
https://cdn.doubleverify.com/dv-measurements289.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.232.109 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-109.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 /
Resource Hash
bbe4f1029e40458992a7f81787a6c2ffd5e861f80e463620ec9ce7131919cb2e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:42 GMT
Content-Encoding
gzip
Last-Modified
Mon, 07 Oct 2019 13:39:28 GMT
Server
Microsoft-IIS/10.0
ETag
"0e8e7a3147dd51:0"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
max-age=946080000
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
63718
main.19.8.22.js
static.adsafeprotected.com/ Frame 0C04
158 KB
50 KB
Script
General
Full URL
https://static.adsafeprotected.com/main.19.8.22.js
Requested by
Host: pixel.adsafeprotected.com
URL: https://pixel.adsafeprotected.com/jload?anId=10764&campId=970x250&pubId=63378192&chanId=37592232&placementId=5158696277&pubCreative=138285704442&pubOrder=2594181822&cb=1046498820&custom=leaderboard&custom2=&custom3=0&adsafe_par&impId=0a797dd8-f417-11e9-8572-00259086cbca
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
5df41461e8c29072a827d5fd000d2506238b77e767a34642d6613b79ce49134c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:42 GMT
Content-Encoding
gzip
Last-Modified
Wed, 09 Oct 2019 16:27:21 GMT
X-Server-Name
app37ami.ami.303net.pvt
ETag
"5d9e0a69-c7d3"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
51155
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
redirect
sync.teads.tv/iframe/ Frame 23D5
Redirect Chain
  • https://sync.teads.tv/iframe?pid=78293&userId=03cd9682-f756-4641-8c5f-a96589861161&gdprIab={%22status%22:23,%22consent%22:%22%22,%22reason%22:230}&env=js-web&1571671542300
  • https://sync.teads.tv/iframe/redirect?pid=78293&userId=03cd9682-f756-4641-8c5f-a96589861161&gdprIab=%7B%22status%22:23,%22consent%22:%22%22,%22reason%22:230%7D&env=js-web&1571671542300
0
0
Document
General
Full URL
https://sync.teads.tv/iframe/redirect?pid=78293&userId=03cd9682-f756-4641-8c5f-a96589861161&gdprIab=%7B%22status%22:23,%22consent%22:%22%22,%22reason%22:230%7D&env=js-web&1571671542300
Requested by
Host: a.teads.tv
URL: https://a.teads.tv/media/format/v3/teads-format.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
akka-http/10.1.5 /
Resource Hash

Request headers

:method
GET
:authority
sync.teads.tv
:scheme
https
:path
/iframe/redirect?pid=78293&userId=03cd9682-f756-4641-8c5f-a96589861161&gdprIab=%7B%22status%22:23,%22consent%22:%22%22,%22reason%22:230%7D&env=js-web&1571671542300
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
tt_viewer=aa84d3e2-d381-43d9-8dfe-fe112aa6c86a
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
content-type
text/html; charset=UTF-8
server
akka-http/10.1.5
content-length
1844
expires
Mon, 21 Oct 2019 15:25:42 GMT
cache-control
max-age=0, no-cache, no-store
pragma
no-cache
date
Mon, 21 Oct 2019 15:25:42 GMT
set-cookie
tt_exelate=; Expires=Tue, 22 Oct 2019 15:25:42 GMT; Domain=.teads.tv; SameSite=None tt_bluekai=; Expires=Tue, 22 Oct 2019 15:25:42 GMT; Domain=.teads.tv; SameSite=None tt_emetriq=; Expires=Tue, 22 Oct 2019 15:25:42 GMT; Domain=.teads.tv; SameSite=None tt_liveramp=; Expires=Tue, 22 Oct 2019 15:25:42 GMT; Domain=.teads.tv; SameSite=None tt_neustar=; Expires=Tue, 22 Oct 2019 15:25:42 GMT; Domain=.teads.tv; SameSite=None tt_salesforce=; Expires=Tue, 22 Oct 2019 15:25:42 GMT; Domain=.teads.tv; SameSite=None tt_dar=; Expires=Tue, 22 Oct 2019 15:25:42 GMT; Domain=.teads.tv; SameSite=None tt_skp=; Expires=Tue, 22 Oct 2019 15:25:42 GMT; Domain=.teads.tv; SameSite=None

Redirect headers

status
302
content-type
text/html; charset=UTF-8
location
/iframe/redirect?pid=78293&userId=03cd9682-f756-4641-8c5f-a96589861161&gdprIab=%7B%22status%22:23,%22consent%22:%22%22,%22reason%22:230%7D&env=js-web&1571671542300
server
akka-http/10.1.5
content-length
236
expires
Mon, 21 Oct 2019 15:25:42 GMT
cache-control
max-age=0, no-cache, no-store
pragma
no-cache
date
Mon, 21 Oct 2019 15:25:42 GMT
set-cookie
tt_viewer=aa84d3e2-d381-43d9-8dfe-fe112aa6c86a; Expires=Mon, 19 Oct 2020 15:25:42 GMT; Max-Age=31449600; Domain=.teads.tv; Path=/; SameSite=None
track
t.teads.tv/
23 B
157 B
Image
General
Full URL
https://t.teads.tv/track?action=passback-noAd&ts=1571671541885&pageId=46561&pid=78293&env=js-web&pfid=[pfid]&f=1&slot=native&fv=undefined-master
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.18.232.7 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-7.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
328e90a318268aea96180cc31666ae6d6f79d90d078c123bc3d98ee08a192fb7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
pragma
no-cache
date
Mon, 21 Oct 2019 15:25:42 GMT
cache-control
max-age=0, no-cache, no-store
expires
Mon, 21 Oct 2019 15:25:42 GMT
content-length
23
content-type
image/gif
e.js
c.evidon.com/a/ Frame 8321
6 KB
2 KB
Script
General
Full URL
https://c.evidon.com/a/e.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/geo/ba.js?r181114
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
6599efc9733b1cc77e86041522e867b57d40e5865c799bcc16f9ebad194bddd0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
content-encoding
gzip
last-modified
Tue, 18 Oct 2016 17:40:59 GMT
server
AkamaiNetStorage
status
200
etag
"ef75514192b58c83b25afc1276afc691:1476812459"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
access-control-max-age
86400
cache-control
max-age=3600
accept-ranges
bytes
access-control-allow-headers
*
content-length
1825
142330.js
c.evidon.com/a/n/6250/ Frame 8321
1 KB
734 B
Script
General
Full URL
https://c.evidon.com/a/n/6250/142330.js
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/geo/ba.js?r181114
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
c0f9c17c44fedcc390786dd8da39ee9d772b9c146a9d7eeb3357ec2057ffb807

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
content-encoding
gzip
last-modified
Tue, 21 May 2019 11:12:53 GMT
server
AkamaiNetStorage
status
200
etag
"a10172a637e9e98dfd7f5e902f5f5309:1558437173"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS,POST
content-type
application/x-javascript
access-control-allow-origin
access-control-max-age
86400
cache-control
max-age=600
accept-ranges
bytes
access-control-allow-headers
*
content-length
450
t2tv7.html
cdn3.doubleverify.com/ Frame F375
0
0
Document
General
Full URL
https://cdn3.doubleverify.com/t2tv7.html
Requested by
Host: cdn.doubleverify.com
URL: https://cdn.doubleverify.com/dv-measurements289.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.232.109 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-232-109.deploy.static.akamaitechnologies.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash

Request headers

Host
cdn3.doubleverify.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

Cache-Control
max-age=946080000
Content-Type
text/html
Last-Modified
Thu, 11 Sep 2014 19:15:16 GMT
Accept-Ranges
bytes
ETag
"0ba3b8f4cdcf1:0"
Server
Microsoft-IIS/10.0
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Encoding
gzip
Content-Length
3877
Date
Mon, 21 Oct 2019 15:25:42 GMT
Connection
keep-alive
visit.js
tps40.doubleverify.com/ Frame A38F
5 KB
2 KB
Script
General
Full URL
https://tps40.doubleverify.com/visit.js?bridua=3&tstype=2&eparams=DC4FC%3Dl9EEADTbpTauTauHHH%5DC6FE6CD%5D4%40%3ETau2CE%3A4%3D6TauFD%5C2%3D6I%3A%40%3F%5CA92C%3ED%5C752Tau752%5C2AAC%40G6D%5C2%3D6I%3A%40%3FD%5CF%3DE%40%3E%3AC%3AD%5C7%40C%5C2%3F%40E96C%5CC2C6%5C3%3D%40%405%5C5%3AD62D6%5C%3A5%26%24zq%7D%60(*__qU2%3F4r92%3A%3Fl9EEADTbpTauTauHHH%5DC6FE6CD%5D4%40%3ETar9EEADTbpTauTauHHH%5DC6FE6CD%5D4%40%3EU2%26C%3Dl&srcurlD=0&aUrlD=0&ssl=https:&dvp_region=40&aadid=912239f8862a821ea94eecb0091ffde3c2de2aa1&dfs=610&ddur=29&uid=1571671542356171&jsCallback=dvCallback_1571671542356364&dvtagver=6.1.src&navUa=Mozilla%2F5.0%20(Macintosh%3B%20Intel%20Mac%20OS%20X%2010_14_5)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F74.0.3729.169%20Safari%2F537.36&htmlmsging=1&chro=0&hist=2&winh=1200&winw=1600&wouh=1200&wouw=1600&scah=1200&scaw=1600&jsver=289&vavbkt=4,8,1,23&lvvn=26&m1=13&refD=1&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&fwc=0&flt=1&fec=673&fcifrms=19&brh=2&dvp_epl=344&noc=16&ctx=3758893&cmp=250799&sid=36431&plc=2399250799364318&crt=102570365&btreg=2399250799364318&btadsrv=mediaplex&adsrv=8&advid=1498131&dvp_plcd=2399-250799-36431-8
Requested by
Host: cdn.doubleverify.com
URL: https://cdn.doubleverify.com/dv-measurements289.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
213.254.244.22 , Ireland, ASN36062 (DOUBLE-VERIFY - DoubleVerify, Inc., US),
Reverse DNS
Software
Microsoft-IIS/8.0 / ASP.NET
Resource Hash
932350842c1e6c910ccea553e308ce7fb238047f6432ce1dfee4e68ff50f190b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/8.0
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
text/javascript; charset=utf-8
Cache-Control
max-age=0
Transfer-Encoding
chunked
Expires
10/20/2019 3:25:42 PM
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=39ee33eb-fb9f-7ece-5a9a-6235abb6c0f5&tv={c:rHe9Cf,pingTime:-10,time:784,type:s,mvn:ZnNjPTEyLHNkPTMsbm89Nyxhc3A9MQ--,fsc:17.4.95v220002022020220000022002222000022220202020222220222220002222022002222200002220222022222222222000220200000022220222220222222222222202222222222222222222222222222222222222200000022022020020000002002202022022022222222000000000020222202022022222000000020000000000000000000002220002220000022200222202220022200200222022202220022222220020222222000220000222202222202222000002002002222222222220022202200022002220222202,sd:MTcuNC45NXYxMjAwfHwxNjAwfHwxfHwxfHwyNHx8MTIwMHx8MHx8MHx8MXx8bGFuZHNjYXBlLXByaW1hcnl8fDI0fHw0LzN8fDQvM3x8MHx8MTYwMA--,no:MTcuNC45NXZNb3ppbGxhfHxOZXRzY2FwZXx8bnx8MTZ8fG58fDB8fG58fExpbnV4IHg4Nl82NHx8R2Vja298fDIwMDMwMTA3fHwtMTIwfHxNb3ppbGxhLzUuMCAoTWFjaW50b3NoOyBJbnRlbCBNYWMgT1MgWCAxMF8xNF81KSBBcHBsZVdlYktpdC81MzcuMzYgKEtIVE1MLCBsaWtlIEdlY2tvKSBDaHJvbWUvNzQuMC4zNzI5LjE2OSBTYWZhcmkvNTM3LjM2fHwxfHwxfHxHb29nbGUgSW5jLnx8bg--,asp:1571671542470||2abcc1b1c0c91ee98fedee1086685bf2||675c74d5f114ba25a49fb0f4cb02f70f||d56a7c79d4e40836e2b80aed9a6ec2ba||ed88253aeefcaeeb4600936c8f45a275||a68c32ecabf6ccff09190622d09cf19e||1e9c2e63ca502a4863aecbc064b41bd6||ab8645c3e80690cb2155df33de34f518||1529428597,env:{ar:a4de9e56-c401-786d-f6f8-2d071d4513c1.1}}
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt14.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
file.mp4
r4---sn-4g5e6nz7.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,...
Redirect Chain
  • https://gcdn.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/id,itag,source,ctier,acao,ip,ipbits,expire/sig...
  • https://r4---sn-4g5e6nz7.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,i...
2 MB
2 MB
Media
General
Full URL
https://r4---sn-4g5e6nz7.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/56CEFBCBBA99E0CC4E9BC2BE8BC30BD86488E2A3.701BB800280C951808BFB9858487B1B852F0FC2E/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5e6nz7/ms/onc/mt/1571671475/mv/m/mvi/3/pl/41/file/file.mp4
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2a00:1450:4001:65::9 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
gvs 1.0 /
Resource Hash
7efb76927b67f50c1411403ed0710462fb8ea3319d2f893067e4a5d342ae7a43
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Content-Type-Options
nosniff
Last-Modified
Wed, 25 Sep 2019 17:03:56 GMT
Server
gvs 1.0
Content-Type
video/mp4
Content-Range
bytes 0-2268496/2268497
Cache-Control
private, max-age=86400
Connection
close
Accept-Ranges
bytes
Alt-Svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
Content-Length
2268497
Expires
Mon, 21 Oct 2019 15:25:42 GMT

Redirect headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:42 GMT
server
ClientMapServer
status
302
x-frame-options
SAMEORIGIN
content-type
text/html; charset=UTF-8
location
https://r4---sn-4g5e6nz7.c.2mdn.net/videoplayback/id/a24f93b0836c331a/itag/342/source/doubleclick_dmm/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3713879037/sparams/acao,ctier,expire,id,ip,ipbits,itag,mip,mm,mn,ms,mv,mvi,pl,source/signature/56CEFBCBBA99E0CC4E9BC2BE8BC30BD86488E2A3.701BB800280C951808BFB9858487B1B852F0FC2E/key/cms1/cms_redirect/yes/mip/2a01:4f8:192:5414::2/mm/42/mn/sn-4g5e6nz7/ms/onc/mt/1571671475/mv/m/mvi/3/pl/41/file/file.mp4
cache-control
no-cache, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
643
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=0&tuv=-1&tet=242&fi=1&apd=245&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=reuters.com&L1id=63378192&L2id=2594181822&L3id=5158696277&L4id=138285704442&S1id=3735912&S2id=37592232&ord=1571671542232&r=705334989317&t=hdn&bedc=1&q=4&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:42 GMT
sca.17.4.95.js
static.adsafeprotected.com/ Frame 1845
81 KB
20 KB
Script
General
Full URL
https://static.adsafeprotected.com/sca.17.4.95.js
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.32 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.static.adsafeprotected.com
Software
nginx /
Resource Hash
149c8d10677f2f6979fa28c078cf832f575ee53c397d791b739e7c4c687fe7bc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:42 GMT
Content-Encoding
gzip
Last-Modified
Tue, 19 Jun 2018 17:20:43 GMT
X-Server-Name
app37ami.ami.303net.pvt
ETag
"5b293b6b-4fda"
Content-Type
application/javascript
Cache-Control
max-age=315360000
Connection
keep-alive
Content-Length
20442
Server
nginx
Expires
Thu, 31 Dec 2037 23:55:55 GMT
mon
pixel.adsafeprotected.com/
43 B
309 B
Image
General
Full URL
https://pixel.adsafeprotected.com/mon?anId=10764&campId=970x250&pubId=63378192&chanId=37592232&placementId=5158696277&pubCreative=138285704442&pubOrder=2594181822&cb=1046498820&custom=leaderboard&custom2=&custom3=0&adsafe_par&impId=0a797dd8-f417-11e9-8572-00259086cbca&adsafe_url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&adsafe_type=abdfq&adsafe_jsinfo=,id:12c400f5-5bcb-435f-f473-7b216ec2e2d8,c:rHe9CH,sl:inView,em:true,fr:true,mn:app50ami,pt:1-5-15,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,br:u,abv:na,an:n,scm:publ1.grpm1,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,pl:,rend:1,renddet:DIV.qs.sn,rmeas:1,es:0,sc:1,ha:1,gm:1,tt:jload,thd:1,et:216,oid:0b3f8ca5-f417-11e9-b82d-382c4ac630f9,v:19.8.22,sp:1,wr:1600.1200,sr:1600.1200,ov:0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
199.166.0.26 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
anycast.pixel.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
app50ami.ami.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=12c400f5-5bcb-435f-f473-7b216ec2e2d8&tv={c:rHe9CI,pingTime:-8,time:216,type:l,es:0,sc:1,ha:1,gm:1,slTimes:{i:216,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:215,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[13~100],as:[13~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt46.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
SetConsentStatus
analytics.carambo.la/ Frame E8C9
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetConsentStatus
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.210.116.191 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-210-116-191.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:41 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=12c400f5-5bcb-435f-f473-7b216ec2e2d8&tv={c:rHe9De,pingTime:0,time:248,type:pf,clog:[{piv:100,vs:i,r:,w:970,h:250,t:215}],es:0,sc:1,ha:1,gm:1,slTimes:{i:248,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:215,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[45~100],as:[45~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt44.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
COMMON.css
c.evidon.com/a/ Frame 8321
2 KB
976 B
Stylesheet
General
Full URL
https://c.evidon.com/a/COMMON.css?r=0.7523887280474286
Requested by
Host: c.evidon.com
URL: https://c.evidon.com/geo/ba.js?r181114
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
a3c92e8d35e4e636238e577da8cd44aaf8dd699b719e4125ba0029330edf6907

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
content-encoding
gzip
last-modified
Thu, 02 Feb 2017 16:26:10 GMT
server
AkamaiNetStorage
status
200
etag
"c3cc19ce8230df99c7835decc2d79ee8:1486052770"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS,POST
content-type
text/css
access-control-allow-origin
access-control-max-age
86400
accept-ranges
bytes
access-control-allow-headers
*
content-length
715
box_107_top-right.png
c.evidon.com/icon/ Frame 8321
159 B
415 B
Image
General
Full URL
https://c.evidon.com/icon/box_107_top-right.png
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
f2df2303611fcbcfcdc00adadff13e59ed7d7c88f51fceb1c37095484742dedc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
last-modified
Wed, 06 Feb 2013 22:25:18 GMT
server
AkamaiNetStorage
status
200
etag
"b4a2557ad69c5359621fa4d5a65033cd:1360189518"
access-control-max-age
86400
access-control-allow-methods
GET,OPTIONS,POST
content-type
image/png
access-control-allow-origin
cache-control
max-age=172800
accept-ranges
bytes
access-control-allow-headers
*
content-length
159
c_30_de.png
c.evidon.com/icon/ Frame 8321
1008 B
1 KB
Image
General
Full URL
https://c.evidon.com/icon/c_30_de.png
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
23.0.46.190 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a23-0-46-190.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
2d7861b5283e79ceb6ae9078f59c5046ecb082b59b6cc7dc070f95646aecb8ee

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:42 GMT
content-encoding
gzip
last-modified
Wed, 06 Feb 2013 22:25:23 GMT
server
AkamaiNetStorage
status
200
etag
"da1a90724cb9fa8b90b1a0219783c9f4:1360189523"
vary
Accept-Encoding
access-control-allow-methods
GET,OPTIONS,POST
content-type
image/png
access-control-allow-origin
access-control-max-age
86400
cache-control
max-age=172800
accept-ranges
bytes
access-control-allow-headers
*
content-length
997
pixel.gif
l.betrad.com/ct/0_0_0_142330/de/0/1/0/0/0/0/970/250/242/6250/0/ Frame 8321
0
120 B
Image
General
Full URL
https://l.betrad.com/ct/0_0_0_142330/de/0/1/0/0/0/0/970/250/242/6250/0/pixel.gif?v=2_1&ttid=2&d=www.reuters.com&r=0.13682968183871624
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.232.243.86 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-232-243-86.compute-1.amazonaws.com
Software
/ Express
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:42 GMT
content-encoding
gzip
x-powered-by
Express
etag
W/"a-bAsFyilMr4Ra1hIU5PyoyFRunpI"
vary
Accept-Encoding
prebid.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/ Frame E8C9
205 KB
65 KB
XHR
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/prebid.min.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/41AF) /
Resource Hash
6249458482797d7ee8be4da01d4f549ba9994927d14ae92404e0c08181b36206

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:41 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
236064E292235027
x-cache
HIT
status
200
content-length
66427
x-amz-id-2
gQOHFoWiQl7MuJsnFumpDKPDx3zkFHuCxg7YTlszlPMNIizc+Re98cyLiaDVBqa77L9vFdeBxPs=
last-modified
Mon, 12 Aug 2019 09:30:09 GMT
server
ECS (fcn/41AF)
etag
"ea1eea13d68e95de7e03abe6a748ad70"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=12c400f5-5bcb-435f-f473-7b216ec2e2d8&tv={c:rHe9Dt,pingTime:-2,time:263,type:a,im:{sf:0,pom:1,prf:{beA:125,beZ:126,mfA:327,cmA:328,inA:328,inZ:329,prA:329,prZ:337,si:341,poA:341,poZ:348,cmZ:348,mfZ:348,loA:373,loZ:374,ltA:388,ltZ:388,mdA:127,mdZ:163}},sca:{dfp:{df:4,sz:970.254,dom:body}},env:{gca:1},clog:[{piv:100,vs:i,r:,w:970,h:250,t:215}],es:0,sc:1,ha:1,gm:1,slTimes:{i:263,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:215,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[61~100],as:[61~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:0,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1,slid:[google_ads_iframe_/4735792/us.reuters/life/health/article_1,google_ads_iframe_/4735792/us.reuters/life/health/article_1__container__,canvas_leaderboard_6185826132144441_USKBN1WY00B],sinceFw:47,readyFired:true}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt14.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=3b44d41f-d553-031c-b3d6-035bd71ea353&tv={c:rHe9E9,time:897,type:e,env:{ar:a4de9e56-c401-786d-f6f8-2d071d4513c1.2},es:0,sc:1,ha:1,gm:1,slTimes:{i:0,o:897,n:0,pp:0,pm:0},slEvents:[{sl:o,t:272,wc:0.0.1600.1200,ac:1140.3326.300.280,am:i,cc:1140.3326.300.280,piv:0,obst:0,th:0,reas:l,bkn:{piv:[633~0],as:[633~300.280]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:144,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c.10764|1c1|1c2|1d.10764|1e.10764|1e1|1f1|1f2|1f3|1g*.10764|1g1|1h|1i,idMap:1g*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt46.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=fa97b592-b696-3c82-280b-b681a483dc6b&tv={c:rHe9Ee,time:899,type:e,im:{pWait:17},env:{ar:a4de9e56-c401-786d-f6f8-2d071d4513c1.3},es:0,sc:1,ha:1,gm:1,slTimes:{i:899,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:389,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[521~100],as:[521~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:177,fm:rFy5Cr5+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d.10764|1d1|1e*.10764|1e1|1f1|1f2|1f3|1g1|1g2|1h|1i,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt44.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
view
googleads4.g.doubleclick.net/pcs/ Frame 66C3
0
119 B
Image
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsvT7Je3Aau8mEiLmiRF6QU9n3r2chOuhn1Wu10yNcUpbRb7WWfHoHqnntiSB_Lgiii5I831ACujPhQ6Ir3eHODu5bRtac78GQn8Kh-YhQSdX5TdnElf2l2jTKAJYrEgkA0fuxz7U6WWtTd-lX4&sig=Cg0ArKJSzJktMp2EjsjHEAE&urlfix=1&adurl=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
zrh04s05-in-f98.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:42 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
0
x-xss-protection
0
ping.gif
stats-dev.brid.tv/ Frame 66C3
0
347 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&os=l&m=0&apa=0&df=1&ow=14120&pub=p&e=i&aid=9261&par=b&wp=0&at=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.2 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-2.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 20:32:20 GMT
via
1.1 df26103dc140569d7032449c70c3b141.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
68065
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
content-length
0
x-amz-cf-id
WYOVT8-wGjYBH9-Q2DUQeO8j1hYDc782_yuqzjjg08p-jO8z1LpkXw==
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=12c400f5-5bcb-435f-f473-7b216ec2e2d8&tv={c:rHe9Fp,time:383,type:e,env:{ar:a4de9e56-c401-786d-f6f8-2d071d4513c1.4},es:0,sc:1,ha:1,gm:1,slTimes:{i:383,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:215,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[180~100],as:[180~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:88,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:42 GMT
X-Server-Name
dt14.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dc_oe=ChMIx8_S39St5QIVXph3Ch2q7wU0EAAYACD34546;met=1;ecn1=1;etm1=0;eid1=11;
ade.googlesyndication.com/ddm/activity/ Frame 66C3
42 B
201 B
Image
General
Full URL
https://ade.googlesyndication.com/ddm/activity/dc_oe=ChMIx8_S39St5QIVXph3Ch2q7wU0EAAYACD34546;met=1;ecn1=1;etm1=0;eid1=11;
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
zrh04s05-in-f98.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:42 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
activeview
pagead2.googlesyndication.com/pcs/ Frame 66C3
42 B
178 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjssfi3QCPKI-vhyWj_QGSC9Zuo2NA-uAQmZAxbkZP76OdFzfqDh0oOQbx4sZvQXzFj0JwH9FiFyoiSDmXmWNLew4XnYKUTrBfStQ1VxkdJk&sig=Cg0ArKJSzCnnK410XOqZEAE&adk=545836891&tt=1402&bs=1585%2C1200&mtos=1055,1055,1055,1055,1055&tos=1055,0,0,0,0&p=686,1140,936,1440&mcvt=1055&rs=3&ht=0&tfs=362&tls=1417&mc=1&lte=1&bas=0&bac=0&met=no&avms=nio&niot_obs=13&niot_cbk=84&md=2&lm=2&rst=1571671541456&rpt=242&isd=0&msd=0&oseid=3&xdi=0&xosd=1&ps=1600%2C6384&ss=1600%2C1200&pt=16&bin=1&deb=1-5-5-14-12-17-94-10-0-0-0&tvt=1410&r=v&id=osdim&vs=4&uc=12&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=0x0&itpl=19&v=20191014
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:42 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=39ee33eb-fb9f-7ece-5a9a-6235abb6c0f5&tv={c:rHe9LM,pingTime:1,time:1375,type:p,clog:[{piv:100,vs:i,r:,w:300,h:250,t:260}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1375,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:260,wc:0.0.1600.1200,ac:1140.686.300.250,am:i,cc:1140.686.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1132~100],as:[1132~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:91,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1e.10764|1e1|1f1|1f2|1f3|1g.10764|1g1|1h|1i,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt14.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=39ee33eb-fb9f-7ece-5a9a-6235abb6c0f5&tv={c:rHe9LN,pingTime:1,time:1376,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:260}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1376,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:260,wc:0.0.1600.1200,ac:1140.686.300.250,am:i,cc:1140.686.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1133~100],as:[1133~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:91,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1e.10764|1e1|1f1|1f2|1f3|1g.10764|1g1|1h|1i,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt44.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=39ee33eb-fb9f-7ece-5a9a-6235abb6c0f5&tv={c:rHe9LN,pingTime:1,time:1376,type:c,clog:[{piv:100,vs:i,r:,w:300,h:250,t:260}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1376,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:260,wc:0.0.1600.1200,ac:1140.686.300.250,am:i,cc:1140.686.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1134~100],as:[1134~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:91,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1e.10764|1e1|1f1|1f2|1f3|1g.10764|1g1|1h|1i,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1,metricId:publ1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt46.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=39ee33eb-fb9f-7ece-5a9a-6235abb6c0f5&tv={c:rHe9LO,pingTime:1,time:1377,type:c,clog:[{piv:100,vs:i,r:,w:300,h:250,t:260}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1377,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:260,wc:0.0.1600.1200,ac:1140.686.300.250,am:i,cc:1140.686.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1134~100],as:[1134~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:91,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1e.10764|1e1|1f1|1f2|1f3|1g.10764|1g1|1h|1i,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1,metricId:grpm1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt70.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=fa97b592-b696-3c82-280b-b681a483dc6b&tv={c:rHe9Nu,pingTime:1,time:1473,type:p,clog:[{piv:100,vs:i,r:,w:2,h:2,t:389}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1473,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:389,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1095~100],as:[1095~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:111,fm:rFy5Cr5+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d.10764|1d1|1e*.10764|1e1|1f1|1f2|1f3|1g1|1g2|1h|1i,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt70.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=fa97b592-b696-3c82-280b-b681a483dc6b&tv={c:rHe9Nv,pingTime:1,time:1474,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:389}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1474,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:389,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1096~100],as:[1096~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:111,fm:rFy5Cr5+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d.10764|1d1|1e*.10764|1e1|1f1|1f2|1f3|1g1|1g2|1h|1i,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt46.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=fa97b592-b696-3c82-280b-b681a483dc6b&tv={c:rHe9Nw,pingTime:1,time:1475,type:c,clog:[{piv:100,vs:i,r:,w:2,h:2,t:389}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1475,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:389,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1097~100],as:[1097~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:111,fm:rFy5Cr5+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d.10764|1d1|1e*.10764|1e1|1f1|1f2|1f3|1g1|1g2|1h|1i,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0,metricId:publ1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt14.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=fa97b592-b696-3c82-280b-b681a483dc6b&tv={c:rHe9Nw,pingTime:1,time:1475,type:c,clog:[{piv:100,vs:i,r:,w:2,h:2,t:389}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1475,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:389,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[1097~100],as:[1097~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:111,fm:rFy5Cr5+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d.10764|1d1|1e*.10764|1e1|1f1|1f2|1f3|1g1|1g2|1h|1i,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0,metricId:grpm1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt44.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
activeview
pagead2.googlesyndication.com/pcs/ Frame 8321
42 B
110 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstQRJazQnGAlP6Ez_yz_p-h3-A0TN1XMglMlDuPC4kJ1FvduNC_ZB0Tc14EywvqYbfpy3FSoikEv8-XfittApD_R_7z_66dYoGSaK6jYWc&sig=Cg0ArKJSzPYhHRzlqjGREAE&adk=249291572&tt=1709&bs=1585%2C1200&mtos=1020,1020,1020,1020,1020&tos=1020,0,0,0,0&p=92,315,342,1285&mcvt=1020&rs=3&ht=0&tfs=704&tls=1724&mc=1&lte=1&bas=0&bac=0&met=no&la=1&avms=nio&niot_obs=13&niot_cbk=84&md=2&lm=2&rst=1571671541461&rpt=736&isd=0&msd=0&oseid=3&xdi=0&xosd=1&ps=1600%2C6384&ss=1600%2C1200&pt=16&bin=1&deb=1-5-5-17-15-17-109-13-0-0-0&tvt=1717&r=v&id=osdim&vs=4&uc=11&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=0x0&itpl=19&v=20191014
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:824::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:43 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel.gif
reutersdfpcw319687550988.s.moatpixel.com/
43 B
409 B
Image
General
Full URL
https://reutersdfpcw319687550988.s.moatpixel.com/pixel.gif?m=1&iv=1&tuv=851&tet=1049&fi=1&apd=1052&ui=0&uit=0&h=0&th=-1&s=0&ts=-1&bfa=0&d=reuters.com&L1id=63378192&L2id=2594181822&L3id=5158696277&L4id=138285704442&S1id=3735912&S2id=37592232&ord=1571671542232&r=705334989317&t=iv&bedc=1&q=5&nu=1&ib=0&dc=1&ob=1&oh=0&lt=0&ab=1&n=1&nm=1&sp=0&pt=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:43 GMT
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=12c400f5-5bcb-435f-f473-7b216ec2e2d8&tv={c:rHe9Tn,pingTime:1,time:1249,type:p,clog:[{piv:100,vs:i,r:,w:970,h:250,t:215}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1249,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:215,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1046~100],as:[1046~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:88,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt46.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=12c400f5-5bcb-435f-f473-7b216ec2e2d8&tv={c:rHe9Tn,pingTime:1,time:1249,type:pf,clog:[{piv:100,vs:i,r:,w:970,h:250,t:215}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1249,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:215,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1046~100],as:[1046~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:88,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt44.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=12c400f5-5bcb-435f-f473-7b216ec2e2d8&tv={c:rHe9To,pingTime:1,time:1250,type:c,clog:[{piv:100,vs:i,r:,w:970,h:250,t:215}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1250,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:215,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1047~100],as:[1047~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:88,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1,metricId:publ1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt14.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=12c400f5-5bcb-435f-f473-7b216ec2e2d8&tv={c:rHe9To,pingTime:1,time:1250,type:c,clog:[{piv:100,vs:i,r:,w:970,h:250,t:215}],es:0,sc:1,ha:1,gm:1,slTimes:{i:1250,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:215,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[1047~100],as:[1047~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:88,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1,metricId:grpm1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
X-Server-Name
dt70.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
event.png
tps20228.doubleverify.com/ Frame A38F
67 B
490 B
Other
General
Full URL
https://tps20228.doubleverify.com/event.png?impid=7006ce3c3a7a4a6e8a153a0d270d6561&vdur=35&eoid=6&msrjs=289&pltfrm=Linux%20x86_64&isvelg=1&vit=2&engms=1&engisel=1&dvp_esdtms=2201&mpt=1571671544524542
Requested by
Host: cdn.doubleverify.com
URL: https://cdn.doubleverify.com/dv-measurements289.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
213.254.244.11 , Ireland, ASN36062 (DOUBLE-VERIFY - DoubleVerify, Inc., US),
Reverse DNS
Software
Microsoft-IIS/8.0 / ASP.NET
Resource Hash
ebf4f635a17d10d6eb46ba680b70142419aa3220f228001a036d311a22ee9d2a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/8.0
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
image/png
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
max-age=0
Transfer-Encoding
chunked
Access-Control-Allow-Credentials
true
Expires
10/20/2019 3:25:44 PM
ping.gif
stats-dev.brid.tv/ Frame 66C3
0
347 B
Image
General
Full URL
https://stats-dev.brid.tv/ping.gif?p=14815&pr=o&b=c&pid=11615&s=undefined|undefined&os=l&m=0&apa=0&df=1&ow=14120&pub=p&e=vi&aid=9261&par=b&wp=0&at=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
13.225.78.2 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-13-225-78-2.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 20 Oct 2019 20:32:20 GMT
via
1.1 df26103dc140569d7032449c70c3b141.cloudfront.net (CloudFront)
last-modified
Tue, 04 Dec 2018 09:25:32 GMT
server
AmazonS3
age
68067
etag
"d41d8cd98f00b204e9800998ecf8427e"
x-cache
Hit from cloudfront
content-type
image/gif
status
200
cache-control
max-age=0, no-cache, no-store
x-amz-cf-pop
FRA2-C2
accept-ranges
bytes
content-length
0
x-amz-cf-id
qYJV_wQoB4YRvX6ihWxnRP7uzjt9D8ECkG6hWNJI2_oldLUQw-j9hA==
protobuf.min.js
cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/ Frame E8C9
69 KB
21 KB
XHR
General
Full URL
https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/external/protobuf.min.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.195.39.46 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/41A4) /
Resource Hash
04b075859121bd8bae2825f760da6f0a2f0a5e9c7755370a55d51c961e41354c

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:44 GMT
content-encoding
deflate
vary
Accept-Encoding
x-amz-request-id
A8B632884A513621
x-cache
HIT
status
200
content-length
21141
x-amz-id-2
LIxM34qSYgQSMFcnE5VM++HTN095A+Z4uJMIBCtIWHZQWZTGDiXjKlxTSn8vBhFTYGzXUrX0RN0=
last-modified
Mon, 12 Aug 2019 09:30:10 GMT
server
ECS (fcn/41A4)
etag
"0b2aa9f2e7a587c31a287a8c3cdc3acd"
access-control-max-age
3000
access-control-allow-methods
GET
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=63072000,s-maxage=63072000
accept-ranges
bytes
KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
fonts.gstatic.com/s/roboto/v20/ Frame E8C9
11 KB
11 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v20/KFOmCnqEu92Fr1Mu4mxKKTU1Kg.woff2
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
5d1bc9b443f3f81fa4b4ad4634c1bb9702194c1898e3a9de0ab5e2cdc0e9f479
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Roboto:500,300,700,400
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 11 Oct 2019 17:55:15 GMT
x-content-type-options
nosniff
last-modified
Wed, 24 Jul 2019 01:18:50 GMT
server
sffe
age
855029
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
11016
x-xss-protection
0
expires
Sat, 10 Oct 2020 17:55:15 GMT
mem5YaGs126MiZpBA-UNirkOUuhpKKSTjw.woff2
fonts.gstatic.com/s/opensans/v17/ Frame E8C9
9 KB
9 KB
Font
General
Full URL
https://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UNirkOUuhpKKSTjw.woff2
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:816::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
b8e23a845bc6b7fd417d29182e0e38d353e64b5e12e06bb1de2b5ce063db1dcc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,600,300,700,800
Origin
https://www.reuters.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 14 Oct 2019 23:10:17 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 19:30:44 GMT
server
sffe
age
576927
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
9180
x-xss-protection
0
expires
Tue, 13 Oct 2020 23:10:17 GMT
blacklist_script.js
tagan.adlightning.com/carambola/ Frame F709
67 KB
26 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blacklist_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.26 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-26.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
892ec7484196a683e2534b74a1463adf6908963930ec9248eb1d3ae3e6f0a8f6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
fgs5hKmV4uxy7PmBXZ6xQ816WdGBIsWJ
content-encoding
gzip
etag
"79b48bcfa76215407d1685458fd5ebf4"
x-amz-cf-pop
FRA50-C1
x-cache
Hit from cloudfront
status
200
content-length
25823
x-amz-meta-git_commit
e5df4b9
last-modified
Sun, 20 Oct 2019 18:29:18 GMT
server
AmazonS3
date
Mon, 21 Oct 2019 11:33:06 GMT
content-type
application/javascript
via
1.1 6b4954a8411e7b2a232537f8000c5c9d.cloudfront.net (CloudFront)
cache-control
max-age=900
accept-ranges
bytes
x-amz-cf-id
2mEFM8rXbIdNyYiBIfXIivlV26xGLivgXU8LEjOm818k_BXYPcqb4g==
blocking_script.js
tagan.adlightning.com/carambola/ Frame F709
51 KB
14 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blocking_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.26 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-26.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89e2a6149ffa9306be8353f88f60111c9976ef77681059262318551fc3ff1a45

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
R4ROrLSRtw9OG4KaHY69v06kGYSAlhfQ
content-encoding
gzip
etag
"c7306f799f7635ded477731fe3e0138b"
age
73223
x-cache
Hit from cloudfront
status
200
content-length
13901
x-amz-meta-git_commit
e5df4b9
last-modified
Tue, 15 Oct 2019 19:04:40 GMT
server
AmazonS3
date
Sun, 20 Oct 2019 19:05:22 GMT
content-type
application/javascript
via
1.1 6b4954a8411e7b2a232537f8000c5c9d.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
_Mw0hnvzZ0UqbSKYjRv5All4Nv4PPG4dkHSr9-hSeOVh4PowpNWD9A==
SetAdsRequest
analytics.carambo.la/ Frame E8C9
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetAdsRequest
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.210.116.191 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-210-116-191.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:44 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
blacklist_script.js
tagan.adlightning.com/carambola/ Frame 18D7
67 KB
26 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blacklist_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.26 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-26.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
892ec7484196a683e2534b74a1463adf6908963930ec9248eb1d3ae3e6f0a8f6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
fgs5hKmV4uxy7PmBXZ6xQ816WdGBIsWJ
content-encoding
gzip
etag
"79b48bcfa76215407d1685458fd5ebf4"
x-amz-cf-pop
FRA50-C1
x-cache
Hit from cloudfront
status
200
content-length
25823
x-amz-meta-git_commit
e5df4b9
last-modified
Sun, 20 Oct 2019 18:29:18 GMT
server
AmazonS3
date
Mon, 21 Oct 2019 11:33:06 GMT
content-type
application/javascript
via
1.1 6b4954a8411e7b2a232537f8000c5c9d.cloudfront.net (CloudFront)
cache-control
max-age=900
accept-ranges
bytes
x-amz-cf-id
ycdTRMPmtkCVH7syzKZf6f-5JbkHrvOWRf9Zqnw5v-p92CyDkA9l3g==
blocking_script.js
tagan.adlightning.com/carambola/ Frame 18D7
51 KB
14 KB
Script
General
Full URL
https://tagan.adlightning.com/carambola/blocking_script.js
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.101.26 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-101-26.fra50.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89e2a6149ffa9306be8353f88f60111c9976ef77681059262318551fc3ff1a45

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-version-id
R4ROrLSRtw9OG4KaHY69v06kGYSAlhfQ
content-encoding
gzip
etag
"c7306f799f7635ded477731fe3e0138b"
age
73223
x-cache
Hit from cloudfront
status
200
content-length
13901
x-amz-meta-git_commit
e5df4b9
last-modified
Tue, 15 Oct 2019 19:04:40 GMT
server
AmazonS3
date
Sun, 20 Oct 2019 19:05:22 GMT
content-type
application/javascript
via
1.1 6b4954a8411e7b2a232537f8000c5c9d.cloudfront.net (CloudFront)
cache-control
max-age=86400
x-amz-cf-pop
FRA50-C1
accept-ranges
bytes
x-amz-cf-id
9E7FUpoKYSKIVTiIqvvoel-IJj95eakGvVtTZg1se3Lk0mI1AE6-vQ==
jstag
carambola-d.openx.net/w/1.0/ Frame 18D7
63 KB
23 KB
Script
General
Full URL
https://carambola-d.openx.net/w/1.0/jstag
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
ee0a3c8a57caeab9d5839eb87c6e6890397673ec7341c1bdb236109a34449259

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:44 GMT
content-encoding
gzip
server
OXGW/16.163.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
22918
via
1.1 google
expires
Mon, 21 Oct 2019 16:25:44 GMT
SetAdsRequest
analytics.carambo.la/ Frame E8C9
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetAdsRequest
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.210.116.191 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-210-116-191.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
application/x-www-form-urlencoded; charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:43 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
SetHbBidRequestProto
analytics.carambo.la/ Frame E8C9
0
176 B
Fetch
General
Full URL
https://analytics.carambo.la/SetHbBidRequestProto
Requested by
Host: cdata.carambo.la
URL: https://cdata.carambo.la/Layer/InImage/Prod/cbola_platform/version_2.28.1/js/Carambola_layer_152.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.210.116.191 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-18-210-116-191.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
*
Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:44 GMT
Cache-Control
no-cache
Connection
keep-alive
Expires
-1
siab.js
cdn.tynt.com/ Frame F709
15 KB
6 KB
Script
General
Full URL
https://cdn.tynt.com/siab.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4b3f0ca4c12f7e2cbcca6c51cda0e51542801315a1b8aaa63abbadb68da5628e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:44 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Mon, 07 Oct 2019 18:43:10 GMT
server
cloudflare
age
160918
etag
W/"5d9b873e-3c45"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=259200
cf-ray
52943ef3090c97a8-FRA
expires
Thu, 24 Oct 2019 15:25:44 GMT
bFJBfaR2Or54kOaKkv7mNO.js
sc.tynt.com/script/sc/ Frame F709
2 KB
1 KB
Script
General
Full URL
https://sc.tynt.com/script/sc/bFJBfaR2Or54kOaKkv7mNO.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
0955d7f885f72563f66c56a86cf98c93cff8f70b50aafa307e9b715540130c66
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
age
20382
status
200, 200 OK
x-xss-protection
1; mode=block
x-request-id
327f7cff-4763-4e93-bc58-87bffa84c9d2
x-runtime
0.002089
x-content-digest
575a77f733111aa22f71abcabea9559386c79873
last-modified
Sun, 20 Oct 2019 14:09:51 GMT
server
cloudflare
x-frame-options
SAMEORIGIN
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript; charset=utf-8
cache-control
max-age=3600, public, s-maxage=172800
cf-ray
52943ef3495797a8-FRA
x-rack-cache
fresh
expires
Mon, 21 Oct 2019 08:16:12 GMT
p
ic.tynt.com/b/
0
294 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571671544821&dn=SIAB&iso=0&img=https%3A%2F%2Fs4.reutersmedia.net%2Fresources_v2%2Fimages%2Frcom-default.png&ct=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease&t=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease%20-%20Reuters&cu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda-idUSKBN1WY00B&ah=https%3A%2F%2Fmobile.reuters.com%2Farticle%2Famp%2FidUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.190 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip190.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:44 GMT
server
nginx/1.14.0
p3p
policyref="/w3c/p3p.xml", CP="CUR ADM OUR NOR STA NID", CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
acj
carambola-d.openx.net/w/1.0/ Frame 18D7
Redirect Chain
  • https://carambola-d.openx.net/w/1.0/acj?ai=df0c5bbb-566c-42f0-88d3-3411842b0dea&o=8241388711&callback=OX_8241388711&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-...
  • https://carambola-d.openx.net/w/1.0/acj?cc=1&ai=df0c5bbb-566c-42f0-88d3-3411842b0dea&o=8241388711&callback=OX_8241388711&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alex...
2 KB
2 KB
Script
General
Full URL
https://carambola-d.openx.net/w/1.0/acj?cc=1&ai=df0c5bbb-566c-42f0-88d3-3411842b0dea&o=8241388711&callback=OX_8241388711&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&jr=&auid=540746705&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=300x250&ifr=1&tws=1600x1200&mt=1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
d8c8e6c10cc91f0de88978afc4555e3cf31c61da5ada1e74bc410eb43e14f0fb

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:44 GMT
via
1.1 google
server
OXGW/16.163.0
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
private, max-age=0, no-cache
content-type
application/json
alt-svc
clear
content-length
2247
expires
Mon, 26 Jul 1997 05:00:00 GMT

Redirect headers

date
Mon, 21 Oct 2019 15:25:44 GMT
via
1.1 google
server
OXGW/16.163.0
status
302
p3p
CP="CUR ADM OUR NOR STA NID"
location
https://carambola-d.openx.net/w/1.0/acj?cc=1&ai=df0c5bbb-566c-42f0-88d3-3411842b0dea&o=8241388711&callback=OX_8241388711&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&jr=&auid=540746705&dims=&adxy=&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=300x250&ifr=1&tws=1600x1200&mt=1
alt-svc
clear
content-length
0
pd
eu-u.openx.net/w/1.0/ Frame F415
Redirect Chain
  • https://eu-u.openx.net/w/1.0/pd?plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
  • https://eu-u.openx.net/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
i=a2cfeba8-1276-080d-171b-91a84ba2869b|1571671544
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
vary
Accept
set-cookie
i=a2cfeba8-1276-080d-171b-91a84ba2869b|1571671544; Version=1; Expires=Tue, 20-Oct-2020 15:25:44 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571671544|mOgikimWiygu; Version=1; Expires=Tue, 05-Nov-2019 15:25:44 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.163.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 21 Oct 2019 15:25:44 GMT
content-type
text/html
content-length
592
via
1.1 google
alt-svc
clear

Redirect headers

status
302
set-cookie
i=a2cfeba8-1276-080d-171b-91a84ba2869b|1571671544; Version=1; Expires=Tue, 20-Oct-2020 15:25:44 GMT; Max-Age=31536000; Domain=.openx.net; Path=/
server
OXGW/16.163.0
p3p
CP="CUR ADM OUR NOR STA NID"
location
https://eu-u.openx.net/w/1.0/pd?cc=1&plm=6&ph=c60c4e0c-5442-4600-876b-e4035d01b1eb
date
Mon, 21 Oct 2019 15:25:44 GMT
content-length
0
via
1.1 google
alt-svc
clear
sic.js
cdn-sic.33across.com/1/javascripts/ Frame F709
447 KB
125 KB
Script
General
Full URL
https://cdn-sic.33across.com/1/javascripts/sic.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.39.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
a89cd6ceb08d82e5d55e591af5e48663e1d4df60381d75d357f981fcf5a6931b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:44 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:59 GMT
server
cloudflare
age
3415
x-powered-by
Love
etag
W/"5d82b32f-6fce0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=3600
cf-ray
52943ef39d4d96b0-FRA
expires
Mon, 21 Oct 2019 16:25:44 GMT
siab.js
cdn.tynt.com/ Frame 200D
15 KB
6 KB
Script
General
Full URL
https://cdn.tynt.com/siab.js?0xTPOWkJpE&_ADTIME_&$RANDOM&%%CACHEBUSTER%%&
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4b3f0ca4c12f7e2cbcca6c51cda0e51542801315a1b8aaa63abbadb68da5628e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
cf-cache-status
MISS
last-modified
Mon, 07 Oct 2019 18:43:15 GMT
server
cloudflare
etag
W/"5d9b8743-3c45"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=259200
cf-ray
52943ef389b197a8-FRA
expires
Thu, 24 Oct 2019 15:25:45 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/ Frame 0378
46 KB
15 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
f89fcb038aae8bf3e1723e73c705348add5a889d87ac1cc6be57377ccde8b96f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"313 / 333 of 1000 / last-modified: 1571666774"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14723
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:45 GMT
sic.css
cdn-sic.33across.com/1/stylesheets/ Frame F709
11 KB
3 KB
Stylesheet
General
Full URL
https://cdn-sic.33across.com/1/stylesheets/sic.css
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.39.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
81c1d3e8b32d5f970c6f4a7e971031b77d19c5570d1416b9c81e3820875a3390

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:10 GMT
server
cloudflare
age
3080
x-powered-by
Love
etag
W/"5d82b2fe-2a1b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
status
200
cache-control
public, max-age=3600
cf-ray
52943ef44e1c96b0-FRA
expires
Mon, 21 Oct 2019 16:25:45 GMT
authorize
sic.33across.com/ Frame F709
1 KB
1 KB
Script
General
Full URL
https://sic.33across.com/authorize?gdprConsentLength=0&version=2.58.0&agent=Mozilla%2F5.0%20(Macintosh%3B%20Intel%20Mac%20OS%20X%2010_14_5)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F74.0.3729.169%20Safari%2F537.36&product=siab&userId=&sessionId=&publisherURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&referrerURL=&publisherId=bFJBfaR2Or54kOaKkv7mNO&publisher=reuters_3_300_B.com&displayableSizes=300x250&viewportWidth=300&viewportHeight=250&screenWidth=1600&screenHeight=1200&scrollX=0&scrollY=0&pageVisibility=visible&pageWidth=300&pageHeight=250&_=1571671545003&callback=_tynt_jp.ahirbwzrn
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.164.3.90 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-164-3-90.compute-1.amazonaws.com
Software
/ Love
Resource Hash
7041ec50842da7a16a9b86d12b1d112b56b5d4c30cc70ec4d16ab36e31662e04
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
status
200, 200 OK
x-powered-by
Love
etag
W/"5c5-vDdhLwelvIwRS8VwCWHBgRNUPDo"
vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, DELETE
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
access-control-allow-origin
*
access-control-allow-credentials
true
content-type
text/javascript; charset=utf-8
access-control-allow-headers
X-Requested-With, Authorization
integrator.js
adservice.google.de/adsid/ Frame 0378
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/ Frame 0378
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019101401.js
securepubads.g.doubleclick.net/gpt/ Frame 0378
156 KB
57 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
f8800772f0dd827877029d9d634a170a156ff82b6b6bdf251b62c750b73cfe93
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58589
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:45 GMT
v2
de.tynt.com/deb/
4 B
200 B
Script
General
Full URL
https://de.tynt.com/deb/v2?id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=1&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.181 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip181.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
date
Mon, 21 Oct 2019 15:25:43 GMT
cache-control
max-age=86400
content-type
application/javascript
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
expires
Tue, 22 Oct 2019 15:25:44 GMT
v2
de.tynt.com/deb/
4 B
200 B
Script
General
Full URL
https://de.tynt.com/deb/v2?m=xch&id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=1&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.181 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip181.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
date
Mon, 21 Oct 2019 15:25:44 GMT
cache-control
max-age=86400
content-type
application/javascript
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
expires
Tue, 22 Oct 2019 15:25:44 GMT
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571671544821&dn=SIAB&iso=0&img=https%3A%2F%2Fs4.reutersmedia.net%2Fresources_v2%2Fimages%2Frcom-default.png&ct=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease&t=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease%20-%20Reuters&cu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.190 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip190.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:44 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571671544821&dn=SIAB&iso=0&img=https%3A%2F%2Fs4.reutersmedia.net%2Fresources_v2%2Fimages%2Frcom-default.png&ct=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease&t=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease%20-%20Reuters
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.190 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip190.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:44 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
jpt
ib.adnxs.com/ Frame F709
0
662 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251243&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&prod=SIAB&psa=0&pf=90&cc=59&ivt=19&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.a6l66lbql
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 , Ascension Island, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 536.bm-nginx-loadbalancer.mgmt.fra1; *.adnxs.com; 37.252.172.254:80
AN-X-Request-Uuid
470c128c-e3b3-4c04-8f9d-10cf2e132d43
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame F709
0
661 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251239&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&prod=SIAB&psa=0&pf=30&cc=59&ivt=19&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.a8ejj7025
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 , Ascension Island, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 536.bm-nginx-loadbalancer.mgmt.fra1; *.adnxs.com; 37.252.173.40:80
AN-X-Request-Uuid
9846f921-d886-49e6-813a-a6707d67e418
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame F709
0
661 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251244&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&prod=SIAB&psa=0&pf=30&cc=59&ivt=19&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.a38arp9tf
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 , Ascension Island, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 536.bm-nginx-loadbalancer.mgmt.fra1; *.adnxs.com; 37.252.173.90:80
AN-X-Request-Uuid
9852acb0-b257-403d-81b0-527e15d2d16a
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 3E02
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
b87d50ea12db9d9895afe880a1a21c4d596571979dd81ea1e10604a6bd11ec99

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
server
OXGW/16.163.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57433
via
1.1 google
expires
Mon, 21 Oct 2019 16:25:45 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 38F4
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
48935eaa683406d563bc486df73014a844db4dcc2065f3901878ba0216fd2d6c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
server
OXGW/16.163.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57433
via
1.1 google
expires
Mon, 21 Oct 2019 16:25:45 GMT
jstag
33across-d.openx.net/w/1.0/ Frame D1F7
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
c6ca8850a210afd31de031056b6cf3f62fcea6f1a2d8cfd6dc8d5a456c348ebc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
server
OXGW/16.163.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57432
via
1.1 google
expires
Mon, 21 Oct 2019 16:25:45 GMT
exchange
ssc.33across.com/api/ Frame F709
141 B
408 B
XHR
General
Full URL
https://ssc.33across.com/api/exchange
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.173 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip173.208-100-17.static.steadfastdns.net
Software
/ 33Across
Resource Hash
3d4b80f3533ab14bac30c79b2631b049b72c782e8205674122aabcd19a2981bf

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
status
200, 200 OK
x-powered-by
33Across
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
bFJBfaR2Or54kOaKkv7mNO.js
sc.tynt.com/script/sc/ Frame 200D
2 KB
903 B
Script
General
Full URL
https://sc.tynt.com/script/sc/bFJBfaR2Or54kOaKkv7mNO.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.87.26 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
0955d7f885f72563f66c56a86cf98c93cff8f70b50aafa307e9b715540130c66
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
age
20383
status
200, 200 OK
x-xss-protection
1; mode=block
x-request-id
327f7cff-4763-4e93-bc58-87bffa84c9d2
x-runtime
0.002089
x-content-digest
575a77f733111aa22f71abcabea9559386c79873
last-modified
Sun, 20 Oct 2019 14:09:51 GMT
server
cloudflare
x-frame-options
SAMEORIGIN
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript; charset=utf-8
cache-control
max-age=3600, public, s-maxage=172800
cf-ray
52943ef67dda97a8-FRA
x-rack-cache
fresh
expires
Mon, 21 Oct 2019 08:16:12 GMT
sic.js
cdn-sic.33across.com/1/javascripts/ Frame 200D
447 KB
125 KB
Script
General
Full URL
https://cdn-sic.33across.com/1/javascripts/sic.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.39.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
a89cd6ceb08d82e5d55e591af5e48663e1d4df60381d75d357f981fcf5a6931b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:59 GMT
server
cloudflare
age
3416
x-powered-by
Love
etag
W/"5d82b32f-6fce0"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=3600
cf-ray
52943ef6895596b0-FRA
expires
Mon, 21 Oct 2019 16:25:45 GMT
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571671544821&dn=SIAB&iso=0&img=https%3A%2F%2Fs4.reutersmedia.net%2Fresources_v2%2Fimages%2Frcom-default.png&ct=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.190 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip190.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:44 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
acj
33across-d.openx.net/w/1.0/ Frame 3E02
454 B
687 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=2eb639aa77a61e&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&jr=&nl=17&ul=39&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier1&c.pf=90&c.cc=59&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
4543b41530fdec8af346a0990cd6e6cf123acdb194666d68790ac993a17d5803

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:45 GMT
via
1.1 google
server
OXGW/16.163.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
acj
33across-d.openx.net/w/1.0/ Frame D1F7
454 B
638 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=26136390bfeaa1&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&jr=&nl=17&ul=39&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=59&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
5b7e7ec274cd40bc8d3fb0ed36377a8caaec566a7c3329da80bf2b6bb2e0352c

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:45 GMT
via
1.1 google
server
OXGW/16.163.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/ Frame 351E
46 KB
14 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
f89fcb038aae8bf3e1723e73c705348add5a889d87ac1cc6be57377ccde8b96f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"313 / 810 of 1000 / last-modified: 1571666774"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
14723
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:45 GMT
sic.css
cdn-sic.33across.com/1/stylesheets/ Frame 200D
11 KB
2 KB
Stylesheet
General
Full URL
https://cdn-sic.33across.com/1/stylesheets/sic.css
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.16.39.14 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare / Love
Resource Hash
81c1d3e8b32d5f970c6f4a7e971031b77d19c5570d1416b9c81e3820875a3390

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 18 Sep 2019 22:43:10 GMT
server
cloudflare
age
3080
x-powered-by
Love
etag
W/"5d82b2fe-2a1b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
status
200
cache-control
public, max-age=3600
cf-ray
52943ef71a0596b0-FRA
expires
Mon, 21 Oct 2019 16:25:45 GMT
authorize
sic.33across.com/ Frame 200D
1 KB
1 KB
Script
General
Full URL
https://sic.33across.com/authorize?gdprConsentLength=0&version=2.58.0&agent=Mozilla%2F5.0%20(Macintosh%3B%20Intel%20Mac%20OS%20X%2010_14_5)%20AppleWebKit%2F537.36%20(KHTML%2C%20like%20Gecko)%20Chrome%2F74.0.3729.169%20Safari%2F537.36&product=siab&userId=&sessionId=&publisherURL=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&referrerURL=&publisherId=bFJBfaR2Or54kOaKkv7mNO&publisher=reuters_3_300_B.com&displayableSizes=300x250&viewportWidth=300&viewportHeight=250&screenWidth=1600&screenHeight=1200&scrollX=0&scrollY=0&pageVisibility=visible&pageWidth=300&pageHeight=250&_=1571671545450&callback=_tynt_jp.a2phkafpp
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.164.3.90 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-54-164-3-90.compute-1.amazonaws.com
Software
/ Love
Resource Hash
2e02c8baf181fdc52eda9db7403fc91f93305a4dc02ed36e70025af21cf9b3be
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
status
200, 200 OK
x-powered-by
Love
etag
W/"5c5-Zu7r5Hm5t6xhO8ve/TH3mca1MA4"
vary
Accept-Encoding
access-control-allow-methods
GET, POST, PUT, DELETE
p3p
CP="NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA"
access-control-allow-origin
*
access-control-allow-credentials
true
content-type
text/javascript; charset=utf-8
access-control-allow-headers
X-Requested-With, Authorization
acj
33across-d.openx.net/w/1.0/ Frame 38F4
454 B
638 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=242d5dec11fcc9&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&jr=&nl=17&ul=39&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier2&c.pf=30&c.cc=59&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
eadb4e65c3e5325696fa738c317f59d2b98fb92d6585b1a2503ea7c98179299c

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:45 GMT
via
1.1 google
server
OXGW/16.163.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
pd
eu-u.openx.net/w/1.0/ Frame 1481
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
pd=v2|1571671544|mOgikimWiygu; i=50adef71-b274-0c36-2135-8f8716424095|1571671544
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
vary
Accept
set-cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; Version=1; Expires=Tue, 20-Oct-2020 15:25:45 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571671544.1|kimWiymOgugi.rsfcsHgqsLomgensn0oa; Version=1; Expires=Tue, 05-Nov-2019 15:25:45 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.163.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 21 Oct 2019 15:25:45 GMT
content-type
text/html
content-length
821
via
1.1 google
alt-svc
clear
integrator.js
adservice.google.de/adsid/ Frame 351E
109 B
171 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:815::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/ Frame 351E
109 B
171 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.reuters.com
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
104
x-xss-protection
0
pubads_impl_2019101401.js
securepubads.g.doubleclick.net/gpt/ Frame 351E
156 KB
57 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
f8800772f0dd827877029d9d634a170a156ff82b6b6bdf251b62c750b73cfe93
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
58589
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:45 GMT
pd
eu-u.openx.net/w/1.0/ Frame C0B3
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; pd=v2|1571671544.1|kimWiymOgugi.rsfcsHgqsLomgensn0oa
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
vary
Accept
set-cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; Version=1; Expires=Tue, 20-Oct-2020 15:25:45 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571671544.1|kimWiymOgugi.rsj8gmfcvmsHtlqGgqmufQnIsLiSomgelEnsn0oa; Version=1; Expires=Tue, 05-Nov-2019 15:25:45 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.163.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 21 Oct 2019 15:25:45 GMT
content-type
text/html
content-length
808
via
1.1 google
alt-svc
clear
pd
eu-u.openx.net/w/1.0/ Frame 8EC3
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; pd=v2|1571671544.1|kimWiymOgugi.rsfcsHgqsLomgensn0oa
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
vary
Accept
set-cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; Version=1; Expires=Tue, 20-Oct-2020 15:25:45 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571671544.1|kimWiymOgugi.rsj8gmfcvmsHtlqGgqmufQnIsLiSomgelEnsn0oa; Version=1; Expires=Tue, 05-Nov-2019 15:25:45 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.163.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 21 Oct 2019 15:25:45 GMT
content-type
text/html
content-length
808
via
1.1 google
alt-svc
clear
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571671544821&dn=SIAB&iso=0&img=https%3A%2F%2Fs4.reutersmedia.net%2Fresources_v2%2Fimages%2Frcom-default.png&ct=FDA%20approves%20Alexion%27s%20Ultomiris%20for%20another%20rare%20blood%20disease
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.190 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip190.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:44 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
event.png
tps20228.doubleverify.com/ Frame A38F
67 B
490 B
Other
General
Full URL
https://tps20228.doubleverify.com/event.png?impid=7006ce3c3a7a4a6e8a153a0d270d6561&msrcanlm=920&msrcannum=3&eoid=9&ismms=57&isumms=56&isvelg=1&nvr=6&isbxdms=2257&b11=2350&adhgt=250&adwdth=970&norwdth=970&norhgt=250&engisel=1&vsos=13&dvp_vsosnmr=16&dvp_mvpw=device-width&dvp_mvpis=1&dvp_mvpiss=1&lftb=2350&sftb=2350&msrdp=1&naral=656&vct=1&vphgt=1200&vpwdth=1600&scrhgt=1200&scrwdth=1600&strp=100&advisonl=true&isiabvms=957&isuiabvms=957&ispmxpms=957&iscvmvms=1957&engalms=55&dvp_hdnAd=7000&dvp_dpr=1&dvp_ltspl=4549&dvp_esdtms=3204&mpt=1571671545527842
Requested by
Host: cdn.doubleverify.com
URL: https://cdn.doubleverify.com/dv-measurements289.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
213.254.244.11 , Ireland, ASN36062 (DOUBLE-VERIFY - DoubleVerify, Inc., US),
Reverse DNS
Software
Microsoft-IIS/8.0 / ASP.NET
Resource Hash
ebf4f635a17d10d6eb46ba680b70142419aa3220f228001a036d311a22ee9d2a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:44 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/8.0
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
image/png
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
max-age=0
Transfer-Encoding
chunked
Access-Control-Allow-Credentials
true
Expires
10/20/2019 3:25:45 PM
jpt
ib.adnxs.com/ Frame 200D
0
661 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251243&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&prod=SIAB&psa=0&pf=90&cc=59&ivt=19&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.ah2cmkvez
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 , Ascension Island, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 536.bm-nginx-loadbalancer.mgmt.fra1; *.adnxs.com; 37.252.173.87:80
AN-X-Request-Uuid
81b0f5f8-df10-4acd-8616-49a474be211c
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame 200D
0
662 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251239&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&prod=SIAB&psa=0&pf=30&cc=59&ivt=19&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.a9rm32y3a
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 , Ascension Island, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 536.bm-nginx-loadbalancer.mgmt.fra1; *.adnxs.com; 37.252.172.183:80
AN-X-Request-Uuid
c3ce15ec-ef8c-4f92-8181-d8d5f47b2b03
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jpt
ib.adnxs.com/ Frame 200D
0
661 B
Script
General
Full URL
https://ib.adnxs.com/jpt?id=12251244&size=300x250&referrer=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&prod=SIAB&psa=0&pf=30&cc=59&ivt=19&iva=4&ivb=3&ivc=1&ivd=1&ive=0&ivp=6&osr=6&33xvis=0&callback=_tynt_jp.a8yx3is04
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 , Ascension Island, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 536.bm-nginx-loadbalancer.mgmt.fra1; *.adnxs.com; 37.252.173.45:80
AN-X-Request-Uuid
aca51624-b164-41d3-bd9a-6cff5beac865
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 3272
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
ae72debdb4e64875f49474c2beb64eb11b8484e30e67b09680cb782b5389632f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
server
OXGW/16.163.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57434
via
1.1 google
expires
Mon, 21 Oct 2019 16:25:45 GMT
jstag
33across-d.openx.net/w/1.0/ Frame C5A5
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
c9ba59120f294d3775ae29f0c0b63b50f71d246cc6904c8d7f74eebedd80b057

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
server
OXGW/16.163.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57431
via
1.1 google
expires
Mon, 21 Oct 2019 16:25:45 GMT
jstag
33across-d.openx.net/w/1.0/ Frame 8072
164 KB
56 KB
Script
General
Full URL
https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
9ace239a02ca40c7ec5da3495c163aed11f778ed8ef5295c3e935ee87f32e768

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
server
OXGW/16.163.0
vary
Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
status
200
cache-control
max-age=3600
content-type
text/javascript
alt-svc
clear
content-length
57434
via
1.1 google
expires
Mon, 21 Oct 2019 16:25:45 GMT
exchange
ssc.33across.com/api/ Frame 200D
141 B
408 B
XHR
General
Full URL
https://ssc.33across.com/api/exchange
Requested by
Host: cdn-sic.33across.com
URL: https://cdn-sic.33across.com/1/javascripts/sic.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.173 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip173.208-100-17.static.steadfastdns.net
Software
/ 33Across
Resource Hash
78abc3f40c3ba54cb470bc087d238fa38343075bd497dd8c06b8c1df99563aad

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

date
Mon, 21 Oct 2019 15:25:45 GMT
content-encoding
gzip
status
200, 200 OK
x-powered-by
33Across
vary
Accept-Encoding, Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.reuters.com
access-control-allow-credentials
true
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571671544821&dn=SIAB&iso=0&img=https%3A%2F%2Fs4.reutersmedia.net%2Fresources_v2%2Fimages%2Frcom-default.png
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.190 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip190.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:44 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
v2
de.tynt.com/deb/
4 B
200 B
Script
General
Full URL
https://de.tynt.com/deb/v2?m=xch&id=bFJBfaR2Or54kOaKkv7mNO&dn=SIAB&cc=2&r=
Requested by
Host: cdn.tynt.com
URL: https://cdn.tynt.com/siab.js?0xTPOWkJpE&_ADTIME_&$RANDOM&%%CACHEBUSTER%%&
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.181 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip181.208-100-17.static.steadfastdns.net
Software
/
Resource Hash
d21021784cda31eeae5c8295e047a14bda6ed5a9b5963fca9e7ceb398a9c9179

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
date
Mon, 21 Oct 2019 15:25:44 GMT
cache-control
max-age=86400
content-type
application/javascript
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
content-length
4
expires
Tue, 22 Oct 2019 15:25:44 GMT
acj
33across-d.openx.net/w/1.0/ Frame 3272
454 B
638 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=2d0a6017a871d3&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&jr=&nl=17%252C20%252C23%252C16&ul=39%252C40%252C42%252C36&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier1&c.pf=90&c.cc=59&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
59299f584420ced6f0ca6a50ee948a924c7dff59c1eeaeedf95321c55dd6b543

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:45 GMT
via
1.1 google
server
OXGW/16.163.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
acj
33across-d.openx.net/w/1.0/ Frame 8072
454 B
638 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=257cdf7c17ab39&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&jr=&nl=17%252C20%252C23%252C16&ul=39%252C40%252C42%252C36&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier3&c.pf=30&c.cc=59&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
f8d90026d64c8cc93d62fb0e02800db701157f2a0a7eef034f815411c4f31363

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:45 GMT
via
1.1 google
server
OXGW/16.163.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
acj
33across-d.openx.net/w/1.0/ Frame C5A5
454 B
638 B
XHR
General
Full URL
https://33across-d.openx.net/w/1.0/acj?o=2d3b362ae40f4d&ju=https%3A//www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&jr=&nl=17%252C20%252C23%252C16&ul=39%252C40%252C42%252C36&be=1&prf=0&auid=538526169&aus=300x250&bc=hb_2api&bt=5000&c.placement=bFJBfaR2Or54kOaKkv7mNO%3ASIAB%3Adesktop%3AINTL%3Atier2&c.pf=30&c.cc=59&c.33xvis=0&res=1600x1200x24&plg=pm&ch=UTF-8&tz=-120&ws=1x1&ifr=1&tws=300x250
Requested by
Host: 33across-d.openx.net
URL: https://33across-d.openx.net/w/1.0/jstag?nc=17118521-33Across
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
a097d34e7807cce4599f25b2a942c36aa7a051f04ecb55ad69ff8067025a3b1f

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:45 GMT
via
1.1 google
server
OXGW/16.163.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
454
expires
Mon, 26 Jul 1997 05:00:00 GMT
pd
eu-u.openx.net/w/1.0/ Frame 7C0D
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; pd=v2|1571671544.1|kimWiymOgugi.rsj8gmfcvmsHtlqGgqmufQnIsLiSomgelEnsn0oa
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
vary
Accept
set-cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; Version=1; Expires=Tue, 20-Oct-2020 15:25:45 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571671544.1|kimWiymOgugi.forsgSj8tKgmjotufcvmsHtlqGgqmufQnIsLiSomgesflEnsn0rFoa; Version=1; Expires=Tue, 05-Nov-2019 15:25:45 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.163.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 21 Oct 2019 15:25:45 GMT
content-type
text/html
content-length
828
via
1.1 google
alt-svc
clear
pd
eu-u.openx.net/w/1.0/ Frame 1253
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; pd=v2|1571671544.1|kimWiymOgugi.rsj8gmfcvmsHtlqGgqmufQnIsLiSomgelEnsn0oa
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
vary
Accept
set-cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; Version=1; Expires=Tue, 20-Oct-2020 15:25:45 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571671544.1|kimWiymOgugi.forsgSj8tKgmjotufcvmsHtlqGgqmufQnIsLiSomgesflEnsn0rFoa; Version=1; Expires=Tue, 05-Nov-2019 15:25:45 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.163.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 21 Oct 2019 15:25:45 GMT
content-type
text/html
content-length
828
via
1.1 google
alt-svc
clear
pd
eu-u.openx.net/w/1.0/ Frame 151B
0
0
Document
General
Full URL
https://eu-u.openx.net/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash

Request headers

:method
GET
:authority
eu-u.openx.net
:scheme
https
:path
/w/1.0/pd?plm=10&ph=8f5ed5d4-642c-4222-968a-d709c87ac3c8&gdpr=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
accept-encoding
gzip, deflate, br
cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; pd=v2|1571671544.1|kimWiymOgugi.forsgSj8tKgmjotufcvmsHtlqGgqmufQnIsLiSomgesflEnsn0rFoa
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B

Response headers

status
200
vary
Accept
set-cookie
i=50adef71-b274-0c36-2135-8f8716424095|1571671544; Version=1; Expires=Tue, 20-Oct-2020 15:25:45 GMT; Max-Age=31536000; Domain=.openx.net; Path=/ pd=v2|1571671544.1|kimWiymOgugi.forsgSj8tKgmjotufcvmsHtlqGgqmufQnIsLiSomgesflEnsn0rFoa; Version=1; Expires=Tue, 05-Nov-2019 15:25:45 GMT; Max-Age=1296000; Domain=.openx.net; Path=/
server
OXGW/16.163.0
p3p
CP="CUR ADM OUR NOR STA NID"
date
Mon, 21 Oct 2019 15:25:45 GMT
content-type
text/html
content-length
68
via
1.1 google
alt-svc
clear
p
ic.tynt.com/b/
0
119 B
Image
General
Full URL
https://ic.tynt.com/b/p?id=bFJBfaR2Or54kOaKkv7mNO&lm=5&ts=1571671544821&dn=SIAB&iso=0
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
208.100.17.190 Chicago, United States, ASN32748 (STEADFAST - Steadfast, US),
Reverse DNS
ip190.208-100-17.static.steadfastdns.net
Software
nginx/1.14.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:44 GMT
server
nginx/1.14.0
p3p
CP=NOI DSP COR NID PSA PSD OUR IND UNI COM NAV INT DEM STA
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=39ee33eb-fb9f-7ece-5a9a-6235abb6c0f5&tv={c:rHeaOi,pingTime:5,time:5375,type:p,clog:[{piv:100,vs:i,r:,w:300,h:250,t:260}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5375,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:260,wc:0.0.1600.1200,ac:1140.686.300.250,am:i,cc:1140.686.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5132~100],as:[5132~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:90,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1e.10764|1e1|1f1|1f2|1f3|1g.10764|1g1|1h|1i,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Server-Name
dt70.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=39ee33eb-fb9f-7ece-5a9a-6235abb6c0f5&tv={c:rHeaOi,pingTime:5,time:5375,type:pf,clog:[{piv:100,vs:i,r:,w:300,h:250,t:260}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5375,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:260,wc:0.0.1600.1200,ac:1140.686.300.250,am:i,cc:1140.686.300.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5132~100],as:[5132~300.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:90,fm:rFy5CqX+11|12|13|14|15|16|17|18|19|1a|1b|1c*.10764|1c1|1d.10764|1e.10764|1e1|1f1|1f2|1f3|1g.10764|1g1|1h|1i,idMap:1c*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Server-Name
dt46.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=fa97b592-b696-3c82-280b-b681a483dc6b&tv={c:rHeaQ1,pingTime:5,time:5474,type:p,clog:[{piv:100,vs:i,r:,w:2,h:2,t:389}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5474,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:389,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[5096~100],as:[5096~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:90,fm:rFy5Cr5+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d.10764|1d1|1e*.10764|1e1|1f1|1f2|1f3|1g1|1g2|1h|1i,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Server-Name
dt70.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=fa97b592-b696-3c82-280b-b681a483dc6b&tv={c:rHeaQ1,pingTime:5,time:5474,type:pf,clog:[{piv:100,vs:i,r:,w:2,h:2,t:389}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5474,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:389,wc:0.0.1600.1200,ac:0.0.2.2,am:i,cc:0.0.2.2,piv:100,obst:0,th:0,reas:,bkn:{piv:[5096~100],as:[5096~2.2]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:90,fm:rFy5Cr5+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d.10764|1d1|1e*.10764|1e1|1f1|1f2|1f3|1g1|1g2|1h|1i,idMap:1e*,rend:0,renddet:WINDOW,rmeas:0}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Server-Name
dt46.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
ads
securepubads.g.doubleclick.net/gampad/ Frame 0378
389 B
294 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=4159008017849041&correlator=3179835753000065&output=ldjh&impl=fif&adsid=NT&eid=21062415&vrg=2019101401&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20191021&iu=%2F32867010%2FSIAB_300x250&sz=300x250&scp=c%3D50%26r%3D110%26d%3Dreuters_3_300_B.com%26g%3DbFJBfaR2Or54kOaKkv7mNO%26gd%3DbFJBfaR2Or54kOaKkv7mNO%253Adesktop%26cc%3D59%26pf%3D30%26ivt%3D19%26iva%3D4%26ivb%3D3%26ivc%3D1%26ivd%3D1%26ive%3D0%26ivp%3D6%26osr%3D6%26vis%3D0%26pre%3Dapnx%253At%2Cox%253A0%2Cttx%253A0%26pre_sz%3Dapnx%253A0x0%2Cox%253A0x0%2Cttx%253A0x0%26tier%3Dapnx%253A0%2Cox%253A0%2Cttx%253A0%26hb%3D0&cookie_enabled=1&cdm=www.reuters.com&bc=31&abxe=1&lmt=1571671547&dt=1571671547316&dlt=1571671544998&idt=61&ea=0&frm=23&biw=1585&bih=1200&isw=1&ish=1&oid=3&adx=-8560&ady=-6674&adk=62473835&uci=ui07p6t8vdh2&ifi=1&ifk=3070032842&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&nhd=3&iag=63&url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&top=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&dssz=4&icsg=170&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1x0&msz=300x250&ga_vid=548415160.1571671547&ga_sid=1571671547&ga_hid=1339604&fws=256&ohw=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
99facad01b8f422515e59cb83c58cf746c34358bd9edf928b079a2c877dcb626
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:47 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
205
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019101401.js
securepubads.g.doubleclick.net/gpt/ Frame 0378
64 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
f123fae1ceff20dea7ee2ff8895276a22cddecc8e0ef503b5e95419e76909a54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24836
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:47 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/ Frame 0378
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html?n=3
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=12c400f5-5bcb-435f-f473-7b216ec2e2d8&tv={c:rHeaVT,pingTime:5,time:5249,type:p,clog:[{piv:100,vs:i,r:,w:970,h:250,t:215}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5249,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:215,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5046~100],as:[5046~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:90,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Server-Name
dt46.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
dt
dt.adsafeprotected.com/
43 B
301 B
Image
General
Full URL
https://dt.adsafeprotected.com/dt?anId=10764&asId=12c400f5-5bcb-435f-f473-7b216ec2e2d8&tv={c:rHeaVT,pingTime:5,time:5249,type:pf,clog:[{piv:100,vs:i,r:,w:970,h:250,t:215}],es:0,sc:1,ha:1,gm:1,slTimes:{i:5249,o:0,n:0,pp:0,pm:0},slEvents:[{sl:i,t:215,wc:0.0.1600.1200,ac:315.92.970.250,am:i,cc:315.92.970.250,piv:100,obst:0,th:0,reas:,bkn:{piv:[5046~100],as:[5046~970.250]}}],slEventCount:1,em:true,fr:true,e:,tt:jload,dtt:90,fm:rFy5CAA+11|12|13|14|15|16|17|18|19|1a|1b|1c1|1c2|1d*.10764|1d1|1d2|1d3|1d4|1e1|1e2|1f1|1f2|1f3|1g1|1g2|1h|1i|1j,idMap:1d*,rend:1,renddet:DIV.qs.sn,rmeas:1}&br=u
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
104.244.36.20 , United States, ASN7415 (ADSAFE-1 - Integral Ad Science, Inc., US),
Reverse DNS
nyidt.adsafeprotected.com
Software
nginx /
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
X-Server-Name
dt70.303net.pvt
P3P
CP="COM NAV INT STA NID OUR IND NOI"
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
Server
nginx
ads
securepubads.g.doubleclick.net/gampad/ Frame 351E
295 B
201 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=1449308354277438&correlator=4136329049647456&output=ldjh&impl=fif&adsid=NT&eid=21062796&vrg=2019101401&npa=1&guci=1.2.0.0.2.1.0.0&plat=1%3A536903688%2C2%3A536903688%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20191021&iu=%2F32867010%2FSIAB_300x250&sz=300x250&scp=c%3D50%26r%3D110%26d%3Dreuters_3_300_B.com%26g%3DbFJBfaR2Or54kOaKkv7mNO%26gd%3DbFJBfaR2Or54kOaKkv7mNO%253Adesktop%26cc%3D59%26pf%3D30%26ivt%3D19%26iva%3D4%26ivb%3D3%26ivc%3D1%26ivd%3D1%26ive%3D0%26ivp%3D6%26osr%3D6%26vis%3D0%26pre%3Dapnx%253At%2Cox%253A0%2Cttx%253A0%26pre_sz%3Dapnx%253A0x0%2Cox%253A0x0%2Cttx%253A0x0%26tier%3Dapnx%253A0%2Cox%253A0%2Cttx%253A0%26hb%3D0&cookie=ID%3D27581dc15ea5717e%3AT%3D1571671547%3AS%3DALNI_MZoLdszTECvzJ458p6s0CzAuQeAMQ&cookie_enabled=1&cdm=www.reuters.com&bc=31&abxe=1&lmt=1571671547&dt=1571671547561&dlt=1571671545446&idt=76&ea=0&frm=23&biw=1585&bih=1200&isw=1&ish=1&oid=3&adx=-8560&ady=-6674&adk=62473835&uci=balmxcbiwl99&ifi=1&ifk=3070032842&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&nhd=4&iag=255&url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&top=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&dssz=4&icsg=170&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1x0&msz=300x250&ga_vid=1484264534.1571671548&ga_sid=1571671548&ga_hid=1372611598&fws=256&ohw=0
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019101401.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
cafe /
Resource Hash
ad5476ce9f3635bd6c64d87a1d9881bb99d69ee57675dd65f2460ea45ecfce49
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:47 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
124
x-xss-protection
0
google-lineitem-id
-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.reuters.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019101401.js
securepubads.g.doubleclick.net/gpt/ Frame 351E
64 KB
24 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019101401.js
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.194 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra16s08-in-f2.1e100.net
Software
sffe /
Resource Hash
f123fae1ceff20dea7ee2ff8895276a22cddecc8e0ef503b5e95419e76909a54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:25:47 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 14 Oct 2019 13:08:16 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43",h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
24836
x-xss-protection
0
expires
Mon, 21 Oct 2019 15:25:47 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/ Frame 351E
0
0
Other
General
Full URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html?n=4
Requested by
Host: tagan.adlightning.com
URL: https://tagan.adlightning.com/carambola/blocking_script.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:814::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

fpi.js
ap.lijit.com/www/delivery/ Frame F709
5 KB
3 KB
Script
General
Full URL
https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.14 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
430e706a38aa8345ed806537018805937528dd74f2a2856011378b7734efdaa2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:47 GMT
Content-Encoding
gzip
Server
nginx
ETag
W/"5d83bab8-1534"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
private, no-cache, no-store, must-revalidate, max-age=0
Transfer-Encoding
chunked
X-Sovrn-Pod
ap1ams1
Expires
Thu, 01 Jan 1970 00:00:01 GMT
sync
ap.lijit.com/ Frame F709
49 KB
16 KB
Script
General
Full URL
https://ap.lijit.com/sync
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.14 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
79f27a48d65c1c91b36a3ced51915f0064c60f9b7c870b31bb44c9079c03ea3a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:47 GMT
Content-Encoding
gzip
Last-Modified
Thu, 19 Sep 2019 17:28:24 GMT
Server
nginx
ETag
W/"5d83bab8-c373"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
max-age=86400, must-revalidate
Transfer-Encoding
chunked
X-Sovrn-Pod
ap1ams1
Expires
Tue, 22 Oct 2019 15:25:47 GMT
adcfg
ap.lijit.com/ Frame F709
159 B
566 B
Script
General
Full URL
https://ap.lijit.com/adcfg?zoneid=577991&tid=001d08f8d9c84895823e16702e13870b582fb7e5&mode=1&dmn=www.reuters.com
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/sync
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.14 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
5308516c7bb3916d4dd269673d8a48b49d8389c3f276869bf31b98dc445bc082

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:47 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ap1ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
fpi.js
ap.lijit.com/www/delivery/ Frame 200D
5 KB
3 KB
Script
General
Full URL
https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.14 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
430e706a38aa8345ed806537018805937528dd74f2a2856011378b7734efdaa2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:48 GMT
Content-Encoding
gzip
Server
nginx
ETag
W/"5d83babf-1534"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
private, no-cache, no-store, must-revalidate, max-age=0
Transfer-Encoding
chunked
X-Sovrn-Pod
ap1ams1
Expires
Thu, 01 Jan 1970 00:00:01 GMT
sync
ap.lijit.com/ Frame 200D
49 KB
16 KB
Script
General
Full URL
https://ap.lijit.com/sync
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/www/delivery/fpi.js?{random}&_ADTIME_&z=577991&width=300&height=250
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.14 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
79f27a48d65c1c91b36a3ced51915f0064c60f9b7c870b31bb44c9079c03ea3a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:48 GMT
Content-Encoding
gzip
Last-Modified
Thu, 19 Sep 2019 17:28:25 GMT
Server
nginx
ETag
W/"5d83bab9-c373"
Vary
Accept-Encoding
Content-Type
text/javascript
Cache-Control
max-age=86400, must-revalidate
Transfer-Encoding
chunked
X-Sovrn-Pod
ap1ams1
Expires
Tue, 22 Oct 2019 15:25:48 GMT
adcfg
ap.lijit.com/ Frame 200D
159 B
567 B
Script
General
Full URL
https://ap.lijit.com/adcfg?zoneid=577991&tid=e4a5c38f56d549faab1735943d18a23b782bfbe6&mode=1&dmn=www.reuters.com
Requested by
Host: ap.lijit.com
URL: https://ap.lijit.com/sync
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.14 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
5a4aba7b1f91c53667dcf6120ea235b20b013b0a6df3827138842e0e7396e7c6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Mon, 21 Oct 2019 15:25:48 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/x-javascript
Access-Control-Allow-Origin
*
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ap1ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
dc_oe=ChMIx8_S39St5QIVXph3Ch2q7wU0EAAYACD34546;met=1;ecn1=1;etm1=0;eid1=960584;
ade.googlesyndication.com/ddm/activity/ Frame 66C3
42 B
109 B
Image
General
Full URL
https://ade.googlesyndication.com/ddm/activity/dc_oe=ChMIx8_S39St5QIVXph3Ch2q7wU0EAAYACD34546;met=1;ecn1=1;etm1=0;eid1=960584;
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.18.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
zrh04s05-in-f98.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:50 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43",h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
prebid
ib.adnxs.com/ut/v3/ Frame E8C9
258 B
1 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
37.252.173.22 , Ascension Island, ASN29990 (ASN-APPNEXUS - AppNexus, Inc, US),
Reverse DNS
536.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net
Software
nginx/1.13.4 /
Resource Hash
fd24588e232ceca4cbcf48def28753cd50f5bd2f3a147613a5235ee5a83cad9a
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:52 GMT
X-Proxy-Origin
144.76.109.30; 144.76.109.30; 536.bm-nginx-loadbalancer.mgmt.fra1; *.adnxs.com; 37.252.173.41:80
AN-X-Request-Uuid
97d27805-c4b4-4bf8-9c29-a36485e2b964
Server
nginx/1.13.4
P3P
policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
258
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
translator
hbopenbid.pubmatic.com/ Frame E8C9
0
116 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC - PubMatic, Inc., US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

status
204
date
Mon, 21 Oct 2019 15:25:50 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
access-control-allow-origin
https://www.reuters.com
v1
prg.smartadserver.com/prebid/ Frame E8C9
0
1 KB
XHR
General
Full URL
https://prg.smartadserver.com/prebid/v1
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
185.86.138.78 , France, ASN201081 (SMARTADSERVER, FR),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:49 GMT
X-SMRT-D
4%3b11%3b89
P3P
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache, no-store
Access-Control-Allow-Credentials
true
Content-Type
application/json
Content-Length
0
Expires
-1
/
hb.emxdgt.com/ Frame E8C9
0
307 B
XHR
General
Full URL
https://hb.emxdgt.com/?t=2000&ts=1571671550588&src=pbjs
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
18.196.104.43 Frankfurt am Main, Germany, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-196-104-43.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

Date
Mon, 21 Oct 2019 15:25:50 GMT
Content-Type
text/html
Access-Control-Allow-Origin
https://www.reuters.com
Cache-Control
no-cache
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Access-Control-Allow-Headers
security, Content-Type
Content-Length
0
arj
carambola-d.openx.net/w/1.0/ Frame E8C9
173 B
361 B
XHR
General
Full URL
https://carambola-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.reuters.com%2F&jr=&ch=UTF-8&res=1600x1200x24&ifr=true&tz=-120&tws=1600x1200&be=1&bc=hb_pb_2.1.7&dddid=96652c90-99ef-483a-b016-5108962704ed&nocache=1571671550589&x_gdpr_f=1&aus=300x250&divIds=cbola_code_822-1&auid=539874563&
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.95.120.147 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
147.120.95.34.bc.googleusercontent.com
Software
OXGW/16.163.0 /
Resource Hash
25df2933731c68dbfd2fd71c405611e883d83b3df56ac631ab9f37f185f89f5e

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:50 GMT
via
1.1 google
server
OXGW/16.163.0
status
200
vary
Accept
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.reuters.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
173
expires
Mon, 26 Jul 1997 05:00:00 GMT
ADTECH;apid=1A105e1166-f417-11e9-9ab7-1222202f268e;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=203c0db755d142e;misc=1571671550590;bidfloor=0.05
adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ Frame E8C9
Redirect Chain
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;v=2;cmd=bid;cors=yes;alias=203c0db755d142e;misc=1571671550590;bidfloor=0.05;
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;cfp=1;rndc=1571671549;v=2;cmd=bid;cors=yes;alias=203c0db755d142e;misc=1571671550590;bidfloor=0.05
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;apid=1A105e1166-f417-11e9-9ab7-1222202f268e;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=203c0db755d142e;misc=15...
48 B
104 B
XHR
General
Full URL
https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;apid=1A105e1166-f417-11e9-9ab7-1222202f268e;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=203c0db755d142e;misc=1571671550590;bidfloor=0.05
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.199.21.89 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
Adtech Adserver /
Resource Hash
1b2cc9a46c9418e60d2cda9b254d440cf3f2e6a739af8c926a8927bbf2130513

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:51 GMT
server
Adtech Adserver
status
200
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json
access-control-allow-origin
https://www.reuters.com
cache-control
no-store, no-cache
access-control-allow-credentials
true
content-length
48
expires
Mon, 15 Jun 1998 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:50 GMT
server
nginx
status
302
location
https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/4788545/0/1/ADTECH;apid=1A105e1166-f417-11e9-9ab7-1222202f268e;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=203c0db755d142e;misc=1571671550590;bidfloor=0.05
access-control-allow-methods
POST,GET,HEAD,OPTIONS
p3p
CP="NOI DSP DEVa OUR BUS UNI COM NAV INT"
access-control-allow-origin
https://www.reuters.com
cache-control
no-store, no-cache
access-control-allow-credentials
true
content-length
0
expires
Mon, 15 Jun 1998 00:00:00 GMT
ADTECH;apid=1A105e1904-f417-11e9-9a7d-12e614795296;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=21d520127a7074e;misc=1571671550590;bidfloor=0.05
adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ Frame E8C9
Redirect Chain
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;v=2;cmd=bid;cors=yes;alias=21d520127a7074e;misc=1571671550590;bidfloor=0.05;
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=21d520127a7074e;misc=1571671550590;bidfloor=0.05
  • https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;apid=1A105e1904-f417-11e9-9a7d-12e614795296;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=21d520127a7074e;misc=15...
47 B
104 B
XHR
General
Full URL
https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;apid=1A105e1904-f417-11e9-9a7d-12e614795296;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=21d520127a7074e;misc=1571671550590;bidfloor=0.05
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
152.199.21.89 , United States, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
Adtech Adserver /
Resource Hash
22c9d9811cebc28d8b01701d856bf81af0295a22073caa914bab36d1b5562d5c

Request headers

Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:50 GMT
server
Adtech Adserver
status
200
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json
access-control-allow-origin
https://www.reuters.com
cache-control
no-store, no-cache
access-control-allow-credentials
true
content-length
47
expires
Mon, 15 Jun 1998 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Mon, 21 Oct 2019 15:25:50 GMT
server
nginx
status
302
location
https://adserver-us.adtech.advertising.com/pubapi/3.0/10334.1/5126271/0/1/ADTECH;apid=1A105e1904-f417-11e9-9a7d-12e614795296;cfp=1;rndc=1571671550;v=2;cmd=bid;cors=yes;alias=21d520127a7074e;misc=1571671550590;bidfloor=0.05
access-control-allow-methods
POST,GET,HEAD,OPTIONS
p3p
CP="NOI DSP DEVa OUR BUS UNI COM NAV INT"
access-control-allow-origin
https://www.reuters.com
cache-control
no-store, no-cache
access-control-allow-credentials
true
content-length
0
expires
Mon, 15 Jun 1998 00:00:00 GMT
bid
ap.lijit.com/rtb/ Frame E8C9
24 B
555 B
XHR
General
Full URL
https://ap.lijit.com/rtb/bid?src=prebid_prebid_2.23.0
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
72.251.249.14 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET - Internap Corporation, US),
Reverse DNS
Software
nginx /
Resource Hash
b6b60d8b5b627edd395262ba7450ccca219eb9850151a88b57ed815682d26de5

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

Date
Mon, 21 Oct 2019 15:25:50 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Vary
Accept-Encoding
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/json
Access-Control-Allow-Origin
https://www.reuters.com
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ap1ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
mvo
tag.1rx.io/rmp/75109/0/ Frame E8C9
0
270 B
XHR
General
Full URL
https://tag.1rx.io/rmp/75109/0/mvo?z=1r&hbv=2.23,2
Requested by
Host: www.reuters.com
URL: https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
8.41.222.100 , United States, ASN26120 (RHYTHMONE - RhythmOne, LLC, US),
Reverse DNS
Software
nginx /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.reuters.com
Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:51 GMT
Cache-Control
private, max-age=0, no-cache, no-store
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
/
onetag-geo.s-onetag.com/
23 B
433 B
XHR
General
Full URL
https://onetag-geo.s-onetag.com/
Requested by
Host: beacon.s-onetag.com
URL: https://beacon.s-onetag.com/beacon.min.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2156:6c00:5:ae3a:ba00:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
ad16e1b37490fca28df99d039d6373d2fee4d894fcd279d95b90ae872f4d860f

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Mon, 21 Oct 2019 15:07:51 GMT
via
1.1 cc0ab20766d57035422a2c4c69fe0620.cloudfront.net (CloudFront), 1.1 9eb0e845437929074828e0cf53f179af.cloudfront.net (CloudFront)
age
1078
x-amzn-requestid
e51c7628-6589-4132-b4fa-b63412624910
status
200
x-cache
Hit from cloudfront
content-type
application/json
access-control-allow-origin
*
cache-control
max-age=3600
x-amz-cf-pop
FRA2-C2, FRA50-C1
x-amz-apigw-id
B6x3IFVOSK4Fjhw=
content-length
23
x-amz-cf-id
M7YQadAsMNQCeSj2lC-qrbYoO5ifywCkYbI9Q5G0vx9IxiZ6jivzWw==
pixel.gif
px.moatads.com/
43 B
409 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=11&i=REUTERSDFPCW3&hp=1&wf=1&vb=6&cm=6&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&k=&bq=0&f=0&j=&t=1571671541590&de=659252311504&m=0&ar=6907c9d928-clean&iw=6919a0a&q=19&cb=0&ym=0&cu=1571671541590&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4789302609%3A2599246982%3A5189420777%3A138289622787&zMoatTP=mpu&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=37592232&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=37592232&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=37592232&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&id=1&zMoatBlacklist=true&bo=3735912&bd=37592232&dfp=0%2C1&la=37592232&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=173050&na=853560533&cs=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:51 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:51 GMT
pixel.gif
px.moatads.com/
43 B
409 B
Image
General
Full URL
https://px.moatads.com/pixel.gif?e=11&i=REUTERSDFPCW3&hp=1&wf=1&vb=6&cm=3&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&k=&bq=0&f=0&j=&t=1571671541652&de=17994133587&m=0&ar=6907c9d928-clean&iw=6919a0a&q=20&cb=0&ym=0&cu=1571671541652&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=54423312%3A2107429564%3A4741317042%3A138206523841&zMoatTP=canvas&zMoatStory=0&zMoatAU=%2F4735792%2Fus.reuters%2Flife%2Fhealth%2Farticle&zMoatPixelDistance=400&zMoatRawSlicer1=3735912&zMoatRawSlicer2=37592232&zMoatReutersSlicer1=3735912&zMoatReutersSlicer2=37592232&zMoatOrigSlicer1=3735912&zMoatOrigSlicer2=37592232&zGSRS=1&zGSRC=1&gu=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-alexion-pharms-fda%2Ffda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B&id=1&zMoatBlacklist=true&bo=3735912&bd=37592232&dfp=0%2C1&la=37592232&gw=reutersdfpcw319687550988&fd=1&ac=1&it=500&ti=0&ih=1&fs=173050&na=1482675503&cs=0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
2.18.235.40 , Ascension Island, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a2-18-235-40.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.reuters.com/article/us-alexion-pharms-fda/fda-approves-alexions-ultomiris-for-another-rare-blood-disease-idUSKBN1WY00B
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Mon, 21 Oct 2019 15:25:51 GMT
Last-Modified
Fri, 20 May 2016 15:16:00 GMT
Server
Apache
ETag
"ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
Content-Type
image/gif
Cache-Control
max-age=0, no-cache, no-store
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
43
Expires
Mon, 21 Oct 2019 15:25:51 GMT

Verdicts & Comments Add Verdict or Comment

233 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onformdata object| onpointerrawupdate object| analytics object| dataLayer object| google_tag_manager function| postscribe string| GoogleAnalyticsObject function| ga object| google_tag_data object| gaplugins object| gaGlobal object| gaData object| Reuters object| parallelMediaHosts object| tag object| firstScriptTag object| player function| onYouTubeIframeAPIReady function| onPlayerPlaybackQualityChange function| onPlayerReady function| onPlayerStateChange object| player2 function| onYouTubeIframeAPIReady2 function| onPlayerReady2 function| onPlayerPlaybackQualityChange2 function| onPlayerStateChange2 object| player3 function| onYouTubeIframeAPIReady3 function| onPlayerReady3 function| onPlayerPlaybackQualityChange3 function| onPlayerStateChange3 object| player4 function| onYouTubeIframeAPIReady4 function| onPlayerReady4 function| onPlayerPlaybackQualityChange4 function| onPlayerStateChange4 object| player5 function| onYouTubeIframeAPIReady5 function| onPlayerReady5 function| onPlayerPlaybackQualityChange5 function| onPlayerStateChange5 object| player7 function| onYouTubeIframeAPIReady7 function| onPlayerReady7 function| onPlayerPlaybackQualityChange7 function| onPlayerStateChange7 undefined| script object| _sf_async_config number| _sf_startpt object| _cb_shared object| __core-js_shared__ object| RTVEmbedder object| RCOM_Data object| google_optimize function| webpackJsonp object| _cbm object| YT object| YTConfig function| onYTReady object| core object| scrollMonitor object| gptadslots object| googletag function| admantx_callback object| evidon function| __cmp function| renderComponent function| LUPRVdd object| rysff4e6Flags string| rysff3afRnd function| LUPRVTrkFailed object| rysffd2aetc function| commonPopup boolean| rysff63fsdl boolean| rysff63fsdln string| rysffd2aegenat string| rysffd2aesthash boolean| rysffc6fforceimp function| hj object| _hjSettings object| article_date object| author string| content_channel object| keywords object| tp boolean| rysffff1Body object| yt function| ytDomDomGetNextId object| ytEventsEventsListeners object| ytEventsEventsCounter function| _fbq function| fbq function| normalize string| dianomiContextHost function| dianomiLoadContext function| dianomiContextSetHeight function| dianomiContextSetWidth function| dianomiContextSetFloat function| dianomiContextElement function| dianomiReloadContext function| dianomiContextReady object| hjSiteSettings function| hjBootstrap object| hjBootstrapCalled string| segment_user_id object| lazyLoadOptions function| _extends function| LazyLoad function| ___tp object| localCookieStorage object| sessionCookieStorage object| jQuery112408513619602167759 string| __tpVersion string| NativeAIObject function| nativeAI object| TRUE_ANTHEM function| e number| abp object| _comscore function| getValuesGWIQ function| udm_ object| ns_p object| COMSCORE object| $jscomp function| MIIScriptCtrl object| fortyone object| gwiq string| article_platform string| article_edition object| advBidxc function| _mR function| _mD object| _mnHM object| __iasPET function| iasDataHandler string| TB4M82W string| T645KQG object| diagPixSentCodes object| nativeAIWebpackJsonp function| ns360 object| News360 object| NativeAI object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken number| google_srt undefined| google_measure_js_timing boolean| google_noFetch number| __google_ad_urls_id function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter function| googleCompanionsServicePresent function| googleGetCompanionAdSlots function| googleSetCompanionAdContents function| google_show_companion_ad function| google_show_companion_ad_in_slot function| google_get_companion_slot_params function| google_companion_error function| google_companion_loaded function| google_increment_num_ad_mouseovers string| google_ad_output string| google_flash_version boolean| google_webgl_support string| google_ad_section string| google_country string| TF6129H number| google_unique_id object| google_reactive_ads_global_state number| _sf_endpt object| adobeDil object| adobe function| Visitor function| DIL object| s_c_il number| s_c_in string| topic_channel string| channel string| content_type string| adblock string| edition string| platform string| keyword_slug string| content_title string| inline_type string| dcontent_channel string| channel_list object| admp_vars function| getCookie object| pSUPERFLY_mab object| _cbq object| pSUPERFLY object| pSUPERFLY_video object| _cbv_strategies object| _cbv string| state object| __onetag object| __connect boolean| rysfffa3Detect object| rysfffa9Mobile object| rysffd2ae1 object| rysffd2aeo1 object| rysffd2aeo2 object| rysffd2aeo3 object| rysffd2ae2 number| rysffd2aed3 object| rysffd2ae4 object| rysffd2ae5 boolean| rysff520ij object| __google_ad_urls object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| Moat#G26 boolean| Moat#EVA object| MoatSuperV26 object| DOMlessLLDcallback_51917965 object| MoatDataJsonpRequest_51917965 object| teadsscript object| Cbola number| cbola_abTestId string| cbola_pageViewId object| teads object| __IntegralASExec object| a boolean| rysff593Track object| _33Across

8 Cookies

Domain/Path Name / Value
www.reuters.com/ Name: _chartbeat2
Value: .1571671541130.1571671541130.1.DAShHbk-WELnA4YTDFdi25hpR9I.1
www.reuters.com/ Name: _cb_ls
Value: 1
www.reuters.com/ Name: _cb_svref
Value: null
.reuters.com/ Name: ajs_anonymous_id
Value: %22c498a568-88d4-460f-8b7a-3e0ecaebbb41%22
.reuters.com/ Name: _gat
Value: 1
www.reuters.com/ Name: _cb
Value: CW69NUD-8zUxCeeoq-
.reuters.com/ Name: ajs_user_id
Value: %22c498a568-88d4-460f-8b7a-3e0ecaebbb41%22
.reuters.com/ Name: AMCV_4579BF7A580A3C6A0A495DAF%40AdobeOrg
Value: 1585540135%7CMCIDTS%7C18191%7CvVersion%7C4.4.0

20 Console Messages

Source Level URL
Text
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
BODY ITEMS [object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/finance/markets?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/news/world?count=7
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
//wireapi.reuters.com/v7/feed/rcom/us/top-nav/politics?count=7
console-api log (Line 1)
Message:
Blocking Ads: No
console-api log (Line 1)
Message:
comscore new global fired
console-api warning URL: https://connect.facebook.net/en_US/fbevents.js(Line 24)
Message:
[Facebook Pixel] - Unable to parse JSON-LD tag. Malformed JSON found: ' { "@context": "http://schema.org", "@type": "NewsArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.reuters.com/article/us-alexion-pharms-fda-idUSKBN1WY00B" }, "headline": "FDA approves Alexion&#039;s Ultomiris for another rare blood disease", "url": "https://www.reuters.com/article/us-alexion-pharms-fda-idUSKBN1WY00B", "image": { "@type": "ImageObject", "url": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "width": "800", "height": "800" }, "thumbnailUrl": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "dateCreated": "2019-10-19T00:31:35+0000", "dateModified": "2019-10-19T00:31:35+0000", "datePublished": "2019-10-19T00:31:35+0000", "author": { "@type": "Person", "name": "Reuters Editorial" }, "publisher": { "@type": "Organization", "name": "Reuters", "logo": { "@type": "ImageObject", "url": "https://s3.reutersmedia.net/resources_v2/images/reuters_social_logo.png", "width": "200", "height": "200" } }, "description": 'The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc&#039;s treatment for a second rare blood disorder, the company said.', "articleSection": "Homepage", "creator": ["Reuters Editorial"], "keywords": ["US","ALEXION","PHARMS","FDA","Company News","Health / Medicine","Pharmaceuticals (TRBC)","Biotechnology and Medical Research (TRBC)","Europe","Pharmaceuticals and Medical Research (TRBC)","Science","Medical Regulatory Issues","Drug and Device Development","Healthcare (TRBC)","United Kingdom","United States", "Article", "Health"], "about":"Article" } '.
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
Require Evidon Consent: true consent: false undefined
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
Setup media.net with GDPR applied, user not consent
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT SET NON PERSONAL
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT ENABLE SERVICES
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log URL: https://static.reuters.com/resources_v2/react/release/gdpr-updates-cd46412e/common.bundle.js(Line 1)
Message:
GPT DISPLAY!
console-api log (Line 2)
Message:
segment identify user with traits: [object Object]
console-api debug URL: https://static.adsafeprotected.com/sca.17.4.95.js(Line 32)
Message:
a: 0.002197265625ms

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

33across-d.openx.net
a.teads.tv
ad.doubleclick.net
ade.googlesyndication.com
adserver-us.adtech.advertising.com
adservice.google.com
adservice.google.de
altfarm.mediaplex.com
analytics.carambo.la
ap.lijit.com
api.segment.io
async01.admantx.com
beacon.s-onetag.com
beacon.tru.am
c.evidon.com
carambola-d.openx.net
cdata.carambo.la
cdn-sic.33across.com
cdn.adsafeprotected.com
cdn.doubleverify.com
cdn.native.ai
cdn.segment.com
cdn.tinypass.com
cdn.tynt.com
cdn3.doubleverify.com
cdneast2-xch.media.net
cdnjs.cloudflare.com
cmp.teads.mgr.consensu.org
connect.facebook.net
contextual.media.net
de.tynt.com
dfp-gateway.s-onetag.com
dpm.demdex.net
dt.adsafeprotected.com
eu-u.openx.net
evidon.mgr.consensu.org
experience.tinypass.com
fonts.googleapis.com
fonts.gstatic.com
gcdn.2mdn.net
geo.moatads.com
get.s-onetag.com
googleads4.g.doubleclick.net
gwiqcdn.globalwebindex.net
hb.emxdgt.com
hbopenbid.pubmatic.com
iabmap.evidon.com
ib.adnxs.com
ic.tynt.com
img.mediaplex.com
inimage.carambo.la
l.betrad.com
logging.carambo.la
mab.chartbeat.com
mailview.bulletinhealthcare.com
media.carambo.la
onetag-geo.s-onetag.com
p.brid.tv
pagead2.googlesyndication.com
ping.chartbeat.net
pixel.adsafeprotected.com
pixel.watch
prg.smartadserver.com
px.moatads.com
queso-cdn.prod.reuters.tv
r4---sn-4g5e6nz7.c.2mdn.net
reuters.demdex.net
reutersdfpcw319687550988.s.moatpixel.com
route.carambo.la
s.mnet-ad.net
s.ytimg.com
s1.reutersmedia.net
s2.reutersmedia.net
s3.amazonaws.com
sb.scorecardresearch.com
sc.tynt.com
script.hotjar.com
secure.img-cdn.mediaplex.com
securepubads.g.doubleclick.net
services.brid.tv
sic.33across.com
sope.prod.reuters.tv
ssc.33across.com
static.adsafeprotected.com
static.chartbeat.com
static.hotjar.com
static.reuters.com
static.reutersmedia.net
stats-dev.brid.tv
stats.g.doubleclick.net
sync.teads.tv
t.teads.tv
tag.1rx.io
tagan.adlightning.com
tpc.googlesyndication.com
tps20228.doubleverify.com
tps40.doubleverify.com
tru.am
utoumine.net
vars.hotjar.com
vendorlist.consensu.org
wireapi.reuters.com
www.dianomi.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.reuters.com
www.youtube.com
xtr.carambo.la
z.moatads.com
104.16.39.14
104.16.87.26
104.18.135.13
104.244.36.20
13.224.196.15
13.224.196.71
13.225.78.2
13.225.78.60
13.225.78.7
136.243.25.80
143.204.101.12
143.204.101.26
143.204.101.67
143.204.101.92
143.204.101.94
143.204.99.83
147.75.85.119
147.75.85.99
152.195.39.46
152.199.21.89
172.217.16.194
172.217.18.98
18.196.104.43
18.210.116.191
185.64.189.112
185.86.138.78
199.166.0.26
199.166.0.32
2.18.232.109
2.18.232.7
2.18.235.40
2.18.235.93
2.21.37.179
208.100.17.173
208.100.17.181
208.100.17.190
213.254.244.11
213.254.244.22
216.58.205.230
23.0.46.190
23.37.49.134
23.43.115.95
23.62.140.165
2600:1f18:624f:b000:4319:b1c8:f4e4:70ed
2600:9000:200c:8800:18:1fcd:349:ca21
2600:9000:20eb:3200:1:af78:4c0:93a1
2600:9000:20eb:a800:5:9a4c:9b00:93a1
2600:9000:2156:6c00:5:ae3a:ba00:93a1
2600:9000:2156:8400:1f:287:d20a:ce1
2600:9000:2156:9e00:a:52eb:a100:93a1
2600:9000:2156:f600:10:27b4:f500:93a1
2600:9000:21f3:a600:1e:ef1b:aa40:93a1
2606:4700:20::6819:a322
2606:4700::6810:4c33
2606:4700::6813:c497
2a00:1450:4001:65::9
2a00:1450:4001:800::2002
2a00:1450:4001:809::200e
2a00:1450:4001:814::2001
2a00:1450:4001:814::2008
2a00:1450:4001:815::2002
2a00:1450:4001:815::200e
2a00:1450:4001:816::2003
2a00:1450:4001:81a::2003
2a00:1450:4001:81d::2004
2a00:1450:4001:81f::200a
2a00:1450:4001:81f::200e
2a00:1450:4001:824::2002
2a00:1450:4001:825::200e
2a00:1450:400c:c00::9c
2a02:26f0:6c00:292::2c92
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8183:face:b00c:0:25de
2a04:4e42:3::714
3.224.94.188
3.9.224.64
3.9.56.242
34.232.243.86
34.239.9.60
34.95.120.147
35.174.78.7
35.201.93.216
37.252.173.22
50.19.213.168
52.208.212.211
52.216.205.29
52.50.81.152
54.164.3.90
54.172.119.91
54.217.204.244
54.68.89.141
63.215.202.157
65.220.57.119
66.81.204.228
72.251.249.14
8.41.222.100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